The Coca-Cola Company (KO) 10-K25 Feb 152014 FY Annual reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information Document (USD $)	12 Months Ended
Document and Entity Information Document (USD $)	Dec. 31, 2014	Feb. 23, 2015	Jun. 27, 2014
Entity Information [Line Items]
Entity Registrant Name	COCA COLA CO
Entity Central Index Key	21344
Current Fiscal Year End Date	-19
Entity Filer Category	Large Accelerated Filer
Document Type	10-K
Document Period End Date	31-Dec-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Amendment Flag	FALSE
Entity Common Stock, Shares Outstanding		4,366,243,616
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$183,965,638,496

CONSOLIDATED_STATEMENTS_OF_INC

CONSOLIDATED STATEMENTS OF INCOME (USD $)	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
NET OPERATING REVENUES	$45,998		$46,854		$48,017
Cost of goods sold	17,889		18,421		19,053
GROSS PROFIT	28,109		28,433		28,964
Selling, general and administrative expenses	17,218		17,310		17,738
Other operating charges	1,183		895		447
OPERATING INCOME	9,708		10,228		10,779
Interest income	594		534		471
Interest expense	483		463		397
Equity income (loss) - net	769		602		819
Other income (loss) - net	-1,263		576		137
INCOME BEFORE INCOME TAXES	9,325		11,477		11,809
Income taxes	2,201		2,851		2,723
CONSOLIDATED NET INCOME	7,124		8,626		9,086
Less: Net income attributable to noncontrolling interests	26		42		67
NET INCOME ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY	$7,098		$8,584		$9,019
BASIC NET INCOME PER SHARE (in dollars per share)	$1.62	[1]	$1.94	[1]	$2	[1]
DILUTED NET INCOME PER SHARE (in dollars per share)	$1.60	[1]	$1.90	[1]	$1.97	[1]
AVERAGE SHARES OUTSTANDING (in shares)	4,387		4,434		4,504
Effect of dilutive securities (in shares)	63		75		80
AVERAGE SHARES OUTSTANDING ASSUMING DILUTION (in shares)	4,450		4,509		4,584

[1]	Calculated based on net income attributable to shareowners of The Coca-Cola Company.

CONSOLIDATED_STATEMENTS_OF_COM

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
CONSOLIDATED NET INCOME	$7,124	$8,626	$9,086
Other comprehensive income
Net foreign currency translation adjustment	-2,382	-1,187	-182
Net gain (loss) on derivatives	357	151	99
Net urealized gain (loss) on available-for-sale securities	714	-80	178
Net change in pension and other benefit liabilities	-1,039	1,066	-668
TOTAL COMPREHENSIVE INCOME	4,774	8,576	8,513
Less: Comprehensive income (loss) attributable to noncontrolling interests	21	39	105
TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY	$4,753	$8,537	$8,408

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
CURRENT ASSETS
Cash and cash equivalents	$8,958	$10,414
Short-term investments	9,052	6,707
TOTAL CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS	18,010	17,121
Marketable securities	3,665	3,147
Trade accounts receivable, less allowances of $331 and $61, respectively	4,466	4,873
Inventories	3,100	3,277
Prepaid expenses and other assets	3,066	2,886
Assets held for sale	679	0
TOTAL CURRENT ASSETS	32,986	31,304
EQUITY METHOD INVESTMENTS	9,947	10,393
OTHER INVESTMENTS	3,678	1,119
OTHER ASSETS	4,407	4,661
PROPERTY, PLANT AND EQUIPMENT - net	14,633	14,967
TRADEMARKS WITH INDEFINITE LIVES	6,533	6,744
BOTTLERS' FRANCHISE RIGHTS WITH INDEFINITE LIVES	6,689	7,415
GOODWILL	12,100	12,312
OTHER INTANGIBLE ASSETS	1,050	1,140
TOTAL ASSETS	92,023	90,055
CURRENT LIABILITIES
Accounts payable and accrued expenses	9,234	9,577
Loans and notes payable	19,130	16,901
Current maturities of long-term debt	3,552	1,024
Accrued income taxes	400	309
Liabilities held for sale	58	0
TOTAL CURRENT LIABILITIES	32,374	27,811
LONG-TERM DEBT	19,063	19,154
OTHER LIABILITIES	4,389	3,498
DEFERRED INCOME TAXES	5,636	6,152
THE COCA-COLA COMPANY SHAREOWNERS' EQUITY
Common stock, $0.25 par value; Authorized â€” 11,200 shares; Issued â€” 7,040 and 7,040 shares, respectively	1,760	1,760
Capital surplus	13,154	12,276
Reinvested earnings	63,408	61,660
Accumulated other comprehensive income (loss)	-5,777	-3,432
Treasury stock, at cost â€” 2,674 and 2,638 shares, respectively	-42,225	-39,091
EQUITY ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY	30,320	33,173
EQUITY ATTRIBUTABLE TO NONCONTROLLING INTERESTS	241	267
TOTAL EQUITY	30,561	33,440
TOTAL LIABILITIES AND EQUITY	$92,023	$90,055

CONSOLIDATED_BALANCE_SHEET_Par

CONSOLIDATED BALANCE SHEET (Parentheticals) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Allowance for doubtful accounts	$331	$61
Common stock, par value (in dollars per share)	$0.25	$0.25
Common Stock, Shares Authorized	11,200	11,200
Common stock, shares issued	7,040	7,040
Treasury stock, shares	2,674	2,638

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
OPERATING ACTIVITIES
CONSOLIDATED NET INCOME	$7,124	$8,626	$9,086
Depreciation and amortization	1,976	1,977	1,982
Stock-based compensation expense	209	227	259
Deferred income taxes	-40	648	632
Equity (income) loss - net of dividends	-371	-201	-426
Foreign currency adjustments	415	168	-130
Significant (gains) losses on sales of assets - net	831	-670	-98
Other operating charges	761	465	166
Other items	149	234	254
Net change in operating assets and liabilities	-439	-932	-1,080
Net cash provided by operating activities	10,615	10,542	10,645
INVESTING ACTIVITIES
Purchases of investments	-17,800	-14,782	-14,824
Proceeds from disposals of investments	12,986	12,791	7,791
Acquisitions of businesses, equity method investments and nonmarketable securities	-389	-353	-1,486
Proceeds from disposals of businesses, equity method investments and nonmarkatable securities	148	872	20
Purchases of property, plant and equipment	-2,406	-2,550	-2,780
Proceeds from disposals of property, plant and equipment	223	111	143
Other investing activities	-268	-303	-268
Net cash provided by (used in) investing activities	-7,506	-4,214	-11,404
FINANCING ACTIVITIES
Issuances of debt	41,674	43,425	42,791
Payments of debt	-36,962	-38,714	-38,573
Issuances of stock	1,532	1,328	1,489
Purchases of stock for treasury	-4,162	-4,832	-4,559
Dividends	-5,350	-4,969	-4,595
Other financing activities	-363	17	100
Net cash provided by (used in) financing activities	-3,631	-3,745	-3,347
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	-934	-611	-255
CASH AND CASH EQUIVALENTS
Net increase (decrease) during the year	-1,456	1,972	-4,361
Balance at beginning of year	10,414	8,442	12,803
Balance at end of year	$8,958	$10,414	$8,442

CONSOLIDATED_STATEMENTS_OF_SHA

CONSOLIDATED STATEMENTS OF SHAREOWNERS' EQUITY (USD $)	Total	TOTAL EQUITY ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY	COMMON STOCK	CAPITAL SURPLUS	REINVESTED EARNINGS	ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)	TREASURY STOCK	EQUITY ATTRIBUTABLE TO NONCONTROLLING INTERESTS
In Millions, unless otherwise specified	Total		COMMON STOCK	CAPITAL SURPLUS	REINVESTED EARNINGS	ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)	TREASURY STOCK	EQUITY ATTRIBUTABLE TO NONCONTROLLING INTERESTS
Balance at beginning of year at Dec. 31, 2011				$10,332	$53,621	($2,774)	($31,304)	$286
Balance at beginning of year (in shares) at Dec. 31, 2011			4,526
Common Stock			1,760
Increase (Decrease) in Stockholders' Equity
Purchases of treasury stock (in shares)			-121
Treasury stock issued to employees related to stock compensation plans (in shares)			64
Stock issued to employees related to stock compensation plans				640			786
Tax benefit (charge) from stock compensation plans				144
Stock-based compensation				259
Other activities				4
Net income attributable to shareowners of The Coca-Cola Company	9,019				9,019
Dividends (per share â€” $1.22, $1.12 and $1.02 in 2014, 2013 and 2012, respectively)					-4,595
Net other comprehensive income (loss)		-611				-611
Purchases of treasury stock							-4,491
TOTAL EQUITY ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY		32,790
Net income attributable to noncontrolling interests	67							67
Net foreign currency translation adjustment								38
Dividends paid to noncontrolling interests								-48
Acquisition of interests held by noncontrolling owners								-15
Contributions by noncontrolling interests								0
Business combinations								50
Deconsolidation of certain entities								0
Balance at end of year at Dec. 31, 2012				11,379	58,045	-3,385	-35,009	378
Balance at end of year (in shares) at Dec. 31, 2012			4,469
Common Stock	1,760		1,760
Increase (Decrease) in Stockholders' Equity
Purchases of treasury stock (in shares)			-121
Treasury stock issued to employees related to stock compensation plans (in shares)			54
Stock issued to employees related to stock compensation plans				569			745
Tax benefit (charge) from stock compensation plans				144
Stock-based compensation				227
Other activities				-43
Net income attributable to shareowners of The Coca-Cola Company	8,584				8,584
Dividends (per share â€” $1.22, $1.12 and $1.02 in 2014, 2013 and 2012, respectively)					-4,969
Net other comprehensive income (loss)		-47				-47
Purchases of treasury stock							-4,827
TOTAL EQUITY ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY	33,173	33,173
Net income attributable to noncontrolling interests	42							42
Net foreign currency translation adjustment								-3
Dividends paid to noncontrolling interests								-58
Acquisition of interests held by noncontrolling owners								-34
Contributions by noncontrolling interests								6
Business combinations								25
Deconsolidation of certain entities								-89
Balance at end of year at Dec. 31, 2013	33,440			12,276	61,660	-3,432	-39,091	267
Balance at end of year (in shares) at Dec. 31, 2013			4,402
Common Stock	1,760		1,760
Increase (Decrease) in Stockholders' Equity
Purchases of treasury stock (in shares)			-98
Treasury stock issued to employees related to stock compensation plans (in shares)			62
Stock issued to employees related to stock compensation plans				526			891
Tax benefit (charge) from stock compensation plans				169
Stock-based compensation				209
Other activities				-26
Net income attributable to shareowners of The Coca-Cola Company	7,098				7,098
Dividends (per share â€” $1.22, $1.12 and $1.02 in 2014, 2013 and 2012, respectively)					-5,350
Net other comprehensive income (loss)		-2,345				-2,345
Purchases of treasury stock							-4,025
TOTAL EQUITY ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY	30,320	30,320
Net income attributable to noncontrolling interests	26							26
Net foreign currency translation adjustment								-5
Dividends paid to noncontrolling interests								-25
Acquisition of interests held by noncontrolling owners								0
Contributions by noncontrolling interests								0
Business combinations								-22
Deconsolidation of certain entities								0
Balance at end of year at Dec. 31, 2014	$30,561			$13,154	$63,408	($5,777)	($42,225)	$241
Balance at end of year (in shares) at Dec. 31, 2014			4,366

CONSOLIDATED_STATEMENTS_OF_SHA1

CONSOLIDATED STATEMENTS OF SHAREOWNERS' EQUITY (Parentheticals) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Dividends per share	$1.22	$1.12	$1.02

BUSINESS_AND_SUMMARY_OF_SIGNIF

BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Dec. 31, 2014

Summary of Significant Accounting Policies [Abstract]

BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Description of Business

The Coca-Cola Company is the world's largest beverage company. We own or license and market more than 500 nonalcoholic beverage brands, primarily sparkling beverages but also a variety of still beverages such as waters, enhanced waters, juices and juice drinks, ready-to-drink teas and coffees, and energy and sports drinks. We own and market four of the world's top five nonalcoholic sparkling beverage brands: Coca-Cola, Diet Coke, Fanta and Sprite. Finished beverage products bearing our trademarks, sold in the United States since 1886, are now sold in more than 200 countries.

We make our branded beverage products available to consumers throughout the world through our network of Company-owned or -controlled bottling and distribution operations, bottling partners, distributors, wholesalers and retailers — the world's largest beverage distribution system. Beverages bearing trademarks owned by or licensed to us account for 1.9 billion of the approximately 57 billion servings of all beverages consumed worldwide every day.

Our Company markets, manufactures and sells:

•

beverage concentrates, sometimes referred to as "beverage bases," and syrups, including fountain syrups (we refer to this part of our business as our "concentrate business" or "concentrate operations"); and

•

finished sparkling and still beverages (we refer to this part of our business as our "finished product business" or "finished product operations").

Generally, finished product operations generate higher net operating revenues but lower gross profit margins than concentrate operations.

In our concentrate operations, we typically generate net operating revenues by selling concentrates and syrups to authorized bottling and canning operations (to which we typically refer as our "bottlers" or our "bottling partners"). Our bottling partners either combine the concentrates with sweeteners (depending on the product), still water and/or sparkling water, or combine the syrups with sparkling water to produce finished beverages. The finished beverages are packaged in authorized containers — such as cans and refillable and nonrefillable glass and plastic bottles — bearing our trademarks or trademarks licensed to us and are then sold to retailers directly or, in some cases, through wholesalers or other bottlers. Outside the United States, we also sell concentrates for fountain beverages to our bottling partners who are typically authorized to manufacture fountain syrups, which they sell to fountain retailers such as restaurants and convenience stores which use the fountain syrups to produce beverages for immediate consumption, or to authorized fountain wholesalers who in turn sell and distribute the fountain syrups to fountain retailers.

Our finished product operations consist primarily of Company-owned or -controlled bottling, sales and distribution operations, including Coca-Cola Refreshments ("CCR"). Our Company-owned or -controlled bottling, sales and distribution operations, other than CCR, are included in our Bottling Investments operating segment. CCR is included in our North America operating segment. Our finished product operations generate net operating revenues by selling sparkling beverages and a variety of still beverages, such as juices and juice drinks, energy and sports drinks, ready-to-drink teas and coffees, and certain water products, to retailers or to distributors, wholesalers and bottling partners who distribute them to retailers. In addition, in the United States, we manufacture fountain syrups and sell them to fountain retailers, such as restaurants and convenience stores who use the fountain syrups to produce beverages for immediate consumption, or to authorized fountain wholesalers or bottling partners who resell the fountain syrups to fountain retailers. In the United States, we authorize wholesalers to resell our fountain syrups through nonexclusive appointments that neither restrict us in setting the prices at which we sell fountain syrups to the wholesalers nor restrict the territories in which the wholesalers may resell in the United States.

Summary of Significant Accounting Policies

Basis of Presentation

Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States. The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in our consolidated financial statements and accompanying notes. Although these estimates are based on our knowledge of current events and actions we may undertake in the future, actual results may ultimately differ from these estimates and assumptions. Furthermore, when testing assets for impairment in future periods, if management uses different assumptions or if different conditions occur, impairment charges may result.

We use the equity method to account for investments in companies, if our investment provides us with the ability to exercise significant influence over operating and financial policies of the investee. Our consolidated net income includes our Company's proportionate share of the net income or loss of these companies. Our judgment regarding the level of influence over each equity method investment includes considering key factors such as our ownership interest, representation on the board of directors, participation in policy-making decisions and material intercompany transactions.

We eliminate from our financial results all significant intercompany transactions, including the intercompany transactions with consolidated variable interest entities ("VIEs") and the intercompany portion of transactions with equity method investees.

Principles of Consolidation

Our Company consolidates all entities that we control by ownership of a majority voting interest as well as VIEs for which our Company is the primary beneficiary. Generally, we consolidate only business enterprises that we control by ownership of a majority voting interest. However, there are situations in which consolidation is required even though the usual condition of consolidation (ownership of a majority voting interest) does not apply. Generally, this occurs when an entity holds an interest in another business enterprise that was achieved through arrangements that do not involve voting interests, which results in a disproportionate relationship between such entity's voting interests in, and its exposure to the economic risks and potential rewards of, the other business enterprise. This disproportionate relationship results in what is known as a variable interest, and the entity in which we have the variable interest is referred to as a "VIE." An enterprise must consolidate a VIE if it is determined to be the primary beneficiary of the VIE. The primary beneficiary has both (1) the power to direct the activities of the VIE that most significantly impact the entity's economic performance, and (2) the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE.

Our Company holds interests in certain VIEs, primarily bottling and container manufacturing operations, for which we were not determined to be the primary beneficiary. Our variable interests in these VIEs primarily relate to profit guarantees or subordinated financial support. Refer to Note 11. Although these financial arrangements resulted in our holding variable interests in these entities, they did not empower us to direct the activities of the VIEs that most significantly impact the VIEs' economic performance. Our Company's investments, plus any loans and guarantees, related to these VIEs totaled $2,274 million and $2,171 million as of December 31, 2014 and 2013, respectively, representing our maximum exposures to loss. The Company's investments, plus any loans and guarantees, related to these VIEs were not significant to the Company's consolidated financial statements.

In addition, our Company holds interests in certain VIEs, primarily bottling and container manufacturing operations, for which we were determined to be the primary beneficiary. As a result, we have consolidated these entities. Our Company's investments, plus any loans and guarantees, related to these VIEs totaled $266 million and $284 million as of December 31, 2014 and 2013, respectively, representing our maximum exposures to loss. The assets and liabilities of VIEs for which we are the primary beneficiary were not significant to the Company's consolidated financial statements.

Creditors of our VIEs do not have recourse against the general credit of the Company, regardless of whether they are accounted for as consolidated entities.

Assets and Liabilities Held for Sale

Our Company classifies long-lived assets or disposal groups to be sold as held for sale in the period in which all of the following criteria are met: management, having the authority to approve the action, commits to a plan to sell the asset or disposal group; the asset or disposal group is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such assets or disposal groups; an active program to locate a buyer and other actions required to complete the plan to sell the asset or disposal group have been initiated; the sale of the asset or disposal group is probable, and transfer of the asset or disposal group is expected to qualify for recognition as a completed sale within one year, except if events or circumstances beyond our control extend the period of time required to sell the asset or disposal group beyond one year; the asset or disposal group is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.

We initially measure a long-lived asset or disposal group that is classified as held for sale at the lower of its carrying value or fair value less any costs to sell. Any loss resulting from this measurement is recognized in the period in which the held-for-sale criteria are met. Conversely, gains are not recognized on the sale of a long-lived asset or disposal group until the date of sale. We assess the fair value of a long-lived asset or disposal group less any costs to sell each reporting period it remains classified as held for sale and report any subsequent changes as an adjustment to the carrying value of the asset or disposal group, as long as the new carrying value does not exceed the carrying value of the asset at the time it was initially classified as held for sale.

Upon determining that a long-lived asset or disposal group meets the criteria to be classified as held for sale, the Company reports long-lived assets and/or the assets and liabilities of the disposal group, if material, in the line items assets held for sale and liabilities held for sale, respectively, in our consolidated balance sheet. Refer to Note 2.

Revenue Recognition

Our Company recognizes revenue when persuasive evidence of an arrangement exists, delivery of products has occurred, the sales price charged is fixed or determinable, and collectibility is reasonably assured. For our Company, this generally means that we recognize revenue when title to our products is transferred to our bottling partners, resellers or other customers. In particular, title usually transfers upon shipment to or receipt at our customers' locations, as determined by the specific sales terms of the transactions. Our sales terms do not allow for a right of return except for matters related to any manufacturing defects on our part.

Deductions from Revenue

Our customers can earn certain incentives including, but not limited to, cash discounts, funds for promotional and marketing activities, volume-based incentive programs and support for infrastructure programs. The costs associated with these incentives are included in deductions from revenue, a component of net operating revenues in our consolidated statements of income. For customer incentives that must be earned, management must make estimates related to the contractual terms, customer performance and sales volume to determine the total amounts earned and to be recorded in deductions from revenue. In making these estimates, management considers past results. The actual amounts ultimately paid may be different from our estimates.

In some situations, the Company may determine it to be advantageous to make advance payments to specific customers to fund certain marketing activities intended to generate profitable volume and/or invest in infrastructure programs with our bottlers that are directed at strengthening our bottling system and increasing unit case volume. The Company also makes advance payments to certain customers for distribution rights. The advance payments made to customers are initially capitalized and included in our consolidated balance sheets in prepaid expenses and other assets and noncurrent other assets, depending on the duration of the agreements. The assets are amortized over the applicable periods and included in deductions from revenue. The duration of these agreements typically ranges from 4 to 10 years.

Amortization expense for infrastructure programs was $72 million, $69 million and $86 million in 2014, 2013 and 2012, respectively. The aggregate deductions from revenue recorded by the Company in relation to these programs, including amortization expense on infrastructure programs, were $7.0 billion, $6.9 billion and $6.1 billion in 2014, 2013 and 2012, respectively.

Advertising Costs

Our Company expenses production costs of print, radio, television and other advertisements as of the first date the advertisements take place. All other marketing expenditures are expensed in the annual period in which the expenditure is incurred. Advertising costs included in the line item selling, general and administrative expenses in our consolidated statements of income were $3.5 billion, $3.3 billion and $3.3 billion in 2014, 2013 and 2012, respectively. As of December 31, 2014 and 2013, advertising and production costs of $228 million and $363 million, respectively, were primarily recorded in the line item prepaid expenses and other assets in our consolidated balance sheets.

For interim reporting purposes, we allocate our estimated full year marketing expenditures that benefit multiple interim periods to each of our interim reporting periods. We use the proportion of each interim period's actual unit case volume to the estimated full year unit case volume as the basis for the allocation. This methodology results in our marketing expenditures being recognized at a standard rate per unit case. At the end of each interim reporting period, we review our estimated full year unit case volume and our estimated full year marketing expenditures in order to evaluate if a change in estimate is necessary. The impact of any changes in these full year estimates is recognized in the interim period in which the change in estimate occurs. Our full year marketing expenditures are not impacted by this interim accounting policy.

Shipping and Handling Costs

Shipping and handling costs related to the movement of finished goods from manufacturing locations to our sales distribution centers are included in the line item cost of goods sold in our consolidated statements of income. Shipping and handling costs incurred to move finished goods from our sales distribution centers to customer locations are included in the line item selling, general and administrative expenses in our consolidated statements of income. During the years ended December 31, 2014, 2013 and 2012, the Company recorded shipping and handling costs of $2.7 billion, $2.7 billion and $2.8 billion, respectively, in the line item selling, general and administrative expenses. Our customers do not pay us separately for shipping and handling costs related to finished goods.

Net Income Per Share

Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. Diluted net income per share is computed similarly to basic net income per share, except that it includes the potential dilution that could occur if dilutive securities were exercised. Approximately 38 million, 28 million and 34 million stock option awards were excluded from the computations of diluted net income per share in 2014, 2013 and 2012, respectively, because the awards would have been antidilutive for the years presented.

Cash Equivalents

We classify time deposits and other investments that are highly liquid and have maturities of three months or less at the date of purchase as cash equivalents. We manage our exposure to counterparty credit risk through specific minimum credit standards, diversification of counterparties and procedures to monitor our credit risk concentrations.

Short-Term Investments

We classify time deposits and other investments that have maturities of greater than three months but less than one year as short-term investments.

Investments in Equity and Debt Securities

We use the equity method to account for our investments in equity securities if our investment gives us the ability to exercise significant influence over operating and financial policies of the investee. We include our proportionate share of earnings and/or losses of our equity method investees in equity income (loss) — net in our consolidated statements of income. The carrying value of our equity investments is reported in equity method investments in our consolidated balance sheets. Refer to Note 6.

We account for investments in companies that we do not control or account for under the equity method either at fair value or under the cost method, as applicable. Investments in equity securities, other than investments accounted for under the equity method, are carried at fair value if the fair value of the security is readily determinable. Equity investments carried at fair value are classified as either trading or available-for-sale securities with their cost basis determined by the specific identification method. Realized and unrealized gains and losses on trading securities and realized gains and losses on available-for-sale securities are included in other income (loss) — net in our consolidated statements of income. Unrealized gains and losses, net of deferred taxes, on available-for-sale securities are included in our consolidated balance sheets as a component of accumulated other comprehensive income (loss) ("AOCI"), except for the change in fair value attributable to the currency risk being hedged, if applicable, which is included in other income (loss) — net in our consolidated statements of income. Trading securities are reported as either marketable securities or other assets in our consolidated balance sheets. Securities classified as available-for-sale are reported as either marketable securities, other investments or other assets in our consolidated balance sheets, depending on the length of time we intend to hold the investment. Refer to Note 3.

Investments in equity securities that we do not control or account for under the equity method and do not have readily determinable fair values for are accounted for under the cost method. Cost method investments are originally recorded at cost, and we record dividend income when applicable dividends are declared. Cost method investments are reported as other investments in our consolidated balance sheets, and dividend income from cost method investments is reported in the line item other income (loss) — net in our consolidated statements of income.

Our investments in debt securities are carried at either amortized cost or fair value. Investments in debt securities that the Company has the positive intent and ability to hold to maturity are carried at amortized cost and classified as held-to-maturity. Investments in debt securities that are not classified as held-to-maturity are carried at fair value and classified as either trading or available-for-sale.

Each reporting period we review all of our investments in equity and debt securities, except for those classified as trading, to determine whether a significant event or change in circumstances has occurred that may have an adverse effect on the fair value of each investment. When such events or changes occur, we evaluate the fair value compared to our cost basis in the investment. We also perform this evaluation every reporting period for each investment for which our cost basis exceeded the fair value in the prior period. The fair values of most of our investments in publicly traded companies are often readily available based on quoted market prices. For investments in nonpublicly traded companies, management's assessment of fair value is based on valuation methodologies including discounted cash flows, estimates of sales proceeds and appraisals, as appropriate. We consider the assumptions that we believe hypothetical marketplace participants would use in evaluating estimated future cash flows when employing the discounted cash flow or estimates of sales proceeds valuation methodologies.

In the event the fair value of an investment declines below our cost basis, management determines if the decline in fair value is other than temporary. If management determines the decline is other than temporary, an impairment charge is recorded. Management's assessment as to the nature of a decline in fair value is based on, among other things, the length of time and the extent to which the market value has been less than our cost basis, the financial condition and near-term prospects of the issuer, and our intent and ability to retain the investment for a period of time sufficient to allow for any anticipated recovery in market value.

Trade Accounts Receivable

We record trade accounts receivable at net realizable value. This value includes an appropriate allowance for estimated uncollectible accounts to reflect any loss anticipated on the trade accounts receivable balances and charged to the provision for doubtful accounts. We calculate this allowance based on our history of write-offs, the level of past-due accounts based on the contractual terms of the receivables, and our relationships with, and the economic status of, our bottling partners and customers. We believe our exposure to concentrations of credit risk is limited due to the diverse geographic areas covered by our operations. Activity in the allowance for doubtful accounts was as follows (in millions):

Year Ended December 31,

2014

2013

2012

Balance at beginning of year

Net charges to costs and expenses1

308

Write-offs

(13

)

(14

)

(19

)

Other2

(25

)

(16

)

Balance at end of year

331

The increase in 2014 was primarily related to concentrate sales receivables from our bottling partner in Venezuela. See Hyperinflationary Economies discussion below for additional information.

2 Other includes foreign currency translation and the impact of transferring certain assets to assets held for sale. See Note 2.

A significant portion of our net operating revenues and corresponding accounts receivable is derived from sales of our products in international markets. Refer to Note 19. We also generate a significant portion of our net operating revenues by selling concentrates and syrups to bottlers in which we have a noncontrolling interest, including Coca-Cola FEMSA, S.A.B. de C.V. ("Coca-Cola FEMSA"), Coca-Cola HBC AG ("Coca-Cola Hellenic"), and Coca-Cola Amatil Limited ("Coca-Cola Amatil"). Refer to Note 6.

Inventories

Inventories consist primarily of raw materials and packaging (which includes ingredients and supplies) and finished goods (which include concentrates and syrups in our concentrate operations and finished beverages in our finished product operations). Inventories are valued at the lower of cost or market. We determine cost on the basis of the average cost or first-in, first-out methods. Refer to Note 4.

Derivative Instruments

Our Company, when deemed appropriate, uses derivatives as a risk management tool to mitigate the potential impact of certain market risks. The primary market risks managed by the Company through the use of derivative instruments are foreign currency exchange rate risk, commodity price risk and interest rate risk. All derivatives are carried at fair value in our consolidated balance sheets in the line items prepaid expenses and other assets; other assets; or accounts payable and accrued expenses; and other liabilities, as applicable. The cash flow impact of the Company's derivative instruments is primarily included in our consolidated statements of cash flows in net cash provided by operating activities. Refer to Note 5.

Property, Plant and Equipment

Property, plant and equipment are stated at cost. Repair and maintenance costs that do not improve service potential or extend economic life are expensed as incurred. Depreciation is recorded principally by the straight-line method over the estimated useful lives of our assets, which are reviewed periodically and generally have the following ranges: buildings and improvements: 40 years or less; and machinery, equipment and vehicle fleet: 20 years or less. Land is not depreciated, and construction in progress is not depreciated until ready for service. Leasehold improvements are amortized using the straight-line method over the shorter of the remaining lease term, including renewals that are deemed to be reasonably assured, or the estimated useful life of the improvement. Depreciation is not recorded during the period in which a long-lived asset or disposal group is classified as held for sale, even if the asset or disposal group continues to generate revenue during the period. Depreciation expense, including the depreciation expense of assets under capital lease, totaled $1,716 million, $1,727 million and $1,704 million in 2014, 2013 and 2012, respectively. Amortization expense for leasehold improvements totaled $20 million, $16 million and $19 million in 2014, 2013 and 2012, respectively.

Certain events or changes in circumstances may indicate that the recoverability of the carrying amount of property, plant and equipment should be assessed, including, among others, a significant decrease in market value, a significant change in the business climate in a particular market, or a current period operating or cash flow loss combined with historical losses or projected future losses. When such events or changes in circumstances are present, we estimate the future cash flows expected to result from the use of the asset or asset group and its eventual disposition. These estimated future cash flows are consistent with those we use in our internal planning. If the sum of the expected future cash flows (undiscounted and without interest charges) is less than the carrying amount, we recognize an impairment loss. The impairment loss recognized is the amount by which the carrying amount exceeds the fair value. We use a variety of methodologies to determine the fair value of property, plant and equipment, including appraisals and discounted cash flow models, which are consistent with the assumptions we believe hypothetical marketplace participants would use. Refer to Note 7.

Goodwill, Trademarks and Other Intangible Assets

We classify intangible assets into three categories: (1) intangible assets with definite lives subject to amortization, (2) intangible assets with indefinite lives not subject to amortization and (3) goodwill. We determine the useful lives of our identifiable intangible assets after considering the specific facts and circumstances related to each intangible asset. Factors we consider when determining useful lives include the contractual term of any agreement related to the asset, the historical performance of the asset, the Company's long-term strategy for using the asset, any laws or other local regulations which could impact the useful life of the asset, and other economic factors, including competition and specific market conditions. Intangible assets that are deemed to have definite lives are amortized, primarily on a straight-line basis, over their useful lives, generally ranging from 1 to 20 years. Refer to Note 8.

When facts and circumstances indicate that the carrying value of definite-lived intangible assets may not be recoverable, management assesses the recoverability of the carrying value by preparing estimates of sales volume and the resulting profit and cash flows. These estimated future cash flows are consistent with those we use in our internal planning. If the sum of the expected future cash flows (undiscounted and without interest charges) is less than the carrying amount, we recognize an impairment loss. The impairment loss recognized is the amount by which the carrying amount of the asset or asset group exceeds the fair value. We use a variety of methodologies to determine the fair value of these assets, including discounted cash flow models, which are consistent with the assumptions we believe hypothetical marketplace participants would use.

We test intangible assets determined to have indefinite useful lives, including trademarks, franchise rights and goodwill, for impairment annually, or more frequently if events or circumstances indicate that assets might be impaired. Our Company performs these annual impairment reviews as of the first day of our third fiscal quarter. We use a variety of methodologies in conducting impairment assessments of indefinite-lived intangible assets, including, but not limited to, discounted cash flow models, which are based on the assumptions we believe hypothetical marketplace participants would use. For indefinite-lived intangible assets, other than goodwill, if the carrying amount exceeds the fair value, an impairment charge is recognized in an amount equal to that excess.

The Company has the option to perform a qualitative assessment of indefinite-lived intangible assets, other than goodwill, prior to completing the impairment test described above. The Company must assess whether it is more likely than not that the fair value of the intangible asset is less than its carrying amount. If the Company concludes that this is the case, it must perform the testing described above. Otherwise, the Company does not need to perform any further assessment. During 2014, the Company performed qualitative assessments on less than 10 percent of our indefinite-lived intangible assets balance.

We perform impairment tests of goodwill at our reporting unit level, which is one level below our operating segments. Our operating segments are primarily based on geographic responsibility, which is consistent with the way management runs our business. Our operating segments are subdivided into smaller geographic regions or territories that we sometimes refer to as "business units." These business units are also our reporting units. The Bottling Investments operating segment includes all Company-owned or consolidated bottling operations, regardless of geographic location, except for bottling operations managed by CCR, which are included in our North America operating segment. Generally, each Company-owned or consolidated bottling operation within our Bottling Investments operating segment is its own reporting unit. Goodwill is assigned to the reporting unit or units that benefit from the synergies arising from each business combination.

The goodwill impairment test consists of a two-step process, if necessary. The first step is to compare the fair value of a reporting unit to its carrying value, including goodwill. We typically use discounted cash flow models to determine the fair value of a reporting unit. The assumptions used in these models are consistent with those we believe hypothetical marketplace participants would use. If the fair value of the reporting unit is less than its carrying value, the second step of the impairment test must be performed in order to determine the amount of impairment loss, if any. The second step compares the implied fair value of the reporting unit's goodwill with the carrying amount of that goodwill. If the carrying amount of the reporting unit's goodwill exceeds its implied fair value, an impairment charge is recognized in an amount equal to that excess. The loss recognized cannot exceed the carrying amount of goodwill.

The Company has the option to perform a qualitative assessment of goodwill prior to completing the two-step process described above to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill and other intangible assets. If the Company concludes that this is the case, it must perform the two-step process. Otherwise, the Company will forego the two-step process and does not need to perform any further testing. During 2014, the Company performed qualitative assessments on less than 10 percent of our consolidated goodwill balance.

Impairment charges related to intangible assets are generally recorded in the line item other operating charges or, to the extent they relate to equity method investees, in the line item equity income (loss) — net in our consolidated statements of income.

Contingencies

Our Company is involved in various legal proceedings and tax matters. Due to their nature, such legal proceedings and tax matters involve inherent uncertainties including, but not limited to, court rulings, negotiations between affected parties and governmental actions. Management assesses the probability of loss for such contingencies and accrues a liability and/or discloses the relevant circumstances, as appropriate. Refer to Note 11.

Stock-Based Compensation

Our Company sponsors stock option and restricted stock award plans. The fair value of our stock option grants is estimated on the grant date using a Black-Scholes-Merton option-pricing model. The Company recognizes compensation expense on a straight-line basis over the period the grant is earned by the employee, generally four years.

The fair value of our restricted stock awards is the quoted market value of the Company's stock on the grant date less the present value of the expected dividends not received during the relevant holding period. For certain restricted stock awards granted beginning in 2014, the Company includes a relative total shareowner return ("TSR") modifier to determine the number of restricted shares or share units earned at the end of the performance period. For these awards, the number of restricted shares or share units earned based on the certified achievement of the predefined performance criteria will be reduced or increased if total shareowner return over the performance period relative to a predefined compensation comparator group of companies falls outside of a defined range. The fair value of performance share units that include the TSR modifier is determined using a Monte Carlo valuation model.

In the period it becomes probable that the minimum performance criteria specified in the restricted stock award plan will be achieved, we recognize expense for the proportionate share of the total fair value of the award related to the vesting period that has already lapsed. The remaining fair value of the award is expensed on a straight-line basis over the balance of the vesting period. In the event the Company determines it is no longer probable that we will achieve the minimum performance criteria specified in the plan, we reverse all of the previously recognized compensation expense in the period such a determination is made. Refer to Note 12.

Pension and Other Postretirement Benefit Plans

Our Company sponsors and/or contributes to pension and postretirement health care and life insurance benefit plans covering substantially all U.S. employees. We also sponsor nonqualified, unfunded defined benefit pension plans for certain associates and participate in multi-employer pension plans in the United States. In addition, our Company and its subsidiaries have various pension plans and other forms of postretirement arrangements outside the United States. Refer to Note 13.

Income Taxes

Income tax expense includes United States, state, local and international income taxes, plus a provision for U.S. taxes on undistributed earnings of foreign subsidiaries not deemed to be indefinitely reinvested. Deferred tax assets and liabilities are recognized for the tax consequences of temporary differences between the financial reporting basis and the tax basis of existing assets and liabilities. The tax rate used to determine the deferred tax assets and liabilities is the enacted tax rate for the year and manner in which the differences are expected to reverse. Valuation allowances are recorded to reduce deferred tax assets to the amount that will more likely than not be realized. The Company records taxes that are collected from customers and remitted to governmental authorities on a net basis in our consolidated statements of income.

The Company is involved in various tax matters, with respect to some of which the outcome is uncertain. We establish reserves to remove some or all of the tax benefit of any of our tax positions at the time we determine that it becomes uncertain based upon one of the following conditions: (1) the tax position is not "more likely than not" to be sustained, (2) the tax position is "more likely than not" to be sustained, but for a lesser amount, or (3) the tax position is "more likely than not" to be sustained, but not in the financial period in which the tax position was originally taken. For purposes of evaluating whether or not a tax position is uncertain, (1) we presume the tax position will be examined by the relevant taxing authority that has full knowledge of all relevant information; (2) the technical merits of a tax position are derived from authorities such as legislation and statutes, legislative intent, regulations, rulings and case law and their applicability to the facts and circumstances of the tax position; and (3) each tax position is evaluated without consideration of the possibility of offset or aggregation with other tax positions taken. A number of years may elapse before a particular uncertain tax position is audited and finally resolved or when a tax assessment is raised. The number of years subject to tax assessments varies depending on the tax jurisdiction. The tax benefit that has been previously reserved because of a failure to meet the "more likely than not" recognition threshold would be recognized in our income tax expense in the first interim period when the uncertainty disappears under any one of the following conditions: (1) the tax position is "more likely than not" to be sustained, (2) the tax position, amount, and/or timing is ultimately settled through negotiation or litigation, or (3) the statute of limitations for the tax position has expired. Refer to Note 14.

Translation and Remeasurement

We translate the assets and liabilities of our foreign subsidiaries from their respective functional currencies to U.S. dollars at the appropriate spot rates as of the balance sheet date. Generally, our foreign subsidiaries use the local currency as their functional currency. Changes in the carrying value of these assets and liabilities attributable to fluctuations in spot rates are recognized in foreign currency translation adjustment, a component of AOCI. Refer to Note 15. Income statement accounts are translated using the monthly average exchange rates during the year.

Monetary assets and liabilities denominated in a currency that is different from a reporting entity's functional currency must first be remeasured from the applicable currency to the legal entity's functional currency. The effect of this remeasurement process is recognized in the line item other income (loss) — net in our consolidated statements of income and is partially offset by the impact of our economic hedging program for certain exposures on our consolidated balance sheets. Refer to Note 5.

Hyperinflationary Economies

A hyperinflationary economy is one that has cumulative inflation of 100 percent or more over a three-year period. In accordance with accounting principles generally accepted in the United States, local subsidiaries in hyperinflationary economies are required to use the U.S. dollar as their functional currency and remeasure the monetary assets and liabilities not denominated in U.S. dollars using the rate applicable to conversion of a currency for purposes of dividend remittances. All exchange gains and losses resulting from remeasurement are recognized currently in income.

Venezuela has been designated as a hyperinflationary economy. In February 2013, the Venezuelan government devalued its currency to an official rate of exchange ("official rate") of 6.3 bolivars per U.S. dollar. At that time, the Company remeasured the net monetary assets of our Venezuelan subsidiary at the official rate. As a result of the devaluation, we recognized a loss of $140 million from remeasurement in the line item other income (loss) — net in our consolidated statement of income.

Beginning in the first quarter of 2014, the Venezuelan government recognized three legal exchange rates to convert bolivars to the U.S. dollar: 1) the official rate of 6.3 bolivars per U.S. dollar; 2) SICAD 1, which is available to foreign investments and designated industry sectors to exchange a limited volume of bolivars for U.S. dollars using a bid rate established at weekly auctions; and 3) SICAD 2, which applies to transactions that do not qualify for either the official rate or SICAD 1. As of March 28, 2014, the three legal exchange rates were 6.3 (official rate), 10.8 (SICAD 1) and 50.9 (SICAD 2). We determined that the SICAD 1 rate was the most appropriate rate to use for remeasurement given our circumstances and estimates of the applicable rate at which future transactions could be settled, including the payment of dividends. Therefore, as of March 28, 2014, we remeasured the net monetary assets of our Venezuelan subsidiary using an exchange rate of 10.8 bolivars per U.S. dollar, resulting in a charge of $226 million recorded in the line item other income (loss) — net in our consolidated statement of income.

In December 2014, due to the continued lack of liquidity and increasing economic uncertainty, the Company reevaluated the rate that should be used to remeasure the monetary assets and liabilities of our Venezuelan subsidiary. As of December 31, 2014, we determined that the SICAD 2 rate of 50 bolivars per U.S. dollar was the most appropriate legally available rate and remeasured the net monetary assets of our Venezuelan subsidiary, resulting in a charge of $146 million recorded in the line item other income (loss) — net in our consolidated statement of income.

In addition to the foreign currency exchange exposure related to our Venezuelan subsidiary's net monetary assets, we also sell concentrate to our bottling partner in Venezuela from outside the country. These sales are denominated in U.S. dollars. During the year ended December 31, 2014, as a result of the continued lack of liquidity and our revised assessment of the U.S. dollar value we expect to realize upon the conversion of Venezuelan bolivars into U.S. dollars by our bottling partner to pay our concentrate sales receivables, we recorded a write-down of $296 million recorded in the line item other operating charges in our consolidated statement of income.

We also have certain U.S. dollar denominated intangible assets associated with products sold in Venezuela. In January 2014, the Venezuelan government enacted a new law which imposes limits on profit margins earned in the country, reducing the Company's cash flows for as long as the law remains in effect. As a result of this law and the Company's revised expectations regarding the convertibility of the local currency, we recognized an impairment charge of $18 million during the year ended December 31, 2014, recorded in the line item other operating charges in our consolidated statement of income. Further government regulation or changes in exchange rates could result in additional impairments of these intangible assets.

As of December 31, 2014, the combined value of the net monetary assets of our Venezuelan subsidiary, the concentrate sales receivables from our bottling partner and the intangible assets associated with products sold in Venezuela was $180 million. Included in this combined value is $52 million of cash and cash equivalents. Despite the additional currency conversion mechanisms, the Company's ability to pay dividends from Venezuela is still restricted due to the low volume of U.S. dollars available for conversion. If the bolivar devalues further, it would likely result in our Company recognizing additional foreign currency exchange losses, write-downs of receivables or impairment charges and our share of any charges recorded by our equity method investee.

Recently Issued Accounting Guidance

In April 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity. Under ASU 2014-08, only disposals representing a strategic shift in operations should be presented as discontinued operations. Those strategic shifts should have a major effect on the organization's operations and financial results. Additionally, ASU 2014-08 requires expanded disclosures about discontinued operations that will provide financial statement users with more information about the assets, liabilities, income and expenses of discontinued operations. ASU 2014-08 is effective for fiscal and interim periods beginning on or after December 15, 2014. The impact on our consolidated financial statements will depend on the facts and circumstances of any specific future transactions.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, which will replace most existing revenue recognition guidance in U.S. Generally Accepted Accounting Principles and is intended to improve and converge with international standards the financial reporting requirements for revenue from contracts with customers. The core principle of ASU 2014-09 is that an entity should recognize revenue for the transfer of goods or services equal to the amount that it expects to be entitled to receive for those goods or services. ASU 2014-09 also requires additional disclosures about the nature, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments. ASU 2014-09 allows for both retrospective and prospective methods of adoption and is effective for periods beginning after December 15, 2016. The Company is currently evaluating the impact that the adoption of ASU 2014-09 will have on our consolidated financial statements.

ACQUISITIONS_AND_DIVESTITURES

ACQUISITIONS AND DIVESTITURES	12 Months Ended
	Dec. 31, 2014
Acquisitions and Divestitures Disclosure [
ACQUISITIONS AND DIVESTITURES	ACQUISITIONS AND DIVESTITURES
	Acquisitions
	During 2014, our Company's acquisitions of businesses, equity method investments and nonmarketable securities totaled $389 million and primarily included a joint investment with one of our bottling partners in a dairy company in Ecuador, which is accounted for under the equity method of accounting.
	During 2013, our Company's acquisitions of businesses, equity method investments and nonmarketable securities totaled $353 million, which primarily included our acquisition of the majority of the remaining outstanding shares of Fresh Trading Ltd. ("innocent") and a majority interest in bottling operations in Myanmar. The Company previously accounted for our investment in innocent under the equity method of accounting. We remeasured our equity interest in innocent to fair value upon the close of the transaction. The resulting gain on the remeasurement was not significant to our consolidated financial statements.
	During 2012, our Company's acquisitions of businesses, equity method investments and nonmarketable securities totaled $1,486 million. These payments were primarily related to the following: our investments in the existing beverage business of Aujan Industries Company J.S.C. ("Aujan"), one of the largest independent beverage companies in the Middle East; our investment in Mikuni Coca-Cola Bottling Co., Ltd. ("Mikuni"), a bottling partner located in Japan; our acquisition of Sacramento Coca-Cola Bottling Co., Inc. ("Sacramento bottler"); and our acquisition of bottling operations in Vietnam, Cambodia and Guatemala. The Company's investment in Mikuni was accounted for under the equity method of accounting prior to 2013, when this investment was merged with three other bottlers to form Coca-Cola East Japan Bottling Company, Ltd. ("CCEJ"). Refer to Note 17 for details on this transaction. The Company paid $820 million during 2012 under its definitive agreement with Aujan in exchange for an ownership interest of 50 percent in the entity that holds the rights in certain territories to brands produced and distributed by Aujan and an ownership interest of 49 percent in Aujan's bottling and distribution operations in certain territories. The Company's investments in Aujan are being accounted for under the equity method of accounting.
	Green Mountain Coffee Roasters, Inc.
	In February 2014, the Company and Green Mountain Coffee Roasters, Inc., now known as Keurig Green Mountain, Inc. ("Keurig"), entered into a 10-year global strategic agreement to collaborate on the development and introduction of the Company’s global brand portfolio for use in Keurig’s forthcoming Keurig KoldTM at-home beverage system. Under the agreement, the companies will cooperate to bring the Keurig KoldTM beverage system to consumers around the world, and Keurig will be the Company's exclusive partner for the production and sale of our branded single-serve, pod-based cold beverages. Together we will also explore future opportunities to collaborate on the Keurig® platform. In an effort to align long-term interests, we also entered into an agreement to purchase a 10 percent equity position in Keurig, and on February 27, 2014, the Company purchased the newly issued shares in Keurig for approximately $1,265 million, including transaction costs of $14 million.
	In May 2014, the Company purchased additional shares of Keurig in the market for $302 million, which represented an additional 2 percent equity position in Keurig. We account for the investment in Keurig as an available-for-sale security, which is included in the line item other investments in our consolidated balance sheet. These purchases were included in the line item purchases of investments in our consolidated statement of cash flows.
	Subsequent to these purchases, the Company entered into an agreement with Credit Suisse Capital LLC ("CS") to purchase additional shares of Keurig which would increase the Company's equity position to a 16 percent interest based on the total number of issued and outstanding shares of Keurig as of May 1, 2014. Under the agreement, the Company will purchase from CS, on a date selected by CS no later than February 2015, the lesser of (1) 6.5 million shares of Keurig or (2) the number of shares that shall cause our ownership to equal 16 percent. The purchase price per share will be the average of the daily volume-weighted average price per share from May 15, 2014, to the date selected by CS, as adjusted in certain circumstances specified in the agreement. CS will have exclusive ownership and control over any such shares until delivered to the Company. This agreement with CS qualifies as a derivative, and the changes in its fair value are immediately recognized into earnings.
	Coca-Cola Erfrischungsgetränke AG
	In conjunction with the Company's acquisition of 18 German bottling and distribution operations in 2007, the former owners received put options to sell their respective shares in Coca-Cola Erfrischungsgetränke AG ("CCEAG") back to the Company in January 2014. The Company paid $503 million to purchase these shares, which was included in the line item other financing activities in our consolidated statement of cash flows, resulting in 100 percent ownership of CCEAG.
	Divestitures
	During 2014, proceeds from disposals of businesses, equity method investments and nonmarketable securities totaled $148 million, which primarily represented the proceeds from the refranchising of certain of our territories in North America.
	During 2013, proceeds from disposals of businesses, equity method investments and nonmarketable securities totaled $872 million. These proceeds primarily included the sale of a majority ownership interest in our previously consolidated bottling operations in the Philippines ("Philippine bottling operations"), and separately, the deconsolidation of our bottling operations in Brazil ("Brazilian bottling operations").
	North America Refranchising
	In conjunction with implementing a new beverage partnership model in North America, the Company refranchised territories that were previously managed by CCR to certain of our unconsolidated bottling partners. These territories border these bottlers' existing territories, allowing each bottler to better service local customers and provide more efficient execution. Through the execution of comprehensive beverage agreements ("CBAs") with each of the bottlers, we granted certain exclusive territory rights for the distribution, promotion, marketing and sale of Company-owned and licensed beverage products as defined by the CBA. Under the arrangement for these territories, CCR retains the rights to produce these beverage products, and the bottlers will purchase from CCR substantially all of the related finished products needed in order to service the customers in these territories. Each CBA has a term of 10 years and is renewable by the bottler indefinitely for successive additional terms of 10 years each. Under the CBA, the bottlers will make ongoing quarterly payments to CCR based on their future gross profit in these territories throughout the term of the CBA, including renewals, in exchange for the grant of the exclusive territory rights.
	Contemporaneously with the grant of these rights, the Company sold the distribution assets, certain working capital items, and the exclusive rights to distribute certain beverage brands not owned by the Company, but distributed by CCR, in each of these territories to the respective bottlers in exchange for cash. During the year ended December 31, 2014, cash proceeds from these sales totaled $143 million, which included proceeds of $42 million from Coca-Cola Bottling Co. Consolidated, an equity method investee. Under the applicable accounting guidance, we were required to derecognize all of the tangible assets sold as well as the intangible assets transferred, including distribution rights, customer relationships and an allocated portion of goodwill related to these territories. We recognized a noncash loss of $305 million during the year ended December 31, 2014 primarily related to the derecognition of the intangible assets transferred, which was included in the line item other income (loss) — net in our consolidated statements of income. We expect to recover the value of the intangible assets transferred to the bottlers under the CBAs through the future quarterly payments; however, as the payments for the territory rights are dependent on the bottlers' future gross profit in these territories, they are considered a form of contingent consideration.
	There is diversity in practice as it relates to the accounting for contingent consideration by the seller. The seller can account for the future contingent payments received as a gain contingency, recognizing the amounts in the income statement only after the related contingencies are resolved and the gain is realized, which in this arrangement will be quarterly as the bottlers earn gross profit in the transferred territories. Alternatively, the seller can record a receivable for the contingent consideration at fair value on the date of sale and record any future differences between the payments received and this receivable in the income statement as they occur. We elected the gain contingency treatment since the quarterly payments will be received throughout the terms of the CBAs, including all subsequent renewals, regardless of the cumulative amount received as compared to the value of the intangible assets transferred.
	Philippine Bottling Operations
	On December 13, 2012, the Company and Coca-Cola FEMSA executed a share purchase agreement for the sale of a majority ownership interest in our Philippine bottling operations. As of December 31, 2012, our Philippine bottling operations met the criteria to be classified as held for sale, and we were required to record their assets and liabilities at the lower of carrying value or fair value less any costs to sell based on the agreed-upon purchase price. Accordingly, we recorded a total loss of $107 million, primarily during the fourth quarter of 2012, in the line item other income (loss) — net in our consolidated statement of income.
	This transaction was completed on January 25, 2013. The Company now accounts for our remaining 49 percent ownership interest in the Philippine bottling operations under the equity method of accounting. As a result of this transaction, we remeasured our remaining investment in the Philippine bottling operations to fair value taking into consideration the sale price of the majority ownership interest. Coca-Cola FEMSA has an option to purchase our remaining ownership interest in the Philippine bottling operations at any time during the seven years following closing based on the initial purchase price plus a defined return. Coca-Cola FEMSA also has an option exercisable during the sixth year after closing to sell its ownership interest back to the Company at a price not to exceed the initial purchase price.
	Brazilian Bottling Operations
	On December 17, 2012, the Company entered into an agreement with several parties to combine our Brazilian bottling operations with an independent bottler in Brazil in a transaction involving a disposition of shares for cash and an exchange of shares for a 44 percent minority ownership interest in the newly combined entity, which was recorded at fair value. As of December 31, 2012, our Brazilian bottling operations met the criteria to be classified as held for sale, but we were not required to record their assets and liabilities at fair value less any costs to sell because their fair value exceeded our carrying value. This transaction was completed on July 3, 2013, and resulted in the deconsolidation of our Brazilian bottling operations. The Company recognized a gain of $615 million as a result of this transaction.
	The owners of the majority interest have the option to acquire up to 24 percent of the new entity's outstanding shares from us at any time for a period of six years beginning December 31, 2013, based on an agreed-upon formula. In December 2014, the Company received notification that the owners of the majority interest had exercised their option to acquire from us a 10 percent interest in the entity's outstanding shares. During the year ended December 31, 2014, we recorded a loss of $32 million as a result of the exercise price being lower than our carrying value. As a result of the transaction, which closed in January 2015, the Company's ownership was reduced to 34 percent of the entity’s outstanding shares. The owners of the majority interest have a remaining option to acquire an additional 14 percent interest of the entity’s outstanding shares at any time through December 31, 2019, based on an agreed-upon formula.
	Assets and Liabilities Held for Sale
	North America Refranchising
	As of December 31, 2014, the Company had entered into agreements to refranchise additional territories in North America. These territories met the criteria to be classified as held for sale, and we were required to record their assets and liabilities at the lower of carrying value or fair value less any costs to sell based on the agreed-upon sale price. The Company recognized a noncash loss of $494 million during the year ended December 31, 2014 as a result of writing down the assets to their fair value less costs to sell, which was included in the line item other income (loss) — net in our consolidated statement of income. This loss was primarily related to the anticipated derecognition of the intangible assets to be transferred, which we expect to recover under the CBAs through the future quarterly payments. The Company expects these transactions to close by the end of the second quarter of 2015.
	Coca-Cola Beverages Africa Limited
	In November 2014, the Company, SAB Miller plc, and Gutsche Family Investments announced an agreement to combine the bottling operations of their nonalcoholic ready-to-drink beverage businesses in Southern and East Africa. Upon completion of the proposed merger, the Company will have an ownership of 11 percent in the bottler which will be called Coca-Cola Beverages Africa Limited. The Company will also acquire or license several brands in exchange for cash as a result of the transaction. As of December 31, 2014, our South African bottling operations and related equity method investments met the criteria to be held for sale, but we were not required to record these assets and liabilities at fair value less any costs to sell because their fair value exceeded our carrying value. The Company expects the transaction to close in the second half of 2015, subject to regulatory approval. Based on the proposed governance structure, the Company expects to account for its resulting interest in the new entity as an equity method investment.
	Monster Beverage Corporation
	In August 2014, the Company and Monster Beverage Corporation ("Monster") entered into definitive agreements for a long-term strategic relationship in the global energy drink category. Subject to the terms and conditions of the agreements, upon the closing of the transactions (1) the Company will acquire newly issued shares of Monster common stock representing approximately 16.7 percent of the outstanding shares of Monster common stock (after giving effect to the new issuance) and will be represented by two directors on Monster's Board of Directors; (2) the Company will transfer its global energy drink business (including NOS, Full Throttle, Burn, Mother, Nalu, Play and Power Play, and Relentless) to Monster, and Monster will transfer its non-energy drink business (including Hansen's Natural Sodas, Peace Tea, Hubert's Lemonade and Hansen's Juice Products) to the Company; and (3) the parties will amend their current distribution coordination agreements with Monster to expand distribution of Monster products into additional territories pursuant to long-term agreements with the Company's existing network of Company-owned or -controlled bottling operations and bottling and distribution partners. Upon closing, the Company will make a net cash payment of $2.15 billion to Monster. The closing of the transaction is subject to customary closing conditions, including the receipt of regulatory approvals, and is expected to take place in the second quarter of 2015. Based on our anticipated representation on Monster's Board of Directors, the Company expects to account for its resulting interest in Monster as an equity method investment. As of December 31, 2014, the assets held by the Company's global energy drink business met the criteria to be held for sale, however, we were not required to record the assets at their fair value less any costs to sell because their fair value exceeded our carrying value.
	The following table presents information related to the major classes of assets and liabilities that were classified as held for sale in our consolidated balance sheet (in millions):


		31-Dec-14

	Cash, cash equivalents and short-term investments	$	30

	Trade accounts receivable, less allowances	100

	Inventories	54

	Prepaid expenses and other assets	7

	Equity method investments	141

	Other assets	3

	Property, plant and equipment — net	303

	Bottlers' franchise rights with indefinite lives	410

	Trademarks	43

	Goodwill	46

	Other intangible assets	36

	Allowance for reduction of assets held for sale	(494		)
	Total assets	$	679

	Accounts payable and accrued expenses	$	48

	Other liabilities	6

Deferred income taxes	4

Total liabilities	$	58

Included in the amounts above are total assets relating to North America refranchising of $223 million, Coca-Cola Beverages Africa Limited of $333 million, the pending Monster transaction of $43 million, and other assets held for sale of $80 million, and are included in the North America, Eurasia and Africa, Bottling Investments and Corporate operating segments. We determined that these operations did not meet the criteria to be classified as discontinued operations, primarily due to the continued significant involvement we will have in these operations following each transaction.

INVESTMENTS

INVESTMENTS	12 Months Ended
	Dec. 31, 2014
Investments Disclosure [Abstract]
INVESTMENTS	INVESTMENTS
	Investments in debt and marketable securities, other than investments accounted for under the equity method, are classified as trading, available-for-sale or held-to-maturity. Our marketable equity investments are classified as either trading or available-for-sale with their cost basis determined by the specific identification method. Our investments in debt securities are carried at either amortized cost or fair value. Investments in debt securities that the Company has the positive intent and ability to hold to maturity are carried at amortized cost and classified as held-to-maturity. Investments in debt securities that are not classified as held-to-maturity are carried at fair value and classified as either trading or available-for-sale. Realized and unrealized gains and losses on trading securities and realized gains and losses on available-for-sale securities are included in net income. Unrealized gains and losses, net of deferred taxes, on available-for-sale securities are included in our consolidated balance sheets as a component of AOCI, except for the change in fair value attributable to the currency risk being hedged. Refer to Note 5 for additional information related to the Company's fair value hedges of available-for-sale securities.
	Trading Securities
	As of December 31, 2014 and 2013, our trading securities had a fair value of $409 million and $372 million, respectively, and consisted primarily of equity securities. The Company had net unrealized gains on trading securities of $40 million, $12 million, and $19 million as of December 31, 2014, 2013 and 2012, respectively.
	The Company's trading securities were included in the following line items in our consolidated balance sheets (in millions):


	December 31,	2014				2013

	Marketable securities	$	315			$	286

	Other assets	94				86

	Total trading securities	$	409			$	372

	Available-for-Sale and Held-to-Maturity Securities
	As of December 31, 2014 and 2013, the Company did not have any held-to-maturity securities. Available-for-sale securities consisted of the following (in millions):


						Gross Unrealized							Estimated Fair Value
		Cost				Gains			Losses
	2014
	Available-for-sale securities:1
	Equity securities	$	2,687			$	1,463		$	(29	)		$	4,121

	Debt securities	3,796				68			(106		)	2	3,758

		$	6,483			$	1,531		$	(135	)		$	7,879

	2013
	Available-for-sale securities:1
	Equity securities	$	1,097			$	373		$	(17	)		$	1,453

	Debt securities	3,388				24			(23		)		3,389

		$	4,485			$	397		$	(40	)		$	4,842


	1	Refer to Note 16 for additional information related to the estimated fair value.
	2 Includes $101 million recognized in the consolidated income statement line item other income (loss) — net during the year ended December 31, 2014. The amount was primarily offset by changes in the fair value of foreign currency contracts designated as fair value hedges. Refer to Note 5 for additional information.
	The sale and/or maturity of available-for-sale securities resulted in the following activity (in millions):


	Year Ended December 31,	2014				2013			2012

	Gross gains	$	38			$	12		$	41

	Gross losses	(21		)		(24		)	(35		)
	Proceeds	4,157				4,212			5,036

	In 2014 and 2013, the Company had investments classified as available-for-sale securities in which our cost basis exceeded the fair value of our investment. Management assessed each of these investments on an individual basis to determine if the decline in fair value was other than temporary. Management's assessment as to the nature of a decline in fair value is based on, among other things, the length of time and the extent to which the market value has been less than our cost basis; the financial condition and near-term prospects of the issuer; and our intent and ability to retain the investment for a period of time sufficient to allow for any anticipated recovery in market value. As a result of these assessments, management determined that the decline in fair value of these investments was not other than temporary and did not record any impairment charges.
	The Company uses insurance captives to reinsure group annuity insurance contracts that cover the pension obligations of certain of our European and Canadian pension plans. In accordance with local insurance regulations, our insurance captive is required to meet and maintain minimum solvency capital requirements. The Company elected to invest its solvency capital in a portfolio of available-for-sale securities, which have been classified in the line item other assets in our consolidated balance sheets because the assets are not available to satisfy our current obligations. As of December 31, 2014, and December 31, 2013, the Company's available-for-sale securities included solvency capital funds of $836 million and $667 million, respectively.
	In 2014 and 2013, the Company did not have any held-to-maturity securities. The Company's available-for-sale securities were included in the following line items in our consolidated balance sheets (in millions):


	December 31,	2014				2013

	Cash and cash equivalents	$	43			$	245

	Marketable securities	3,350				2,861

	Other investments	3,512				958

	Other assets	974				778

	$	7,879			$	4,842

The contractual maturities of these investments as of December 31, 2014, were as follows (in millions):


	Available-for-Sale Securities
	Cost				Fair Value

Within 1 year	$	1,589			$	1,489

After 1 year through 5 years	1,709				1,747

After 5 years through 10 years	118				130

After 10 years	380				392

Equity securities	2,687				4,121

	$	6,483			$	7,879

The Company expects that actual maturities may differ from the contractual maturities above because borrowers have the right to call or prepay certain obligations.
Cost Method Investments
Cost method investments are initially recorded at cost, and we record dividend income when applicable dividends are declared. Cost method investments are reported as other investments in our consolidated balance sheets, and dividend income from cost method investments is reported in other income (loss) — net in our consolidated statements of income. We review all of our cost method investments quarterly to determine if impairment indicators are present; however, we are not required to determine the fair value of these investments unless impairment indicators exist. When impairment indicators exist, we generally use discounted cash flow analyses to determine the fair value. We estimate that the fair values of our cost method investments approximated or exceeded their carrying values as of December 31, 2014 and 2013. Our cost method investments had a carrying value of $166 million and $162 million as of December 31, 2014 and 2013, respectively.

INVENTORIES

INVENTORIES	12 Months Ended
	Dec. 31, 2014
Inventories [Abstract]
INVENTORIES	INVENTORIES
	Inventories consist primarily of raw materials and packaging (which includes ingredients and supplies) and finished goods (which include concentrates and syrups in our concentrate operations and finished beverages in our finished product operations). Inventories are valued at the lower of cost or market. We determine cost on the basis of the average cost or first-in, first-out methods. Inventories consisted of the following (in millions):


	December 31,	2014		2013

	Raw materials and packaging	$	1,615	$	1,692

	Finished goods	1,134		1,240

	Other	351		345

	Total inventories	$	3,100	$	3,277

HEDGING_TRANSACTIONS_AND_DERIV

HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS	12 Months Ended
	Dec. 31, 2014
Hedging Transactions and Derivative Financial Instruments Disclosures [Abstract]
HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS	HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS
	The Company is directly and indirectly affected by changes in certain market conditions. These changes in market conditions may adversely impact the Company's financial performance and are referred to as "market risks." Our Company, when deemed appropriate, uses derivatives as a risk management tool to mitigate the potential impact of certain market risks. The primary market risks managed by the Company through the use of derivative instruments are foreign currency exchange rate risk, commodity price risk and interest rate risk.
	The Company uses various types of derivative instruments including, but not limited to, forward contracts, commodity futures contracts, option contracts, collars and swaps. Forward contracts and commodity futures contracts are agreements to buy or sell a quantity of a currency or commodity at a predetermined future date, and at a predetermined rate or price. An option contract is an agreement that conveys the purchaser the right, but not the obligation, to buy or sell a quantity of a currency or commodity at a predetermined rate or price during a period or at a time in the future. A collar is a strategy that uses a combination of options to limit the range of possible positive or negative returns on an underlying asset or liability to a specific range, or to protect expected future cash flows. To do this, an investor simultaneously buys a put option and sells (writes) a call option, or alternatively buys a call option and sells (writes) a put option. A swap agreement is a contract between two parties to exchange cash flows based on specified underlying notional amounts, assets and/or indices. We do not enter into derivative financial instruments for trading purposes.
	All derivatives are carried at fair value in our consolidated balance sheets in the following line items, as applicable: prepaid expenses and other assets; other assets; accounts payable and accrued expenses; and other liabilities. The carrying values of the derivatives reflect the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. These master netting agreements allow the Company to net settle positive and negative positions (assets and liabilities) arising from different transactions with the same counterparty.
	The accounting for gains and losses that result from changes in the fair values of derivative instruments depends on whether the derivatives have been designated and qualify as hedging instruments and the type of hedging relationships. Derivatives can be designated as fair value hedges, cash flow hedges or hedges of net investments in foreign operations. The changes in the fair values of derivatives that have been designated and qualify for fair value hedge accounting are recorded in the same line item in our consolidated statements of income as the changes in the fair values of the hedged items attributable to the risk being hedged. The changes in fair values of derivatives that have been designated and qualify as cash flow hedges or hedges of net investments in foreign operations are recorded in AOCI and are reclassified into the line item in our consolidated statement of income in which the hedged items are recorded in the same period the hedged items affect earnings. Due to the high degree of effectiveness between the hedging instruments and the underlying exposures being hedged, fluctuations in the value of the derivative instruments are generally offset by changes in the fair values or cash flows of the underlying exposures being hedged. The changes in fair values of derivatives that were not designated and/or did not qualify as hedging instruments are immediately recognized into earnings.
	For derivatives that will be accounted for as hedging instruments, the Company formally designates and documents, at inception, the financial instrument as a hedge of a specific underlying exposure, the risk management objective and the strategy for undertaking the hedge transaction. In addition, the Company formally assesses, both at the inception and at least quarterly thereafter, whether the financial instruments used in hedging transactions are effective at offsetting changes in either the fair values or cash flows of the related underlying exposures. Any ineffective portion of a financial instrument's change in fair value is immediately recognized into earnings.
	The Company determines the fair values of its derivatives based on quoted market prices or pricing models using current market rates. Refer to Note 16. The notional amounts of the derivative financial instruments do not necessarily represent amounts exchanged by the parties and, therefore, are not a direct measure of our exposure to the financial risks described above. The amounts exchanged are calculated by reference to the notional amounts and by other terms of the derivatives, such as interest rates, foreign currency exchange rates, commodity rates or other financial indices. The Company does not view the fair values of its derivatives in isolation, but rather in relation to the fair values or cash flows of the underlying hedged transactions or other exposures. Virtually all of our derivatives are straightforward over-the-counter instruments with liquid markets.
	The following table presents the fair values of the Company's derivative instruments that were designated and qualified as part of a hedging relationship (in millions):


				Fair Value1,2
	Derivatives Designated as Hedging Instruments	Balance Sheet Location1		December 31,				December 31,
				2014				2013
	Assets:
	Foreign currency contracts	Prepaid expenses and other assets		$	923			$	211

	Foreign currency contracts	Other assets		346				109

	Commodity contracts	Prepaid expenses and other assets		—				1

	Interest rate contracts	Prepaid expenses and other assets		14				—

	Interest rate contracts	Other assets		146				283

	Total assets			$	1,429			$	604

	Liabilities:
	Foreign currency contracts	Accounts payable and accrued expenses		$	24			$	84

	Foreign currency contracts	Other liabilities		249				40

	Commodity contracts	Accounts payable and accrued expenses		1				1

	Interest rate contracts	Accounts payable and accrued expenses		11				—

	Interest rate contracts	Other liabilities		35				—

	Total liabilities			$	320			$	125


	1	All of the Company's derivative instruments are carried at fair value in our consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master netting agreements and cash collateral. Refer to Note 16 for the net presentation of the Company's derivative instruments.

	2	Refer to Note 16 for additional information related to the estimated fair value.
	The following table presents the fair values of the Company's derivative instruments that were not designated as hedging instruments (in millions):


				Fair Value1,2
	Derivatives Not Designated as Hedging Instruments	Balance Sheet Location1		December 31,				December 31,
				2014				2013
	Assets:
	Foreign currency contracts	Prepaid expenses and other assets		$	44			$	21

	Foreign currency contracts	Other assets		231				171

	Commodity contracts	Prepaid expenses and other assets		9				33

	Commodity contracts	Other assets		1				1

	Other derivative instruments	Prepaid expenses and other assets		14				9

	Other derivative instruments	Other assets		2				—

	Total assets			$	301			$	235

Liabilities:
Foreign currency contracts	Accounts payable and accrued expenses		$	33			$	24

Foreign currency contracts	Other liabilities		21				—

Commodity contracts	Accounts payable and accrued expenses		156				23

Commodity contracts	Other liabilities		17				—

Interest rate contracts	Other liabilities		2				3

Other derivative instruments	Accounts payable and accrued expenses		11				—

Total liabilities			$	240			$	50


1	All of the Company's derivative instruments are carried at fair value in our consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master netting agreements and cash collateral. Refer to Note 16 for the net presentation of the Company's derivative instruments.

2	Refer to Note 16 for additional information related to the estimated fair value.
Credit Risk Associated with Derivatives
We have established strict counterparty credit guidelines and enter into transactions only with financial institutions of investment grade or better. We monitor counterparty exposures regularly and review any downgrade in credit rating immediately. If a downgrade in the credit rating of a counterparty were to occur, we have provisions requiring collateral in the form of U.S. government securities for substantially all of our transactions. To mitigate presettlement risk, minimum credit standards become more stringent as the duration of the derivative financial instrument increases. In addition, the Company's master netting agreements reduce credit risk by permitting the Company to net settle for transactions with the same counterparty. To minimize the concentration of credit risk, we enter into derivative transactions with a portfolio of financial institutions. Based on these factors, we consider the risk of counterparty default to be minimal.
Cash Flow Hedging Strategy
The Company uses cash flow hedges to minimize the variability in cash flows of assets or liabilities or forecasted transactions caused by fluctuations in foreign currency exchange rates, commodity prices or interest rates. The changes in the fair values of derivatives designated as cash flow hedges are recorded in AOCI and are reclassified into the line item in our consolidated statement of income in which the hedged items are recorded in the same period the hedged items affect earnings. The changes in fair values of hedges that are determined to be ineffective are immediately reclassified from AOCI into earnings. During the years ended December 31, 2014, 2013 and 2012, the Company did not record any gains or losses into earnings as a result of the discontinuance of cash flow hedges due to forecasted transactions that were no longer expected to occur. The maximum length of time for which the Company hedges its exposure to the variability in future cash flows is typically three years.
The Company maintains a foreign currency cash flow hedging program to reduce the risk that our eventual U.S. dollar net cash inflows from sales outside the United States and U.S. dollar net cash outflows from procurement activities will be adversely affected by changes in foreign currency exchange rates. We enter into forward contracts and purchase foreign currency options (principally euros and Japanese yen) and collars to hedge certain portions of forecasted cash flows denominated in foreign currencies. When the U.S. dollar strengthens against the foreign currencies, the decline in the present value of future foreign currency cash flows is partially offset by gains in the fair value of the derivative instruments. Conversely, when the U.S. dollar weakens, the increase in the present value of future foreign currency cash flows is partially offset by losses in the fair value of the derivative instruments. The total notional values of derivatives that have been designated and qualify for the Company's foreign currency cash flow hedging program were $13,224 million and $8,450 million as of December 31, 2014 and 2013, respectively.
During the year ended December 31, 2014, the Company entered into cross-currency swaps to hedge the changes in the cash flows of its euro-denominated debt due to changes in euro exchange rates. These swaps have been designated as cash flow hedges. The Company records the change in carrying value of the euro-denominated debt due to changes in exchange rates into earnings each period in the line item other income (loss) — net in our consolidated statement of income. The changes in fair value of the cross-currency swap derivatives are recorded into AOCI with an immediate reclassification into earnings for the change in fair value attributable to fluctuations in the euro exchange rates. These swaps have a notional amount of $2,590 million as of December 31, 2014.
The Company has entered into commodity futures contracts and other derivative instruments on various commodities to mitigate the price risk associated with forecasted purchases of materials used in our manufacturing process. The derivative instruments have been designated and qualify as part of the Company's commodity cash flow hedging program. The objective of this hedging program is to reduce the variability of cash flows associated with future purchases of certain commodities. The total notional values of derivatives that have been designated and qualify for this program were $9 million and $26 million as of December 31, 2014 and 2013, respectively.
Our Company monitors our mix of short-term debt and long-term debt regularly. From time to time, we manage our risk to interest rate fluctuations through the use of derivative financial instruments. The Company has entered into interest rate swap agreements and has designated these instruments as part of the Company's interest rate cash flow hedging program. The objective of this hedging program is to mitigate the risk of adverse changes in benchmark interest rates on the Company's future interest payments. The total notional values of these interest rate swap agreements that were designated and qualified for the Company's interest rate cash flow hedging program were $4,328 million and $1,828 million as of December 31, 2014 and 2013, respectively.
The following table presents the pretax impact that changes in the fair values of derivatives designated as cash flow hedges had on AOCI and earnings during the years ended December 31, 2014, 2013 and 2012 (in millions):


	Gain (Loss)				Location of Gain (Loss)		Gain (Loss)				Gain (Loss)
	Recognized				Recognized in Income1		Reclassified from				Recognized in Income
	in Other						AOCI into Income				(Ineffective Portion and
	Comprehensive						(Effective Portion)				Amount Excluded from
	Income ("OCI")										Effectiveness Testing)
2014
Foreign currency contracts	$	973			Net operating revenues		$	121			$	—		2

Foreign currency contracts	50				Cost of goods sold		34				—			2

Foreign currency contracts	(218		)		Other income (loss) — net		(108		)		—

Interest rate contracts	(180		)		Interest expense		—				—

Commodity contracts	—				Cost of goods sold		3				—

Total	$	625					$	50			$	—

2013
Foreign currency contracts	$	218			Net operating revenues		$	149			$	1

Foreign currency contracts	52				Cost of goods sold		32				—			2

Interest rate contracts	169				Interest expense		(12		)		(3		)

Commodity contracts	2				Cost of goods sold		(2		)		—

Total	$	441					$	167			$	(2	)

2012
Foreign currency contracts	$	59			Net operating revenues		$	(46	)		$	2

Foreign currency contracts	34				Cost of goods sold		(23		)		—

Interest rate contracts	1				Interest expense		(12		)		—			2

Commodity contracts	(4		)		Cost of goods sold		(1		)		—

Total	$	90					$	(82	)		$	2


1	The Company records gains and losses reclassified from AOCI in income for the effective portion and ineffective portion, if any, to the same line items in our consolidated statements of income.

2	Includes a de minimis amount of ineffectiveness in the hedging relationship.
As of December 31, 2014, the Company estimates that it will reclassify into earnings during the next 12 months gains of approximately $416 million from the pretax amount recorded in AOCI as the anticipated cash flows occur.
Fair Value Hedging Strategy
The Company uses interest rate swap agreements designated as fair value hedges to minimize exposure to changes in the fair value of fixed-rate debt that results from fluctuations in benchmark interest rates. The changes in fair values of derivatives designated as fair value hedges and the offsetting changes in fair values of the hedged items are recognized in earnings. The ineffective portions of these hedges are immediately recognized into earnings. As of December 31, 2014, such adjustments increased the carrying value of our long-term debt by $34 million. Refer to Note 10. When a derivative is no longer designated as a fair value hedge for any reason, including termination and maturity, the remaining unamortized difference between the carrying value of the hedged item at that time and the par value of the hedged item is amortized to earnings over the remaining life of the hedged item, or immediately if the hedged item has matured. The changes in fair values of hedges that are determined to be ineffective are immediately recognized into earnings. The total notional values of derivatives that related to our fair value hedges of this type were $6,600 million and $5,600 million as of December 31, 2014 and 2013, respectively.
The Company uses fair value hedges to minimize exposure to changes in the fair value of certain available-for-sale securities from fluctuations in foreign currency exchange rates. The changes in fair values of derivatives designated as fair value hedges and the offsetting changes in fair values of the hedged items are recognized in earnings. The changes in fair values of hedges that are determined to be ineffective are immediately recognized into earnings. The total notional values of derivatives that related to our fair value hedges of this type were $1,358 million and $996 million as of December 31, 2014 and 2013, respectively.
The following table summarizes the pretax impact that changes in the fair values of derivatives designated as fair value hedges had on earnings during the years ended December 31, 2014, 2013 and 2012 (in millions):


Hedging Instruments and Hedged Items	Location of Gain (Loss)	Gain (Loss)
	Recognized in Income	Recognized in Income1
2014
Interest rate contracts	Interest expense	$	18

Fixed-rate debt	Interest expense	11

Net impact to interest expense		$	29

Foreign currency contracts	Other income (loss) — net	$	132

Available-for-sale securities	Other income (loss) — net	(165		)
Net impact to other income (loss) — net		$	(33	)
Net impact of fair value hedging instruments		$	(4	)
2013
Interest rate contracts	Interest expense	$	(193	)
Fixed-rate debt	Interest expense	240

Net impact to interest expense		$	47

Foreign currency contracts	Other income (loss) — net	$	24

Available-for-sale securities	Other income (loss) — net	(48		)
Net impact to other income (loss) — net		$	(24	)
Net impact of fair value hedging instruments		$	23

2012
Interest rate contracts	Interest expense	$	89

Fixed-rate debt	Interest expense	(42		)
Net impact to interest expense		$	47

Foreign currency contracts	Other income (loss) — net	$	42

Available-for-sale securities	Other income (loss) — net	(46		)
Net impact to other income (loss) — net		$	(4	)
Net impact of fair value hedging instruments		$	43

1 The net impacts represent the ineffective portions of the hedge relationships and the amounts excluded from the assessment of hedge effectiveness.
Hedges of Net Investments in Foreign Operations Strategy
The Company uses forward contracts to protect the value of our investments in a number of foreign subsidiaries. For derivative instruments that are designated and qualify as hedges of net investments in foreign operations, the changes in fair values of the derivative instruments are recognized in net foreign currency translation gain (loss), a component of AOCI, to offset the changes in the values of the net investments being hedged. Any ineffective portions of net investment hedges are reclassified from AOCI into earnings during the period of change. The total notional values of derivatives under this hedging program were $2,047 million and $2,024 million as of December 31, 2014 and 2013, respectively.
The following table presents the pretax impact that changes in the fair values of derivatives designated as net investment hedges had on AOCI during the years ended December 31, 2014, 2013 and 2012 (in millions):


	Gain (Loss)
	Recognized in OCI
Year Ended December 31,	2014				2013				2012

Foreign currency contracts	$	80			$	61			$	(61	)

The Company did not reclassify any deferred gains or losses related to net investment hedges from AOCI to earnings during the years ended December 31, 2014, 2013 and 2012. In addition, the Company did not have any ineffectiveness related to net investment hedges during the years ended December 31, 2014, 2013 and 2012.
Economic (Non-Designated) Hedging Strategy
In addition to derivative instruments that are designated and qualify for hedge accounting, the Company also uses certain derivatives as economic hedges of foreign currency, interest rate and commodity exposure. Although these derivatives were not designated and/or did not qualify for hedge accounting, they are effective economic hedges. The changes in fair value of economic hedges are immediately recognized into earnings.
The Company uses foreign currency economic hedges to offset the earnings impact that fluctuations in foreign currency exchange rates have on certain monetary assets and liabilities denominated in nonfunctional currencies. The changes in fair value of economic hedges used to offset the monetary assets and liabilities are recognized into earnings in the line item other income (loss) — net in our consolidated statements of income. In addition, we use foreign currency economic hedges to minimize the variability in cash flows associated with changes in foreign currency exchange rates. The changes in fair value of economic hedges used to offset the variability in U.S. dollar net cash flows are recognized into earnings in the line items net operating revenues and cost of goods sold in our consolidated statements of income. The total notional values of derivatives related to our foreign currency economic hedges were $4,334 million and $3,871 million as of December 31, 2014 and 2013, respectively.
The Company also uses certain derivatives as economic hedges to mitigate the price risk associated with the purchase of materials used in the manufacturing process and for vehicle fuel. The changes in fair values of these economic hedges are immediately recognized into earnings in the line items net operating revenues, cost of goods sold, and selling, general and administrative expenses in our consolidated statements of income, as applicable. The total notional values of derivatives related to our economic hedges of this type were $816 million and $1,441 million as of December 31, 2014 and 2013, respectively.
The following table presents the pretax impact that changes in the fair values of derivatives not designated as hedging instruments had on earnings during the years ended December 31, 2014, 2013 and 2012 (in millions):


			Gains (Losses)
Derivatives Not Designated	Location of Gains (Losses)		Year Ended December 31,
as Hedging Instruments	Recognized in Income		2014				2013				2012

Foreign currency contracts	Net operating revenues		$	(6	)		$	5			$	(7	)

Foreign currency contracts	Other income (loss) — net		(85		)		162				24

Foreign currency contracts	Cost of goods sold		—				2				—

Commodity contracts	Net operating revenues		(48		)		5				4

Commodity contracts	Cost of goods sold		(8		)		(122		)		(110		)
Commodity contracts	Selling, general and administrative expenses		(79		)		7				9

Interest rate swaps	Interest expense		—				(3		)		—

Other derivative instruments	Selling, general and administrative expenses		24				55				18

Other derivative instruments	Other income (loss) — net		39				—				—

Total			$	(163	)		$	111			$	(62	)

EQUITY_METHOD_INVESTMENTS

EQUITY METHOD INVESTMENTS	12 Months Ended
	Dec. 31, 2014
EQUITY METHOD INVESTMENTS [Abstract]
EQUITY METHOD INVESTMENTS	EQUITY METHOD INVESTMENTS
	Our consolidated net income includes our Company's proportionate share of the net income or loss of our equity method investees. When we record our proportionate share of net income, it increases equity income (loss) — net in our consolidated statements of income and our carrying value in that investment. Conversely, when we record our proportionate share of a net loss, it decreases equity income (loss) — net in our consolidated statements of income and our carrying value in that investment. The Company's proportionate share of the net income or loss of our equity method investees includes significant operating and nonoperating items recorded by our equity method investees. These items can have a significant impact on the amount of equity income (loss) — net in our consolidated statements of income and our carrying value in those investments. Refer to Note 17 for additional information related to significant operating and nonoperating items recorded by our equity method investees. The carrying values of our equity method investments are also impacted by our proportionate share of items impacting the equity investee's AOCI.
	We eliminate from our financial results all significant intercompany transactions, including the intercompany portion of transactions with equity method investees.
	The Company's equity method investments include our ownership interests in Coca-Cola FEMSA, Coca-Cola Hellenic and Coca-Cola Amatil. As of December 31, 2014, we owned 28 percent, 23 percent and 29 percent, respectively, of these companies' outstanding shares. As of December 31, 2014, our investment in our equity method investees in the aggregate exceeded our proportionate share of the net assets of these equity method investees by $1,671 million. This difference is not amortized.
	A summary of financial information for our equity method investees in the aggregate is as follows (in millions):


	Year Ended December 31,	2014		2013		2012

	Net operating revenues	$	52,627	$	53,038	$	47,087

	Cost of goods sold	31,810		32,377		28,821

	Gross profit	$	20,817	$	20,661	$	18,266

	Operating income	$	4,489	$	4,380	$	4,605

	Consolidated net income	$	2,440	$	2,364	$	2,993

	Less: Net income attributable to noncontrolling interests	74		62		89

	Net income attributable to common shareowners	$	2,366	$	2,302	$	2,904

	Equity income (loss) — net	$	769	$	602	$	819



	December 31,	2014		2013

	Current assets	$	16,184	$	19,229

	Noncurrent assets	40,080		40,427

	Total assets	$	56,264	$	59,656

	Current liabilities	$	12,477	$	14,386

	Noncurrent liabilities	16,657		17,779

	Total liabilities	$	29,134	$	32,165

	Equity attributable to shareowners of investees	$	26,363	$	26,668

	Equity attributable to noncontrolling interests	767		823

	Total equity	$	27,130	$	27,491

	Company equity investment	$	9,947	$	10,393

	Net sales to equity method investees, the majority of which are located outside the United States, were $10,063 million, $9,178 million and $7,082 million in 2014, 2013 and 2012, respectively. Total payments, primarily marketing, made to equity method investees were $1,605 million, $1,807 million and $1,587 million in 2014, 2013 and 2012, respectively. In addition, purchases of finished products from equity method investees were $381 million, $415 million and $392 million in 2014, 2013 and 2012, respectively.
	If valued at the December 31, 2014 quoted closing prices of shares actively traded on stock markets, the value of our equity method investments in publicly traded bottlers would have exceeded our carrying value by $5,443 million.
	Net Receivables and Dividends from Equity Method Investees
	Total net receivables due from equity method investees were $1,448 million and $1,308 million as of December 31, 2014 and 2013, respectively. The total amount of dividends received from equity method investees was $398 million, $401 million and $393 million for the years ended December 31, 2014, 2013 and 2012, respectively. Dividends received included a $35 million special dividend from Coca-Cola Hellenic during 2012. We classified the receipt of the special dividend in cash flows from operating activities because our cumulative equity in earnings from Coca-Cola Hellenic exceeded the cumulative distributions received; therefore, the dividends were deemed to be a return on our investment and not a return of our investment.

PROPERTY_PLANT_AND_EQUIPMENT

PROPERTY, PLANT AND EQUIPMENT	12 Months Ended
	Dec. 31, 2014
Property Plant and Equipament [Abstract]
PROPERTY, PLANT AND EQUIPMENT	PROPERTY, PLANT AND EQUIPMENT
	The following table summarizes our property, plant and equipment (in millions):


	December 31,	2014		2013

	Land	$	972	$	1,011

	Buildings and improvements	5,539		5,605

	Machinery, equipment and vehicle fleet	18,225		17,551

	Construction in progress	522		865

		$	25,258	$	25,032

	Less accumulated depreciation	10,625		10,065

	Property, plant and equipment — net	$	14,633	$	14,967

INTANGIBLE_ASSETS

INTANGIBLE ASSETS	12 Months Ended
	Dec. 31, 2014
INTANGIBLE ASSETS [Abstract]
INTANGIBLE ASSETS	INTANGIBLE ASSETS
	Indefinite-Lived Intangible Assets
	The following table summarizes information related to indefinite-lived intangible assets (in millions):


	December 31,	2014				2013

	Trademarks1	$	6,533			$	6,744

	Bottlers' franchise rights2,3	6,689				7,415

	Goodwill	12,100				12,312

	Other	170				171

	Indefinite-lived intangible assets	$	25,492			$	26,642

	1 The decrease in 2014 was primarily the result of changes in brand strategies causing certain trademarks to become definite-lived, the transfer of the Company's energy brands to assets held for sale and the effect of translation adjustments. This decrease was partially offset by the finalization of purchase accounting related to the Company's consolidation of innocent in 2013. Refer to Note 2 for additional information.

	2	The decrease in 2014 was primarily related to North America refranchising. Refer to Note 2 for additional information.
	3 The Company has agreements with Dr Pepper Snapple Group, Inc. ("DPSG") to distribute Dr Pepper trademark brands in the United States, Canada Dry in the Northeastern United States, and Canada Dry and C' Plus in Canada. As of December 31, 2014, the agreements have remaining terms of 16 years, with automatic 20-year renewal periods unless otherwise terminated under the terms of the agreements and there are no significant costs to renew the agreements. The Company anticipates using the assets indefinitely. The distribution rights acquired from DPSG are the only significant indefinite-lived intangible assets subject to renewal or extension arrangements. The carrying values of these rights as of December 31, 2014 and 2013, were $784 million and $865 million, respectively. The decrease is related to North America refranchising. Refer to Note 2 for additional information.
	The following table provides information related to the carrying value of our goodwill by operating segment (in millions):


		Eurasia &				Europe			Latin			North				Asia Pacific			Bottling			Total
		Africa							America			America							Investments
	2013
	Balance as of January 1	$	34			$	691		$	168		$	10,577			$	123		$	662		$	12,255

	Effect of foreign currency translation	(3		)		29			(12		)	—				(6		)	10			18

	Acquisitions1	5				102			—			—				—			20			127

	Adjustments related to the finalization	—				—			—			(4		)		—			(1		)	(5		)
	of purchase accounting1
	Impairment2	—				—			—			—				—			(82		)	(82		)

	Divestitures, deconsolidations and other	—				—			—			(1		)		—			—			(1		)

	Balance as of December 31	$	36			$	822		$	156		$	10,572			$	117		$	609		$	12,312

	2014
	Balance as of January 1	$	36			$	822		$	156		$	10,572			$	117		$	609		$	12,312

	Effect of foreign currency translation	(2		)		(60		)	(9		)	—				(2		)	(26		)	(99		)

	Acquisitions1	—				—			—			11				16			3			30

	Adjustments related to the finalization	(4		)		(43		)	—			—				—			(14		)	(61		)
	of purchase accounting1
	Divestitures, deconsolidations and other1	(3		)		—			—			(79		)		—			—			(82		)

	Balance as of December 31	$	27			$	719		$	147		$	10,504			$	131		$	572		$	12,100


	1	Refer to Note 2 for information related to the Company's acquisitions and divestitures.

	2	Refer to Note 17 for information related to the Company's impairment of goodwill.
	Definite-Lived Intangible Assets
	The following table summarizes information related to definite-lived intangible assets (in millions):


		December 31, 2014									December 31, 2013
		Gross Carrying Amount			Accumulated Amortization			Net			Gross Carrying Amount		Accumulated Amortization			Net

Customer relationships1	$	597		$	(229	)	$	368		$	642	$	(202	)	$	440

Bottlers' franchise rights1	664			(375		)	289			722		(317		)	405

Trademarks2	222			(39		)	183			105		(26		)	79

Other	96			(56		)	40			128		(83		)	45

Total	$	1,579		$	(699	)	$	880		$	1,597	$	(628	)	$	969


1	The decrease in 2014 was primarily due to the derecognition of intangible assets as a result of the North America refranchising. Refer to Note 2 for additional information.

2	The increase in 2014 was the result of changes in brand strategies causing certain indefinite-lived trademarks to become definite-lived.
Total amortization expense for intangible assets subject to amortization was $168 million, $165 million and $173 million in 2014, 2013 and 2012, respectively.
Based on the carrying value of definite-lived intangible assets as of December 31, 2014, we estimate our amortization expense for the next five years will be as follows (in millions):


		Amortization
		Expense
2015		$	156

2016		149

2017		121

2018		61

2019		59

ACCOUNTS_PAYABLE_AND_ACCRUED_E

ACCOUNTS PAYABLE AND ACCRUED EXPENSES	12 Months Ended
	Dec. 31, 2014
ACCOUNTS PAYABLE AND ACCRUED EXPENSES Disclosure [Abstract]
ACCOUNTS PAYABLES AND ACCRUED EXPENSES	ACCOUNTS PAYABLE AND ACCRUED EXPENSES
	Accounts payable and accrued expenses consisted of the following (in millions):


	December 31,	2014		2013

	Accrued marketing	$	2,103	$	2,407

	Other accrued expenses	3,182		3,515

	Trade accounts payable	2,089		1,933

	Accrued compensation	997		933

	Sales, payroll and other taxes	511		450

	Container deposits	352		339

	Accounts payable and accrued expenses	$	9,234	$	9,577

DEBT_AND_BORROWING_ARRANGEMENT

DEBT AND BORROWING ARRANGEMENTS	12 Months Ended
DEBT AND BORROWING ARRANGEMENTS	Dec. 31, 2014
Debt and Borrowing Arrangements Disclosure [Abstract]
DEBT AND BORROWING ARRANGEMENTS	DEBT AND BORROWING ARRANGEMENTS
	Short-Term Borrowings
	Loans and notes payable consist primarily of commercial paper issued in the United States. As of December 31, 2014 and 2013, we had $19,010 million and $16,853 million, respectively, in outstanding commercial paper borrowings. Our weighted-average interest rates for commercial paper outstanding were approximately 0.2 percent and 0.2 percent per year as of December 31, 2014 and 2013, respectively.
	In addition, we had $8,723 million in lines of credit and other short-term credit facilities as of December 31, 2014. The Company's total lines of credit included $120 million that was outstanding and primarily related to our international operations.
	Included in the credit facilities discussed above, the Company had $7,677 million in lines of credit for general corporate purposes. These backup lines of credit expire at various times from 2015 through 2019. There were no borrowings under these backup lines of credit during 2014. These credit facilities are subject to normal banking terms and conditions. Some of the financial arrangements require compensating balances, none of which is presently significant to our Company.
	Long-Term Debt
	During 2014, the Company issued $3,537 million of long-term debt. The general terms of the notes issued are as follows:

	•	$1,000 million total principal amount of notes due September 1, 2015, at a variable interest rate equal to the three-month London Interbank Offered Rate ("LIBOR") plus 0.01 percent;

	•	$1,015 million total principal amount of euro notes due September 22, 2022, at a fixed interest rate of 1.125 percent; and

	•	$1,522 million total principal amount of euro notes due September 22, 2026, at a fixed interest rate of 1.875 percent.
	During 2014, the Company retired $1,000 million of long-term debt upon maturity.
	During 2013, the Company issued $7,500 million of long-term debt. The general terms of the notes issued are as follows:

	•	$500 million total principal amount of notes due March 5, 2015, at a variable interest rate equal to the three-month LIBOR minus 0.02 percent;

	•	$500 million total principal amount of notes due November 1, 2016, at a variable interest rate equal to the three-month LIBOR plus 0.10 percent;

	•	$500 million total principal amount of notes due November 1, 2016, at a fixed interest rate of 0.75 percent;

	•	$1,250 million total principal amount of notes due April 1, 2018, at a fixed interest rate of 1.15 percent;

	•	$1,250 million total principal amount of notes due November 1, 2018, at a fixed interest rate of 1.65 percent;

	•	$1,250 million total principal amount of notes due November 1, 2020, at a fixed interest rate of 2.45 percent;

	•	$750 million total principal amount of notes due April 1, 2023, at a fixed interest rate of 2.50 percent; and

	•	$1,500 million total principal amount of notes due November 1, 2023, at a fixed interest rate of 3.20 percent.
	During 2013, the Company retired $1,250 million of debt upon maturity. The Company also extinguished $2,154 million of long-term debt prior to maturity, incurring associated extinguishment charges of $50 million. The general terms of the notes that were extinguished were:

	•	$225 million total principal amount of notes due August 15, 2013, at a fixed interest rate of 5.0 percent;

	•	$675 million total principal amount of notes due March 3, 2014, at a fixed interest rate of 7.375 percent;

	•	$900 million total principal amount of notes due March 15, 2014, at a fixed interest rate of 3.625 percent; and

	•	$354 million total principal amount of notes due March 1, 2015, at a fixed interest rate of 4.25 percent.
	During 2012, the Company retired $1,250 million of long-term notes upon maturity and issued $2,750 million of long-term debt. The general terms of the notes issued are as follows:

	•	$1,000 million total principal amount of notes due March 14, 2014, at a variable interest rate equal to the three-month LIBOR minus 0.05 percent;

	•	$1,000 million total principal amount of notes due March 13, 2015, at a fixed interest rate of 0.75 percent; and

	•	$750 million total principal amount of notes due March 14, 2018, at a fixed interest rate of 1.65 percent.
	The Company's long-term debt consisted of the following (in millions, except average rate data):


		December 31, 2014						December 31, 2013
		Amount			Average			Amount			Average
		Amount			Rate 1			Amount			Rate1
	U.S. dollar notes due 2015–2093	$	17,433		1.8	%		$	17,427		1.8	%
	U.S. dollar notes due 2015–2093	$	17,433		1.8	%		$	17,427		1.8	%
	U.S. dollar debentures due 2017–2098	2,157			3.9			2,191			3.9
	U.S. dollar debentures due 2017–2098	2,157			3.9			2,191			3.9
	U.S. dollar zero coupon notes due 20202	143			8.4			138			8.4
	U.S. dollar zero coupon notes due 20202	143			8.4			138			8.4
	Euro notes due 2022 and 20263	2,468			3.7			—			—
	Euro notes due 2022 and 20263	2,468			3.7			—			—
	Other, due through 20984	380			4			370			4
	Other, due through 20984	380			4			370			4
	Fair value adjustment5	34			N/A			52			N/A
	Fair value adjustment5	34			N/A			52			N/A
Total6,7	$	22,615		2.2	%		$	20,178		2.2	%
Total6,7	$	22,615		2.2	%		$	20,178		2.2	%
Less current portion	3,552						1,024
Less current portion	3,552						1,024
Long-term debt	$	19,063					$	19,154
Long-term debt	$	19,063					$	19,154

1	These rates represent the weighted-average effective interest rate on the balances outstanding as of year end, as adjusted for the effects of interest rate swap agreements, cross currency swap agreements and fair value adjustments, if applicable. Refer to Note 5 for a more detailed discussion on interest rate management.

2	This amount is shown net of unamortized discounts of $28 million and $33 million as of December 31, 2014 and 2013, respectively.

3	This amount includes adjustments recorded due to changes in foreign currency exchange rates.

4	As of December 31, 2014, the amount shown includes $199 million of debt instruments that are due through 2031.

5	Refer to Note 5 for additional information about our fair value hedging strategy.

6	As of December 31, 2014 and 2013, the fair value of our long-term debt, including the current portion, was $23,411 million and $20,352 million, respectively. The fair value of our long-term debt is estimated based on quoted prices for those or similar instruments.

7	The above notes and debentures include various restrictions, none of which is presently significant to our Company.
The carrying value of the Company's long-term debt included fair value adjustments related to the debt assumed from Coca-Cola Enterprises Inc. ("CCE") of $464 million and $514 million as of December 31, 2014 and 2013, respectively. These fair value adjustments are being amortized over the number of years remaining until the underlying debt matures. As of December 31, 2014, the weighted-average maturity of the assumed debt to which these fair value adjustments relate was approximately 20 years. The amortization of these fair value adjustments will be a reduction of interest expense in future periods, which will typically result in our interest expense being less than the actual interest paid to service the debt. Total interest paid was $498 million, $498 million and $574 million in 2014, 2013 and 2012, respectively.
Maturities of long-term debt for the five years succeeding December 31, 2014, are as follows (in millions):


	Maturities of
	Long-Term Debt
2015	$	3,552
2015	$	3,552
2016	2,689
2016	2,689
2017	1,363
2017	1,363
2018	3,308
2018	3,308
2019	1,004
2019	1,004

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES
	Guarantees
	As of December 31, 2014, we were contingently liable for guarantees of indebtedness owed by third parties of $565 million, of which $155 million was related to VIEs. Refer to Note 1 for additional information related to the Company's maximum exposure to loss due to our involvement with VIEs. Our guarantees are primarily related to third-party customers, bottlers, vendors and container manufacturing operations and have arisen through the normal course of business. These guarantees have various terms, and none of these guarantees was individually significant. The amount represents the maximum potential future payments that we could be required to make under the guarantees; however, we do not consider it probable that we will be required to satisfy these guarantees.
	We believe our exposure to concentrations of credit risk is limited due to the diverse geographic areas covered by our operations.
	Legal Contingencies
	The Company is involved in various legal proceedings. We establish reserves for specific legal proceedings when we determine that the likelihood of an unfavorable outcome is probable and the amount of loss can be reasonably estimated. Management has also identified certain other legal matters where we believe an unfavorable outcome is reasonably possible and/or for which no estimate of possible losses can be made. Management believes that the total liabilities to the Company that may arise as a result of currently pending legal proceedings will not have a material adverse effect on the Company taken as a whole.
	Indemnifications
	At the time we acquire or divest our interest in an entity, we sometimes agree to indemnify the seller or buyer for specific contingent liabilities. Management believes that any liability to the Company that may arise as a result of any such indemnification agreements will not have a material adverse effect on the Company taken as a whole.
	Tax Audits
	The Company is involved in various tax matters, with respect to some of which the outcome is uncertain. These audits may result in the assessment of additional taxes that are subsequently resolved with authorities or potentially through the courts. Refer to Note 14.
	Risk Management Programs
	The Company has numerous global insurance programs in place to help protect the Company from the risk of loss. In general, we are self-insured for large portions of many different types of claims; however, we do use commercial insurance above our self-insured retentions to reduce the Company's risk of catastrophic loss. Our reserves for the Company's self-insured losses are estimated through actuarial procedures of the insurance industry and by using industry assumptions, adjusted for our specific expectations based on our claim history. The Company's self-insurance reserves totaled $530 million and $537 million as of December 31, 2014 and 2013, respectively.
	Workforce (Unaudited)
	We refer to our employees as "associates." As of December 31, 2014, our Company had approximately 129,200 associates, of which approximately 65,300 associates were located in the United States. Our Company, through its divisions and subsidiaries, is a party to numerous collective bargaining agreements. As of December 31, 2014, approximately 18,000 associates, excluding seasonal hires, in North America were covered by collective bargaining agreements. These agreements typically have terms of three to five years. We currently expect that we will be able to renegotiate such agreements on satisfactory terms when they expire. The Company believes that its relations with its associates are generally satisfactory.
	Operating Leases
	The following table summarizes our minimum lease payments under noncancelable operating leases with initial or remaining lease terms in excess of one year as of December 31, 2014 (in millions):


	Year Ended December 31,	Operating Lease Payments

	2015	$	230

	2016	161

	2017	128

	2018	98

	2019	71

	Thereafter	277

	Total minimum operating lease payments1	$	965


	1	Income associated with sublease arrangements is not significant.

STOCK_COMPENSATION_PLANS

STOCK COMPENSATION PLANS	12 Months Ended
	Dec. 31, 2014
STOCK COMPENSATION PLANS [Abstract]
STOCK COMPENSATION PLANS	STOCK COMPENSATION PLANS
	Our Company grants stock options and restricted stock awards to certain employees of the Company. Total stock-based compensation expense was $209 million, $227 million and $259 million in 2014, 2013 and 2012, respectively, and was included as a component of selling, general and administrative expenses in our consolidated statements of income. The total income tax benefit recognized in our consolidated statements of income related to stock-based compensation arrangements was $57 million, $62 million and $72 million in 2014, 2013 and 2012, respectively.
	As of December 31, 2014, we had $437 million of total unrecognized compensation cost related to nonvested share-based compensation arrangements granted under our plans. This cost is expected to be recognized over a weighted-average period of 2.2 years as stock-based compensation expense. This expected cost does not include the impact of any future stock-based compensation awards.
	The Coca-Cola Company 2014 Equity Plan (the "2014 Equity Plan") was approved by shareowners in April 2014. Under the 2014 Equity Plan, a maximum of 500 million shares of our common stock was approved to be issued, through the grant of equity awards, to certain employees. As of December 31, 2014, no grants have been made under the 2014 Equity Plan. Beginning in 2015, the 2014 Equity Plan will be the primary plan in use for equity awards.
	Stock Option Plans
	The fair value of our stock option grants is amortized over the vesting period, generally four years. The fair value of each option award is estimated on the grant date using a Black-Scholes-Merton option-pricing model.
	The weighted-average fair value of options granted during the past three years and the weighted-average assumptions used in the Black-Scholes-Merton option-pricing model for such grants were as follows:


		2014				2013				2012

	Fair value of options at grant date	$	3.91			$	3.73			$	3.8

	Dividend yield1	2.7		%		2.8		%		2.7		%
	Expected volatility2	16		%		17		%		18		%
	Risk-free interest rate3	1.6		%		0.9		%		1		%
	Expected term of the option4	5 years				5 years				5 years


	1	The dividend yield is the calculated yield on the Company's stock at the time of the grant.

	2	Expected volatility is based on implied volatilities from traded options on the Company's stock, historical volatility of the Company's stock and other factors.

	3	The risk-free interest rate for the period matching the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of the grant.

	4	The expected term of the option represents the period of time that options granted are expected to be outstanding and is derived by analyzing historical exercise behavior.
	Generally, stock options granted from 1999 through July 2003 expire 15 years from the date of grant and stock options granted in December 2003 and thereafter expire 10 years from the date of grant. The shares of common stock to be issued and/or sold under the stock option plans are made available from authorized and unissued Company common stock or from the Company's treasury shares. In 2007, the Company began issuing common stock under these plans from the Company's treasury shares.
	In addition to the 2014 Equity Plan discussed above, the Company had the following stock option plans as of December 31, 2014:

	•	The Coca-Cola Company 1999 Stock Option Plan (the "1999 Option Plan") was approved by shareowners in April 1999. Under the 1999 Option Plan, a maximum of 240 million shares of our common stock was approved to be issued, through the grant of stock options, to certain officers and employees.

	•	The Coca-Cola Company 2002 Stock Option Plan (the "2002 Option Plan") was approved by shareowners in April 2002. An amendment to the 2002 Option Plan which permitted the issuance of stock appreciation rights was approved by shareowners in April 2003. Under the 2002 Option Plan, a maximum of 240 million shares of our common stock was approved to be issued, through the grant of stock options or stock appreciation rights, to certain officers and employees. No stock appreciation rights have been issued under the 2002 Option Plan as of December 31, 2014. There are no longer any shares available for grant from the 2002 Option Plan.

	•	The Coca-Cola Company 2008 Stock Option Plan (the "2008 Option Plan") was approved by shareowners in April 2008. Under the 2008 Option Plan, a maximum of 280 million shares of our common stock was approved to be issued, through the grant of stock options, to certain officers and employees.

	•	As a result of our acquisition of CCE's former North America business, the Company assumed certain stock-based compensation plans previously sponsored by CCE. The assumed Coca-Cola Enterprises Inc. 2001 Stock Option Plan, Coca-Cola Enterprises Inc. 2004 Stock Award Plan and Coca-Cola Enterprises Inc. 2007 Incentive Award Plan previously sponsored by CCE have approximately 1.4 million shares outstanding after conversion of CCE common stock into our common stock. The Company has not granted any equity awards from the assumed plans since the acquisition, and as of December 31, 2014, no shares remain available for grant.
	As of December 31, 2014, there were 2.7 million shares available to be granted under the 1999 Option Plan and 2008 Option Plan. Options to purchase common stock under these plans have generally been granted at the fair market value of the Company's stock at the date of grant.
	Stock option activity for all stock option plans for the year ended December 31, 2014, was as follows:


		Shares			Weighted-Average				Weighted-Average		Aggregate
		(In millions)			Exercise Price				Remaining		Intrinsic Value
									Contractual Life		(In millions)
	Outstanding on January 1, 2014	305			$	29.42

	Granted	68			37.24

	Exercised	(58	)		26.12

	Forfeited/expired	(10	)		35.03

	Outstanding on December 31, 20141	305			$	31.6			6.07 years		$	3,241

	Expected to vest at December 31, 2014	300			$	31.51			6.03 years		$	3,216

	Exercisable on December 31, 2014	173			$	27.85			4.35 years		$	2,480


	1	Includes 1.4 million stock option replacement awards in connection with our acquisition of CCE's former North America business in 2010. These options had a weighted-average exercise price of $16.62 and generally vest over 3 years and expire 10 years from the original date of grant.
	The total intrinsic value of the options exercised was $894 million, $815 million and $780 million in 2014, 2013 and 2012, respectively. The total shares exercised were 58 million, 53 million and 61 million in 2014, 2013 and 2012, respectively.
	Restricted Stock Award Plans
	Under The Coca-Cola Company 1989 Restricted Stock Award Plan and The Coca-Cola Company 1983 Restricted Stock Award Plan (the "Restricted Stock Award Plans"), 80 million and 48 million shares of restricted common stock, respectively, were originally available to be granted to certain officers and key employees of our Company. As of December 31, 2014, 0.2 million shares remain available for grant under the Restricted Stock Award Plans. The Company issues restricted stock to employees as a result of performance share unit awards, time-based awards and performance-based awards.
	For awards prior to January 1, 2008, under the 1983 Restricted Stock Award Plan, participants are reimbursed by our Company for income taxes imposed on the award, but not for taxes generated by the reimbursement payment. The 1983 Restricted Stock Award Plan has been amended to eliminate this tax reimbursement for awards after January 1, 2008. The shares are subject to certain transfer restrictions and may be forfeited if a participant leaves our Company for reasons other than retirement, disability or death, absent a change in control of our Company.
	Performance Share Unit Awards
In 2003, the Company established a program to grant performance share units under The Coca-Cola Company 1989 Restricted Stock Award Plan to executives. In 2008, the Company expanded the program to award a mix of stock options and performance share units to a broader group of eligible employees. Performance share units under The Coca-Cola Company 1989 Restricted Stock Award Plan require achievement of certain performance criteria, which are predefined by the Compensation Committee of the Board of Directors at the time of grant. The primary performance criteria used is compound annual growth in economic profit over a predefined performance period, which is generally three years. The compound annual growth in economic profit, which is adjusted for certain items, is approved and certified by the Audit Committee of the Board of Directors. The purpose of these adjustments is to ensure a consistent year to year comparison of the specific performance criteria. Economic profit is our net operating profit after tax less the cost of the capital used in our business. In the event the certified results equal the predefined performance criteria, the Company will grant the number of restricted shares or share units equal to the target award in the underlying performance share unit agreements. In the event the certified results exceed the predefined performance criteria, additional restricted shares or share units up to the maximum award may be granted. In the event the certified results fall below the predefined performance criteria, a reduced number of restricted shares or share units may be granted. If the certified results fall below the threshold award performance level, no restricted shares or share units will be granted. The restricted shares or share units granted under this program are then generally subject to a holding period before the restricted shares or share units are released. For performance share units granted before 2008, this holding period was generally two years. For performance share units granted in 2008 and after, this holding period is generally one year. Restrictions on such shares or share units lapse at the end of the holding period. Performance share units generally do not pay dividends or allow voting rights during the performance period. For awards granted prior to 2011, participants generally are entitled to dividends or dividend equivalents once the performance criteria have been certified and the restricted shares or share units have been issued. For awards granted in 2011 and later, participants generally are entitled to receive dividends or dividend equivalents once the shares have been released. Accordingly, the fair value of the performance share units is the quoted market value of the Company stock on the grant date less the present value of the expected dividends not received during the relevant period. For certain performance share units granted beginning in 2014, the Company includes a relative TSR modifier to determine the number of restricted shares or share units earned at the end of the performance period. For these awards, the number of restricted shares or share units earned based on the certified achievement of the predefined performance criteria will be reduced or increased if total shareowner return over the performance period relative to a predefined compensation comparator group of companies falls outside of a defined range. The fair value of performance share units that include the TSR modifier is determined using a Monte Carlo valuation model.
In the period it becomes probable that the minimum performance criteria specified in the plan will be achieved, we recognize expense for the proportionate share of the total fair value of the performance share units related to the vesting period that has already lapsed for the shares expected to vest and be released. The remaining fair value of the shares expected to vest and be released is expensed on a straight-line basis over the balance of the vesting period. In the event the Company determines it is no longer probable that we will achieve the minimum performance criteria specified in the plan, we reverse all of the previously recognized compensation expense in the period such a determination is made.
Performance share units are generally settled in stock, except for certain circumstances such as death or disability, in which case former employees or their beneficiaries are provided a cash equivalent payment. As of December 31, 2014, performance share units of 6,017,000, 5,608,000 and 5,801,000 were outstanding for the 2012–2014, 2013–2015 and 2014–2016 performance periods, respectively, based on the target award amounts in the performance share unit agreements.
The following table summarizes information about performance share units based on the target award amounts in the performance share unit agreements:


	Share Units			Weighted-Average
	(In thousands)			Grant Date
				Fair Value
Outstanding on January 1, 2014	17,974			$	30.41

Granted	6,117			32.33

Paid in cash equivalent	(5	)		30.59

Canceled/forfeited	(6,660	)		29.11

Outstanding on December 31, 20141	17,426			$	31.59


1	The outstanding performance share units as of December 31, 2014, at the threshold award and maximum award levels were 8.7 million and 26.1 million, respectively.
The weighted-average grant date fair value of performance share units granted was $32.33 in 2014, $32.67 in 2013 and $29.95 in 2012. The Company converted performance share units of 5,403 in 2014, 54,999 in 2013 and 16,267 in 2012 to cash equivalent payments of $0.2 million, $1.8 million and $0.6 million, respectively, to former employees who were ineligible for restricted stock grants due to certain events such as death or disability.
The following table summarizes information about nonvested restricted stock and stock units:


	Restricted Stock and Stock Units			Weighted-Average
	(In thousands)			Grant Date
				Fair Value1
Nonvested on January 1, 20142	7,014			$	25.17

Vested and released	(6,774	)		25.17

Canceled/forfeited	(110	)		25.17

Nonvested on December 31, 20142	130			$	25.17


1	The weighted-average grant date fair value is based on the fair values of the performance share units granted.

2	The nonvested restricted stock and stock units as of January 1, 2014, and December 31, 2014, are presented at the performance share units' certified award level.
The total intrinsic value of restricted shares that were vested and released was $255 million, $16 million and $148 million in 2014, 2013 and 2012, respectively. The total restricted share units vested and released in 2014 were 6,773,934 at the certified award level. In 2013 and 2012, the total restricted share units vested and released were 405,963 and 4,301,732, respectively.
Replacement performance share unit awards issued by the Company in connection with our acquisition of CCE's former North America business are not included in the tables or discussions above and were originally granted under the Coca-Cola Enterprises Inc. 2007 Incentive Award Plan. These awards were converted into equivalent share units of the Company's common stock on the acquisition date and entitle the participant to dividend equivalents (which vest, in some cases, only if the restricted share units vest), but not the right to vote. Accordingly, the fair value of these units was the quoted value of the Company's stock at the grant date.
On the acquisition date, the Company issued 3.3 million replacement performance share unit awards at target with a weighted-average grant date price of $29.56 per share that were either projected to pay out at, or previously certified at, a payout rate of 200 percent. In accordance with accounting principles generally accepted in the United States, the portion of the fair value of the replacement awards related to services provided prior to the acquisition was included in the total purchase price. The portion of the fair value associated with future service was recognized as expense in the fourth quarter of 2010. The Company released shares with an intrinsic value of $5 million and $22 million in 2013 and 2012, respectively. As of December 31, 2014, the Company had no remaining outstanding replacement performance share units.
Time-Based and Performance-Based Restricted Stock and Restricted Stock Unit Awards
The Coca-Cola Company 1989 Restricted Stock Award Plan allows for the grant of time-based and performance-based restricted stock and restricted stock units. The performance-based restricted awards are released only upon the achievement of specific measurable performance criteria. These awards pay dividends during the performance period. If the performance targets are not met, the awards will be canceled. In the period it becomes probable that the performance criteria will be achieved, we recognize expense for the proportionate share of the total fair value of the shares expected to vest and be released related to the vesting period that has already lapsed. The remaining fair value of the shares expected to vest and be released is expensed on a straight-line basis over the balance of the vesting period.
For time-based and performance-based restricted stock awards, participants are entitled to vote and receive dividends on the restricted shares. The Company also awards time-based and performance-based restricted stock units for which participants may receive payments of dividend equivalents but are not entitled to vote. As of December 31, 2014, the Company had outstanding nonvested time-based and performance-based restricted stock awards, including restricted stock units, of 571,399 and 57,200, respectively. Time-based and performance-based restricted stock awards were not significant to our consolidated financial statements.
In 2010, the Company issued time-based restricted stock replacement awards, including restricted stock units, in connection with our acquisition of CCE's former North America business. These awards were converted into equivalent shares of the Company's common stock. These restricted share awards entitle the participant to dividend equivalents (which vest, in some cases, only if the restricted share unit vests), but not the right to vote. As of December 31, 2014, the Company had no outstanding nonvested time-based restricted stock replacement awards, including restricted stock units.

PENSION_AND_OTHER_POSTRETIREME

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS	12 Months Ended
PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS	Dec. 31, 2014
Pension and Other Postretirement Benefit Plans [Abstract]
PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS	PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS
	Our Company sponsors and/or contributes to pension and postretirement health care and life insurance benefit plans covering substantially all U.S. employees. We also sponsor nonqualified, unfunded defined benefit pension plans for certain associates. In addition, our Company and its subsidiaries have various pension plans and other forms of postretirement arrangements outside the United States.
	We refer to the funded defined benefit pension plan in the United States that is not associated with collective bargaining organizations as the "primary U.S. plan." As of December 31, 2014, the primary U.S. plan represented 58 percent and 61 percent of the Company's consolidated projected benefit obligation and pension assets, respectively.
	In December 2013, the Company modified The Coca-Cola Company Retiree Health Plan. Effective January 1, 2015, the current prescription drug plan will be replaced by a Company-sponsored Medicare Part D Plan. The change reduced the accumulated postretirement benefit obligation of the plan by approximately $71 million. The Coca-Cola Refreshments Welfare Plan for Retirees will not be impacted by this change because of variations in the design of the plan.
	Obligations and Funded Status
	The following table sets forth the changes in benefit obligations and the fair value of plan assets for our benefit plans (in millions):


		Pension Benefits								Other Benefits
		2014				2013				2014				2013
		2014				2013				2014				2013
	Benefit obligation at beginning of year1	$	8,845			$	9,693			$	946			$	1,104
	Benefit obligation at beginning of year1	$	8,845			$	9,693			$	946			$	1,104
	Service cost	261				280				26				36
	Service cost	261				280				26				36
	Interest cost	406				378				43				42
	Interest cost	406				378				43				42
	Foreign currency exchange rate changes	(183		)		(69		)		(4		)		(2		)
	Amendments	—				(1		)		(31		)		(73		)
	Amendments	—				(1		)		(31		)		(73		)
	Actuarial loss (gain)	1,519				(899		)		88				(91		)
	Actuarial loss (gain)	1,519				(899		)		88				(91		)
	Benefits paid2	(522		)		(538		)		(62		)		(77		)
	Business combinations	4				—				—				—
	Business combinations	4				—				—				—
	Settlements	(7		)		(9		)		(1		)		—
	Settlements	(7		)		(9		)		(1		)		—
	Special termination benefits	5				2				—				—
	Special termination benefits	5				2				—				—
	Other	18				8				1				7
	Other	18				8				1				7
	Benefit obligation at end of year1	$	10,346			$	8,845			$	1,006			$	946
	Benefit obligation at end of year1	$	10,346			$	8,845			$	1,006			$	946
	Fair value of plan assets at beginning of year	$	8,746			$	7,584			$	243			$	202
	Fair value of plan assets at beginning of year	$	8,746			$	7,584			$	243			$	202
	Actual return on plan assets	574				1,043				2				40
	Actual return on plan assets	574				1,043				2				40
	Employer contributions	214				639				—				—
	Employer contributions	214				639				—				—
	Foreign currency exchange rate changes	(203		)		(43		)		—				—
	Foreign currency exchange rate changes	(203		)		(43		)		—				—
	Benefits paid	(435		)		(474		)		(3		)		(2		)
	Settlements	(1		)		(5		)		—				—
	Settlements	(1		)		(5		)		—				—
	Other	7				2				4				3
	Other	7				2				4				3
	Fair value of plan assets at end of year	$	8,902			$	8,746			$	246			$	243
	Fair value of plan assets at end of year	$	8,902			$	8,746			$	246			$	243
	Net liability recognized	$	(1,444	)		$	(99	)		$	(760	)		$	(703	)

	1	For pension benefit plans, the benefit obligation is the projected benefit obligation. For other benefit plans, the benefit obligation is the accumulated postretirement benefit obligation. The accumulated benefit obligation for our pension plans was $10,028 million and $8,523 million as of December 31, 2014 and 2013, respectively.

	2	Benefits paid to pension plan participants during 2014 and 2013 included $87 million and $64 million, respectively, in payments related to unfunded pension plans that were paid from Company assets. Benefits paid to participants of other benefit plans during 2014 and 2013 included $59 million and $75 million, respectively, that were paid from Company assets.
	Pension and other benefit amounts recognized in our consolidated balance sheets are as follows (in millions):


		Pension Benefits								Other Benefits
	December 31,	2014				2013				2014				2013
	December 31,	2014				2013				2014				2013
	Noncurrent asset	$	479			$	1,067			$	—			$	—
	Noncurrent asset	$	479			$	1,067			$	—			$	—
	Current liability	(78		)		(76		)		(20		)		(21		)
	Long-term liability	(1,845		)		(1,090		)		(740		)		(682		)
	Net liability recognized	$	(1,444	)		$	(99	)		$	(760	)		$	(703	)
Certain of our pension plans have projected benefit obligations in excess of the fair value of plan assets. For these plans, the projected benefit obligations and the fair value of plan assets were as follows (in millions):


December 31,	2014				2013
December 31,	2014				2013
Projected benefit obligation	$	8,753			$	1,521
Projected benefit obligation	$	8,753			$	1,521
Fair value of plan assets	6,854				374
Fair value of plan assets	6,854				374
Certain of our pension plans have accumulated benefit obligations in excess of the fair value of plan assets. For these plans, the accumulated benefit obligations and the fair value of plan assets were as follows (in millions):


December 31,	2014				2013
December 31,	2014				2013
Accumulated benefit obligation	$	8,501			$	1,446
Accumulated benefit obligation	$	8,501			$	1,446
Fair value of plan assets	6,820				351
Fair value of plan assets	6,820				351
Pension Plan Assets
The following table presents total assets for our U.S. and non-U.S. pension plans (in millions):


	U.S. Plans								Non-U.S. Plans
December 31,	2014				2013				2014				2013
December 31,	2014				2013				2014				2013
Cash and cash equivalents	$	186			$	240			$	75			$	274
Cash and cash equivalents	$	186			$	240			$	75			$	274
Equity securities:
U.S.-based companies	1,274				1,422				542				280
U.S.-based companies	1,274				1,422				542				280
International-based companies	558				698				505				586
International-based companies	558				698				505				586
Fixed-income securities:
Government bonds	455				464				411				304
Government bonds	455				464				411				304
Corporate bonds and debt securities	1,379				1,369				187				137
Corporate bonds and debt securities	1,379				1,369				187				137
Mutual, pooled and commingled funds1	863				1,134				400				453
Mutual, pooled and commingled funds1	863				1,134				400				453
Hedge funds/limited partnerships	756				526				43				17
Hedge funds/limited partnerships	756				526				43				17
Real estate	391				245				17				6
Real estate	391				245				17				6
Other	481				245				379				346
Other	481				245				379				346
Total pension plan assets2	$	6,343			$	6,343			$	2,559			$	2,403
Total pension plan assets2	$	6,343			$	6,343			$	2,559			$	2,403

1	Mutual, pooled and commingled funds include investments in equity securities, fixed-income securities and combinations of both. There are a significant number of mutual, pooled and commingled funds from which investors can choose. The selection of the type of fund is dictated by the specific investment objectives and needs of a given plan. These objectives and needs vary greatly between plans.

2	Fair value disclosures related to our pension assets are included in Note 16. Fair value disclosures include, but are not limited to, the levels within the fair value hierarchy in which the fair value measurements in their entirety fall; a reconciliation of the beginning and ending balances of Level 3 assets; and information about the valuation techniques and inputs used to measure the fair value of our pension assets.
Investment Strategy for U.S. Pension Plans
The Company utilizes the services of investment managers to actively manage the assets of our U.S. pension plans. We have established asset allocation targets and investment guidelines with each investment manager. Our asset allocation targets promote optimal expected return and volatility characteristics given the long-term time horizon for fulfilling the obligations of the plan. Selection of the targeted asset allocation for U.S. plan assets was based upon a review of the expected return and risk characteristics of each asset class, as well as the correlation of returns among asset classes. During 2012, the Company revised the asset allocation targets and restructured the investment manager composition to further diversify investment risk and reduce volatility while maintaining our long-term return objectives. Our revised target allocation is a mix of 42 percent equity investments, 30 percent fixed-income investments and 28 percent alternative investments. We believe this target allocation will enable us to achieve the following long-term investment objectives:

-1	optimize the long-term return on plan assets at an acceptable level of risk;

-2	maintain a broad diversification across asset classes and among investment managers; and

-3	maintain careful control of the risk level within each asset class.
The guidelines that have been established with each investment manager provide parameters within which the investment managers agree to operate, including criteria that determine eligible and ineligible securities, diversification requirements and credit quality standards, where applicable. Unless exceptions have been approved, investment managers are prohibited from buying or selling commodities, futures or option contracts, as well as from short selling of securities. Additionally, investment managers agree to obtain written approval for deviations from stated investment style or guidelines. As of December 31, 2014, no investment manager was responsible for more than 10 percent of total U.S. plan assets.
Our target allocation of 42 percent equity investments is composed of 60 percent global equities, 16 percent emerging market equities and 24 percent domestic small- and mid-cap equities. Optimal returns through our investments in global equities are achieved through security selection as well as country and sector diversification. Investments in the common stock of our Company accounted for approximately 5 percent of our global equities allocation and approximately 2 percent of total U.S. plan assets. Our investments in global equities are intended to provide diversified exposure to both U.S. and non-U.S. equity markets. Our investments in both emerging market equities and domestic small- and mid-cap equities are expected to experience larger swings in their market value on a periodic basis. Our investments in these asset classes are selected based on capital appreciation potential.
Our target allocation of 30 percent fixed-income investments is composed of 33 percent long-duration bonds and 67 percent with multi-strategy alternative credit managers. Long-duration bonds provide a stable rate of return through investments in high-quality publicly traded debt securities. Our investments in long-duration bonds are diversified in order to mitigate duration and credit exposure. Multi-strategy alternative credit managers invest in a combination of high-yield bonds, bank loans, structured credit and emerging market debt. These investments are in lower-rated and non-rated debt securities, which generally produce higher returns compared to long-duration bonds and also help to diversify our overall fixed-income portfolio.
In addition to equity investments and fixed-income investments, we have a target allocation of 28 percent in alternative investments. These alternative investments include hedge funds, reinsurance, private equity limited partnerships, leveraged buyout funds, international venture capital partnerships and real estate. The objective of investing in alternative investments is to provide a higher rate of return than that available from publicly traded equity securities. These investments are inherently illiquid and require a long-term perspective in evaluating investment performance.
Investment Strategy for Non-U.S. Pension Plans
As of December 31, 2014, the long-term target allocation for 59 percent of our international subsidiaries' plan assets, primarily certain of our European and Canadian plans, is 66 percent equity securities; 23 percent fixed-income securities; and 11 percent other investments. The actual allocation for the remaining 41 percent of the Company's international subsidiaries' plan assets consisted of 34 percent mutual, pooled and commingled funds; 10 percent equity securities; 13 percent fixed-income securities; and 43 percent other investments. The investment strategies of our international subsidiaries differ greatly, and in some instances are influenced by local law. None of our pension plans outside the United States is individually significant for separate disclosure.
Other Postretirement Benefit Plan Assets
Plan assets associated with other postretirement benefits primarily represent funding of one of the U.S. postretirement benefit plans through a U.S. Voluntary Employee Beneficiary Association ("VEBA"), a tax-qualified trust. The VEBA assets remain segregated from the U.S. pension master trust and are primarily invested in liquid assets due to the level and timing of expected future benefit payments.
The following table presents total assets for our other postretirement benefit plans (in millions):


December 31,	2014				2013
December 31,	2014				2013
Cash and cash equivalents	$	10			$	10
Cash and cash equivalents	$	10			$	10
Equity securities:
U.S.-based companies	114				112
U.S.-based companies	114				112
International-based companies	7				8
International-based companies	7				8
Fixed-income securities:
Government bonds	79				79
Government bonds	79				79
Corporate bonds and debt securities	9				9
Corporate bonds and debt securities	9				9
Mutual, pooled and commingled funds	16				18
Mutual, pooled and commingled funds	16				18
Hedge funds/limited partnerships	5				3
Hedge funds/limited partnerships	5				3
Real estate	3				2
Real estate	3				2
Other	3				2
Other	3				2
Total other postretirement benefit plan assets1	$	246			$	243
Total other postretirement benefit plan assets1	$	246			$	243

1	Fair value disclosures related to our other postretirement benefit plan assets are included in Note 16. Fair value disclosures include, but are not limited to, the levels within the fair value hierarchy in which the fair value measurements in their entirety fall; a reconciliation of the beginning and ending balances of Level 3 assets; and information about the valuation techniques and inputs used to measure the fair value of our other postretirement benefit plan assets.
Components of Net Periodic Benefit Cost
Net periodic benefit cost for our pension and other postretirement benefit plans consisted of the following (in millions):


	Pension Benefits												Other Benefits
Year Ended December 31,	2014				2013				2012				2014				2013			2012
Year Ended December 31,	2014				2013				2012				2014				2013			2012
Service cost	$	261			$	280			$	291			$	26			$	36		$	34
Service cost	$	261			$	280			$	291			$	26			$	36		$	34
Interest cost	406				378				388				43				42			43
Interest cost	406				378				388				43				42			43
Expected return on plan assets1	(713		)		(659		)		(573		)		(11		)		(9		)	(8		)
Amortization of prior service cost (credit)	(2		)		(2		)		(2		)		(17		)		(10		)	(52		)
Amortization of actuarial loss	73				197				137				2				13			6
Amortization of actuarial loss	73				197				137				2				13			6
Net periodic benefit cost	$	25			$	194			$	241			$	43			$	72		$	23
Net periodic benefit cost	$	25			$	194			$	241			$	43			$	72		$	23
Settlement charge	4				1				3				—				—			—
Settlement charge	4				1				3				—				—			—
Curtailment charge	—				—				6				—				—			—
Curtailment charge	—				—				6				—				—			—
Special termination benefits2	5				2				1				—				—			—
Special termination benefits2	5				2				1				—				—			—
Total cost recognized in statements of income	$	34			$	197			$	251			$	43			$	72		$	23
Total cost recognized in statements of income	$	34			$	197			$	251			$	43			$	72		$	23

1	The Company has elected to use the actual fair value of plan assets as the market-related value of assets in the determination of the expected return on plan assets.

2	The special termination benefits were primarily related to the Company's productivity, restructuring and integration initiatives. Refer to Note 18 for additional information related to our productivity, restructuring and integration initiatives.
The following table sets forth the changes in AOCI for our benefit plans (in millions, pretax):


	Pension Benefits								Other Benefits
	2014				2013				2014				2013
	2014				2013				2014				2013
Beginning balance in AOCI	$	(1,537	)		$	(3,032	)		$	13			$	(186	)
Beginning balance in AOCI	$	(1,537	)		$	(3,032	)		$	13			$	(186	)
Recognized prior service cost (credit)	(2		)		(2		)		(17		)		(10		)
Recognized net actuarial loss (gain)	77				198				2				13
Recognized net actuarial loss (gain)	77				198				2				13
Prior service credit (cost) arising in current year	—				1				31				73
Prior service credit (cost) arising in current year	—				1				31				73
Net actuarial (loss) gain arising in current year	(1,658		)		1,283				(97		)		122
Net actuarial (loss) gain arising in current year	(1,658		)		1,283				(97		)		122
Foreign currency translation gain (loss)	51				15				1				1
Foreign currency translation gain (loss)	51				15				1				1
Ending balance in AOCI	$	(3,069	)		$	(1,537	)		$	(67	)		$	13
Ending balance in AOCI	$	(3,069	)		$	(1,537	)		$	(67	)		$	13
The following table sets forth amounts in AOCI for our benefit plans (in millions, pretax):


	Pension Benefits								Other Benefits
December 31,	2014				2013				2014				2013
December 31,	2014				2013				2014				2013
Prior service credit (cost)	$	10			$	12			$	100			$	86
Prior service credit (cost)	$	10			$	12			$	100			$	86
Net actuarial loss	(3,079		)		(1,549		)		(167		)		(73		)
Ending balance in AOCI	$	(3,069	)		$	(1,537	)		$	(67	)		$	13
Ending balance in AOCI	$	(3,069	)		$	(1,537	)		$	(67	)		$	13
Amounts in AOCI expected to be recognized as components of net periodic pension cost in 2015 are as follows (in millions, pretax):


	Pension Benefits				Other Benefits
Amortization of prior service cost (credit)	$	(2	)		$	(19	)
Amortization of actuarial loss	203				10
Amortization of actuarial loss	203				10
	$	201			$	(9	)
	$	201			$	(9	)
Assumptions
Certain weighted-average assumptions used in computing the benefit obligations are as follows:


	Pension Benefits						Other Benefits
December 31,	2014			2013			2014			2013
December 31,	2014			2013			2014			2013
Discount rate	3.75	%		4.75	%		3.75	%		4.75	%
Rate of increase in compensation levels	3.5	%		3.5	%		N/A			N/A
Rate of increase in compensation levels	3.5	%		3.5	%		N/A			N/A
Certain weighted-average assumptions used in computing net periodic benefit cost are as follows:


	Pension Benefits									Other Benefits
Year Ended December 31,	2014			2013			2012			2014			2013			2012
Year Ended December 31,	2014			2013			2012			2014			2013			2012
Discount rate	4.75	%		4	%		4.75	%		4.75	%		4	%		4.75	%
Rate of increase in compensation levels	3.5	%		3.5	%		3.25	%		N/A			N/A			N/A
Rate of increase in compensation levels	3.5	%		3.5	%		3.25	%		N/A			N/A			N/A
Expected long-term rate of return on plan assets	8.25	%		8.25	%		8.25	%		4.75	%		4.75	%		4.75	%
The expected long-term rate of return assumption for U.S. pension plan assets is based upon the target asset allocation and is determined using forward-looking assumptions in the context of historical returns and volatilities for each asset class, as well as correlations among asset classes. We evaluate the rate of return assumption on an annual basis. The expected long-term rate of return assumption used in computing 2014 net periodic pension cost for the U.S. plans was 8.5 percent. As of December 31, 2014, the 5-year, 10-year, and 15-year annualized return on plan assets for the primary U.S. plan was 10.4 percent, 6.3 percent and 5.5 percent, respectively. The annualized return since inception was 10.9 percent.
The assumed health care cost trend rates are as follows:


December 31,	2014			2013
December 31,	2014			2013
Health care cost trend rate assumed for next year	7.5	%		8	%
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)	5	%		5	%
Year that the rate reaches the ultimate trend rate	2020			2020
Year that the rate reaches the ultimate trend rate	2020			2020
The Company's U.S. postretirement benefit plans are primarily defined dollar benefit plans that limit the effects of medical inflation because the plans have established dollar limits for determining our contributions. As a result, the effect of a 1 percentage point change in the assumed health care cost trend rate would not be significant to the Company.
The discount rate assumptions used to account for pension and other postretirement benefit plans reflect the rates at which the benefit obligations could be effectively settled. Rates for each of our U.S. plans at December 31, 2014, were determined using a cash flow matching technique whereby the rates of a yield curve, developed from high-quality debt securities, were applied to the benefit obligations to determine the appropriate discount rate. For our non-U.S. plans, we base the discount rate on comparable indices within each of the countries. The rate of compensation increase assumption is determined by the Company based upon annual reviews. We review external data and our own historical trends for health care costs to determine the health care cost trend rate assumptions.
Cash Flows
Our estimated future benefit payments for funded and unfunded plans are as follows (in millions):


Year Ended December 31,	2015				2016				2017				2018				2019			2020-2024
Year Ended December 31,	2015				2016				2017				2018				2019			2020-2024
Pension benefit payments	$	494			$	518			$	551			$	560			$	584		$	3,137
Pension benefit payments	$	494			$	518			$	551			$	560			$	584		$	3,137
Other benefit payments1	61				65				67				67				68			343
Other benefit payments1	61				65				67				67				68			343
Total estimated benefit payments	$	555			$	583			$	618			$	627			$	652		$	3,480
Total estimated benefit payments	$	555			$	583			$	618			$	627			$	652		$	3,480

1	The expected benefit payments for our other postretirement benefit plans are net of estimated federal subsidies expected to be received under the Medicare Prescription Drug, Improvement and Modernization Act of 2003. Federal subsidies are estimated to be approximately $5 million for the period 2015–2019, and $4 million for the period 2020–2024.
The Company anticipates making pension contributions in 2015 of approximately $90 million, all of which will be allocated to our international plans. The majority of these contributions are discretionary.
Defined Contribution Plans
Our Company sponsors qualified defined contribution plans covering substantially all U.S. employees. Under the largest U.S. defined contribution plan, we match participants' contributions up to a maximum of 3.5 percent of compensation, subject to certain limitations. Company costs related to the U.S. plans were $92 million, $97 million and $93 million in 2014, 2013 and 2012, respectively. We also sponsor defined contribution plans in certain locations outside the United States. Company costs associated with those plans were $36 million, $32 million and $29 million in 2014, 2013 and 2012, respectively.
Multi-Employer Plans
As a result of our acquisition of CCE's former North America business during the fourth quarter of 2010, the Company now participates in various multi-employer pension plans in the United States. Multi-employer pension plans are designed to cover employees from multiple employers and are typically established under collective bargaining agreements. These plans allow multiple employers to pool their pension resources and realize efficiencies associated with the daily administration of the plan.
Multi-employer plans are generally governed by a board of trustees composed of management and labor representatives and are funded through employer contributions.
The Company's expense for U.S. multi-employer pension plans totaled $38 million, $37 million and $31 million in 2014, 2013 and 2012, respectively. The plans we currently participate in have contractual arrangements that extend into 2019. If, in the future, we choose to withdraw from any of the multi-employer pension plans in which we currently participate, we would need to record the appropriate withdrawal liabilities at that time.

INCOME_TAXES

INCOME TAXES	12 Months Ended
INCOME TAXES	Dec. 31, 2014
Income Taxes [Abstract]
INCOME TAXES	INCOME TAXES
	Income before income taxes consisted of the following (in millions):


	Year Ended December 31,	2014				2013				2012
	Year Ended December 31,	2014				2013				2012
	United States	$	1,567			$	2,451			$	3,526
	United States	$	1,567			$	2,451			$	3,526
	International	7,758				9,026				8,283
	International	7,758				9,026				8,283
	Total	$	9,325			$	11,477			$	11,809
	Total	$	9,325			$	11,477			$	11,809
	Income tax expense consisted of the following for the years ended December 31, 2014, 2013 and 2012 (in millions):


		United States				State and Local				International			Total
		United States				State and Local				International			Total
	2014
	Current	$	867			$	81			$	1,293		$	2,241
	Current	$	867			$	81			$	1,293		$	2,241
	Deferred	(97		)		(21		)		78			(40		)
	Deferred	(97		)		(21		)		78			(40		)
	2013
	Current	$	713			$	102			$	1,388		$	2,203
	Current	$	713			$	102			$	1,388		$	2,203
	Deferred	305				38				305			648
	Deferred	305				38				305			648
	2012
	Current	$	602			$	74			$	1,415		$	2,091
	Current	$	602			$	74			$	1,415		$	2,091
	Deferred	936				33				(337		)	632
	Deferred	936				33				(337		)	632
	We made income tax payments of $1,926 million, $2,162 million and $981 million in 2014, 2013 and 2012, respectively.
	A reconciliation of the statutory U.S. federal tax rate and our effective tax rate is as follows:


	Year Ended December 31,	2014			2013			2012
	Year Ended December 31,	2014			2013			2012
	Statutory U.S. federal tax rate	35	%		35	%		35	%
	State and local income taxes — net of federal benefit	1			1			1.1
	State and local income taxes — net of federal benefit	1			1			1.1
	Earnings in jurisdictions taxed at rates different from the statutory U.S. federal rate	(11.5	)	1,2	(10.3	)	5,6,7	(9.5	)	10,11
	Reversal of valuation allowances	—			—			(2.4	)	12
	Reversal of valuation allowances	—			—			(2.4	)	12
	Equity income or loss	(2.2	)		(1.4	)	8	(2.0	)
	Other operating charges	2.9		3,4	1.2		9	0.4		13
	Other operating charges	2.9		3,4	1.2		9	0.4		13
	Other — net	(1.6	)		(0.7	)		0.5
	Other — net	(1.6	)		(0.7	)		0.5
	Effective tax rate	23.6	%		24.8	%		23.1	%

	1	Includes a $6 million tax expense on a pretax net charge of $372 million (or a 1.5 percent impact on our effective tax rate) due to the remeasurement of the net monetary assets of our local Venezuelan subsidiary into U.S. dollars using the SICAD 2 exchange rate. Refer to Note 1.

	2	Includes a tax expense of $18 million (or a 0.2 percent impact on our effective tax rate) related to amounts required to be recorded for changes to our uncertain tax positions, including interest and penalties, in various international jurisdictions.

	3	Includes a tax expense of $55 million on a pretax charge of $352 million (or a 1.9 percent impact on our effective tax rate) primarily due to an impairment of a Venezuelan trademark, a write-down the Company recorded on the concentrate sales receivables from our bottling partner in Venezuela, a charge associated with certain of the Company's fixed assets, and as a result of the restructuring and transition of the Company's Russian juice operations to an existing joint venture with an unconsolidated bottling partner. Refer to Note 1 and Note 17.

	4	Includes a tax benefit of $191 million on pretax charges of $809 million (or a 1 percent impact on our effective tax rate) primarily related to the Company's productivity and reinvestment program as well as other restructuring initiatives. Refer to Note 18.

	5	Includes a tax benefit of $26 million (or a 0.2 percent impact on our effective tax rate) related to amounts required to be recorded for changes to our uncertain tax positions, including interest and penalties, in various international jurisdictions.

	6	Includes a tax expense of $279 million on pretax net gains of $501 million (or a 0.9 percent impact on our effective tax rate) related to the deconsolidation of our Brazilian bottling operations upon their combination with an independent bottler and a loss due to the merger of four of the Company's Japanese bottling partners. Refer to Note 2 and Note 17.

	7	Includes a tax expense of $3 million (or a 0.5 percent impact on our effective tax rate) related to a charge of $149 million due to the devaluation of the Venezuelan bolivar. Refer to Note 19.

8	Includes an $8 million tax benefit on a pretax charge of $159 million (or a 0.4 percent impact on our effective tax rate) related to our proportionate share of unusual or infrequent items recorded by our equity method investees. Refer to Note 17.

9	Includes a tax benefit of $175 million on pretax charges of $877 million (or a 1.2 percent impact on our effective tax rate) primarily related to impairment charges recorded on certain of the Company's intangible assets and charges related to the Company's productivity and reinvestment program as well as other restructuring initiatives. Refer to Note 17 and Note 18.

10	Includes a tax expense of $133 million (or a 1.1 percent impact on our effective tax rate) related to amounts required to be recorded for changes to our uncertain tax positions, including interest and penalties, in various international jurisdictions.

11	Includes a tax expense of $57 million on pretax net gains of $76 million (or a 0.3 percent impact on our effective tax rate) related to the following: a gain recognized as a result of the merger of Embotelladora Andina S.A. ("Andina") and Embotelladoras Coca-Cola Polar S.A. ("Polar"); a gain recognized as a result of Coca-Cola FEMSA, an equity method investee, issuing additional shares of its own stock at a per share amount greater than the carrying value of the Company's per share investment; the loss recognized on the then pending sale of a majority ownership interest in our consolidated Philippine bottling operations to Coca-Cola FEMSA; and the expense recorded for the premium the Company paid over the publicly traded market price to acquire an ownership interest in Mikuni. Refer to Note 17.

12	Relates to a net tax benefit of $283 million associated with the reversal of valuation allowances in certain of the Company's foreign jurisdictions.

13	Includes a tax benefit of $95 million on pretax charges of $416 million (or a 0.4 percent impact on our effective tax rate) primarily related to the Company's productivity and reinvestment program as well as other restructuring initiatives; the refinement of previously established accruals related to the Company's 2008–2011 productivity initiatives; and the refinement of previously established accruals related to the Company's integration of CCE's former North America business. Refer to Note 18.
Our effective tax rate reflects the tax benefits of having significant operations outside the United States, which are generally taxed at rates lower than the U.S. statutory rate of 35 percent. As a result of employment actions and capital investments made by the Company, certain tax jurisdictions provide income tax incentive grants, including Brazil, Costa Rica, Singapore and Swaziland. The terms of these grants expire from 2016 to 2023. We anticipate that we will be able to extend or renew the grants in these locations. Tax incentive grants favorably impacted our income tax expense by $265 million, $279 million and $280 million for the years ended December 31, 2014, 2013 and 2012, respectively. In addition, our effective tax rate reflects the benefits of having significant earnings generated in investments accounted for under the equity method of accounting, which are generally taxed at rates lower than the U.S. statutory rate.
The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. U.S. tax authorities have completed their federal income tax examinations for all years prior to 2005. With respect to state and local jurisdictions and countries outside the United States, with limited exceptions, the Company and its subsidiaries are no longer subject to income tax audits for years before 2002. For U.S. federal and state tax purposes, the net operating losses and tax credit carryovers acquired in connection with our acquisition of CCE's former North America business that were generated between the years of 1990 through 2010 are subject to adjustments until the year in which they are actually utilized is no longer subject to examination. Although the outcome of tax audits is always uncertain, the Company believes that adequate amounts of tax, including interest and penalties, have been provided for any adjustments that are expected to result from those years.
As of December 31, 2014, the gross amount of unrecognized tax benefits was $211 million. If the Company were to prevail on all uncertain tax positions, the net effect would be a benefit to the Company's effective tax rate of $173 million, exclusive of any benefits related to interest and penalties. The remaining $38 million, which was recorded as a deferred tax asset, primarily represents tax benefits that would be received in different tax jurisdictions in the event the Company did not prevail on all uncertain tax positions.
A reconciliation of the changes in the gross balance of unrecognized tax benefit amounts is as follows (in millions):


Year Ended December 31,	2014				2013				2012
Year Ended December 31,	2014				2013				2012
Beginning balance of unrecognized tax benefits	$	230			$	302			$	320
Beginning balance of unrecognized tax benefits	$	230			$	302			$	320
Increases related to prior period tax positions	13				1				69
Increases related to prior period tax positions	13				1				69
Decreases related to prior period tax positions	(2		)		(7		)		(15		)
Increases related to current period tax positions	11				8				23
Increases related to current period tax positions	11				8				23
Decreases related to settlements with taxing authorities	(5		)		(4		)		(45		)
Reductions as a result of a lapse of the applicable statute of limitations	(32		)		(59		)		(36		)
Increases (decreases) from effects of foreign currency exchange rates	(4		)		(11		)		(14		)
Ending balance of unrecognized tax benefits	$	211			$	230			$	302
Ending balance of unrecognized tax benefits	$	211			$	230			$	302
The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense. The Company had $113 million, $105 million and $113 million in interest and penalties related to unrecognized tax benefits accrued as of December 31, 2014, 2013 and 2012, respectively. Of these amounts, $8 million of expense, $8 million of benefit and $33 million of expense were recognized through income tax expense in 2014, 2013 and 2012, respectively. If the Company were to prevail on all uncertain tax positions, the reversal of this accrual would also be a benefit to the Company's effective tax rate.
It is expected that the amount of unrecognized tax benefits will change in the next 12 months; however, we do not expect the change to have a significant impact on our consolidated statements of income or consolidated balance sheets. These changes may be the result of settlements of ongoing audits, statute of limitations expiring or final settlements in transfer pricing matters that are the subject of litigation. At this time, an estimate of the range of the reasonably possible outcomes cannot be made.
As of December 31, 2014, undistributed earnings of the Company's foreign subsidiaries amounted to $33.3 billion. Those earnings are considered to be indefinitely reinvested and, accordingly, no U.S. federal and state income taxes have been provided thereon. Upon distribution of those earnings in the form of dividends or otherwise, the Company would be subject to both U.S. income taxes (subject to an adjustment for foreign tax credits) and withholding taxes payable to the various foreign countries. Determination of the amount of unrecognized deferred U.S. income tax liability is not practicable because of the complexities associated with its hypothetical calculation; however, unrecognized foreign tax credits would be available to reduce a portion of the U.S. tax liability.
The tax effects of temporary differences and carryforwards that give rise to deferred tax assets and liabilities consist of the following (in millions):


December 31,	2014				2013
December 31,	2014				2013
Deferred tax assets:
Property, plant and equipment	$	96			$	102
Property, plant and equipment	$	96			$	102
Trademarks and other intangible assets	68				63
Trademarks and other intangible assets	68				63
Equity method investments (including foreign currency translation adjustment)	462				243
	462				243
Derivative financial instruments	134				50
Derivative financial instruments	134				50
Other liabilities	1,082				1,102
Other liabilities	1,082				1,102
Benefit plans	1,673				1,237
Benefit plans	1,673				1,237
Net operating/capital loss carryforwards	729				790
Net operating/capital loss carryforwards	729				790
Other	196				225
Other	196				225
Gross deferred tax assets	$	4,440			$	3,812
Gross deferred tax assets	$	4,440			$	3,812
Valuation allowances	(649		)		(586		)
Total deferred tax assets1,2	$	3,791			$	3,226
Total deferred tax assets1,2	$	3,791			$	3,226
Deferred tax liabilities:
Property, plant and equipment	$	(2,342	)		$	(2,417	)
Trademarks and other intangible assets	(4,020		)		(4,192		)
Equity method investments (including foreign currency translation adjustment)	(1,038		)		(1,070		)
Derivative financial instruments	(457		)		(147		)
Other liabilities	(110		)		(69		)
Benefit plans	(487		)		(473		)
Other	(944		)		(810		)
Total deferred tax liabilities3	$	(9,398	)		$	(9,178	)
Net deferred tax liabilities	$	(5,607	)		$	(5,952	)

1	Noncurrent deferred tax assets of $319 million and $328 million were included in the line item other assets in our consolidated balance sheets as of December 31, 2014 and 2013, respectively.

2	Current deferred tax assets of $160 million and $211 million were included in the line item prepaid expenses and other assets in our consolidated balance sheets as of December 31, 2014 and 2013, respectively.

3	Current deferred tax liabilities of $450 million and $339 million were included in the line item accounts payable and accrued expenses in our consolidated balance sheets as of December 31, 2014 and 2013, respectively.
As of December 31, 2014 and 2013, we had $643 million and $198 million, respectively, of net deferred tax liabilities located in countries outside the United States.
As of December 31, 2014, we had $6,408 million of loss carryforwards available to reduce future taxable income. Loss carryforwards of $497 million must be utilized within the next five years, and the remainder can be utilized over a period greater than five years.
An analysis of our deferred tax asset valuation allowances is as follows (in millions):


Year Ended December 31,	2014				2013				2012
Year Ended December 31,	2014				2013				2012
Balance at beginning of year	$	586			$	487			$	859
Balance at beginning of year	$	586			$	487			$	859
Additions	104				169				126
Additions	104				169				126
Decrease due to transfer to assets held for sale	—				—				(146		)
Decrease due to transfer to assets held for sale	—				—				(146		)
Deductions	(41		)		(70		)		(352		)
Balance at end of year	$	649			$	586			$	487
Balance at end of year	$	649			$	586			$	487
The Company's deferred tax asset valuation allowances are primarily the result of uncertainties regarding the future realization of recorded tax benefits on tax loss carryforwards from operations in various jurisdictions. These valuation allowances were primarily related to deferred tax assets generated from net operating losses. Current evidence does not suggest we will realize sufficient taxable income of the appropriate character within the carryforward period to allow us to realize these deferred tax benefits. If we were to identify and implement tax planning strategies to recover these deferred tax assets or generate sufficient income of the appropriate character in these jurisdictions in the future, it could lead to the reversal of these valuation allowances and a reduction of income tax expense. The Company believes that it will generate sufficient future taxable income to realize the tax benefits related to the remaining net deferred tax assets in our consolidated balance sheets.
In 2014, the Company recognized a net increase of $63 million in its valuation allowances. This increase was primarily due to the increase in net operating losses during the normal course of business operations and due to the remeasurement of the net monetary assets of our local Venezuelan subsidiary into U.S. dollars using the SICAD 2 exchange rate. The Company recognized a reduction in the valuation allowances primarily due to changes in deferred tax assets and related valuation allowances on certain equity investments and decreases in net operating losses during the normal course of business operations.
In 2013, the Company recognized a net increase of $99 million in its valuation allowances. This increase was primarily due to the addition of a deferred tax asset and related valuation allowance on certain equity method investments and increases in net operating losses during the normal course of business operations. In addition, the Company recognized a reduction in the valuation allowances primarily due to the reversal of a deferred tax asset and related valuation allowance on certain equity method investments.
In 2012, the Company recognized a net decrease of $372 million in its valuation allowances. This decrease was primarily related to the reversal of valuation allowances in several foreign jurisdictions. As a result of considering recent significant positive evidence, including, among other items, a consistent pattern of earnings in the past three years, as well as business plans showing continued profitability, it was determined that a valuation allowance was no longer required for certain deferred tax assets primarily recorded on net operating losses in foreign jurisdictions. This decrease was also partially due to a transfer of a valuation allowance into assets held for sale as required by accounting principles generally accepted in the United States upon execution of the share purchase agreement for the sale of a majority interest in our consolidated Philippine bottling operations. Refer to Note 1 for additional information on the Company's accounting policy related to assets and liabilities held for sale. Refer to Note 2 for additional information on the Company's Philippine bottling operations. In addition, the Company recognized an increase in its valuation allowances primarily due to the addition of a deferred tax asset and related valuation allowance on certain equity method investments and increases in net operating losses during the normal course of business operations.

OTHER_COMPREHENSIVE_INCOME

OTHER COMPREHENSIVE INCOME	12 Months Ended
	Dec. 31, 2014
OTHER COMPREHENSIVE INCOME [Abstract]
OTHER COMPREHENSIVE INCOME	OTHER COMPREHENSIVE INCOME
	AOCI attributable to shareowners of The Coca-Cola Company is separately presented on our consolidated balance sheets as a component of The Coca-Cola Company's shareowners' equity, which also includes our proportionate share of equity method investees' AOCI. Other comprehensive income (loss) ("OCI") attributable to noncontrolling interests is allocated to, and included in, our balance sheets as part of the line item equity attributable to noncontrolling interests.
	AOCI attributable to shareowners of The Coca-Cola Company consisted of the following (in millions):


	December 31,	2014				2013

	Foreign currency translation adjustment	$	(5,226	)		$	(2,849	)
	Accumulated derivative net gains (losses)	554				197

	Unrealized net gains (losses) on available-for-sale securities	972				258

	Adjustments to pension and other benefit liabilities	(2,077		)		(1,038		)
	Accumulated other comprehensive income (loss)	$	(5,777	)		$	(3,432	)
	The following table summarizes the allocation of total comprehensive income between shareowners of The Coca-Cola Company and noncontrolling interests (in millions):


		Year Ended December 31, 2014
		Shareowners of			Noncontrolling			Total
		The Coca-Cola Company			Interests
	Consolidated net income	$	7,098		$	26		$	7,124

	Other comprehensive income:
	Net foreign currency translation adjustment	(2,377		)	(5		)	(2,382		)
	Net gain (loss) on derivatives1	357			—			357

	Net unrealized gain (loss) on available-for-sale securities2	714			—			714

	Net change in pension and other benefit liabilities3	(1,039		)	—			(1,039		)

	Total comprehensive income	$	4,753		$	21		$	4,774


	1	Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments.

	2	Refer to Note 3 for information related to the net unrealized gain or loss on available-for-sale securities.

	3	Refer to Note 13 for additional information related to the Company's pension and other postretirement benefit liabilities.
	OCI attributable to shareowners of The Coca-Cola Company, including our proportionate share of equity method investees' OCI, for the years ended December 31, 2014, 2013 and 2012, is as follows (in millions):


		Before-Tax Amount				Income Tax				After-Tax Amount

	2014
	Foreign currency translation adjustments:
	Translation adjustment arising in the period	$	(2,560	)		$	183			$	(2,377	)

	Net foreign currency translation adjustment	(2,560		)		183				(2,377		)

	Derivatives:
	Unrealized gains (losses) arising during the year	620				(231		)		389

	Reclassification adjustments recognized in net income	(50		)		18				(32		)

	Net gain (loss) on derivatives1	570				(213		)		357

	Available-for-sale securities:
	Unrealized gains (losses) arising during the year	1,139				(412		)		727

	Reclassification adjustments recognized in net income	(17		)		4				(13		)

	Net change in unrealized gain (loss) on available-for-sale securities2	1,122				(408		)		714

	Pension and other benefit liabilities:
Net pension and other benefits arising during the year	(1,666		)		588				(1,078		)

Reclassification adjustments recognized in net income	60				(21		)		39

Net change in pension and other benefit liabilities3	(1,606		)		567				(1,039		)

Other comprehensive income (loss) attributable to The Coca-Cola Company	$	(2,474	)		$	129			$	(2,345	)


1	Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments.

2	Includes reclassification adjustments related to divestitures of certain available-for-sale securities. Refer to Note 3 for additional information related to these divestitures.

3	Refer to Note 13 for additional information related to the Company's pension and other postretirement benefit liabilities.


	Before-Tax Amount				Income Tax				After-Tax Amount

2013
Foreign currency translation adjustments:
Translation adjustment arising in the period	$	(1,046	)		$	56			$	(990	)

Reclassification adjustments recognized in net income	(194		)		—				(194		)

Net foreign currency translation adjustment	(1,240		)		56				(1,184		)

Derivatives:
Unrealized gains (losses) arising during the year	425				(173		)		252

Reclassification adjustments recognized in net income	(167		)		66				(101		)

Net gain (loss) on derivatives1	258				(107		)		151

Available-for-sale securities:
Unrealized gains (losses) arising during the year	(134		)		42				(92		)

Reclassification adjustments recognized in net income	12				—				12

Net change in unrealized gain (loss) on available-for-sale securities2	(122		)		42				(80		)

Pension and other benefit liabilities:
Net pension and other benefits arising during the year	1,490				(550		)		940

Reclassification adjustments recognized in net income	198				(72		)		126

Net change in pension and other benefit liabilities3	1,688				(622		)		1,066

Other comprehensive income (loss) attributable to The Coca-Cola Company	$	584			$	(631	)		$	(47	)


1	Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments.

2	Includes reclassification adjustments related to divestitures of certain available-for-sale securities. Refer to Note 3 for additional information related to these divestitures.

3	Refer to Note 13 for additional information related to the Company's pension and other postretirement benefit liabilities.


	Before-Tax Amount				Income Tax				After-Tax Amount

2012
Net foreign currency translation adjustment	$	(219	)		$	(1	)		$	(220	)
Derivatives:
Unrealized gains (losses) arising during the year	77				(29		)		48

Reclassification adjustments recognized in net income	82				(31		)		51

Net gain (loss) on derivatives1	159				(60		)		99

Available-for-sale securities:
Unrealized gains (losses) arising during the year	248				(64		)		184

Reclassification adjustments recognized in net income	(6		)		—				(6		)

Net change in unrealized gain (loss) on available-for-sale securities2	242				(64		)		178

Pension and other benefit liabilities:
Net pension and other benefits arising during the year	(1,132		)		405				(727		)

Reclassification adjustments recognized in net income	92				(33		)		59

Net change in pension and other benefit liabilities3	(1,040		)		372				(668		)

Other comprehensive income (loss) attributable to The Coca-Cola Company	$	(858	)		$	247			$	(611	)


1	Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments.

2	Includes reclassification adjustments related to divestitures of certain available-for-sale securities. Refer to Note 3 for additional information related to these divestitures.

3	Refer to Note 13 for additional information related to the Company's pension and other postretirement benefit liabilities.
The following table presents the amounts and line items in our consolidated statements of income where adjustments reclassified from AOCI into income were recorded during the year ended December 31, 2014 (in millions):


Description of AOCI Component	Financial Statement Line Item	Amount Reclassified from
		AOCI into Income
Derivatives:
Foreign currency contracts	Net operating revenues	$	(121	)
Foreign currency and commodity contracts	Cost of goods sold	(37		)
Foreign currency contracts	Other income (loss) — net	108

	Income before income taxes	$	(50	)
	Income taxes	18

	Consolidated net income	$	(32	)
Available-for-sale securities:
Sale of securities	Other income (loss) — net	$	(17	)
	Income before income taxes	$	(17	)
	Income taxes	4

	Consolidated net income	$	(13	)
Pension and other benefit liabilities:
Amortization of net actuarial loss	*	$	79

Amortization of prior service cost (credit)	*	(19		)
	Income before income taxes	$	60

	Income taxes	(21		)
	Consolidated net income	$	39


*	This component of AOCI is included in the Company's computation of net periodic benefit cost and is not reclassified out of AOCI into a single line item in our consolidated statements of income in its entirety. Refer to Note 13 for additional information.

FAIR_VALUE_MEASUREMENTS

FAIR VALUE MEASUREMENTS	12 Months Ended
	Dec. 31, 2014
Fair Value Measurements Disclosure [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS
	Accounting principles generally accepted in the United States define fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. Additionally, the inputs used to measure fair value are prioritized based on a three-level hierarchy. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:

	•	Level 1 — Quoted prices in active markets for identical assets or liabilities.

	•	Level 2 — Observable inputs other than quoted prices included in Level 1. We value assets and liabilities included in this level using dealer and broker quotations, certain pricing models, bid prices, quoted prices for similar assets and liabilities in active markets, or other inputs that are observable or can be corroborated by observable market data.

	•	Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.
	Recurring Fair Value Measurements
	In accordance with accounting principles generally accepted in the United States, certain assets and liabilities are required to be recorded at fair value on a recurring basis. For our Company, the only assets and liabilities that are adjusted to fair value on a recurring basis are investments in equity and debt securities classified as trading or available-for-sale and derivative financial instruments. Additionally, the Company adjusts the carrying value of certain long-term debt as a result of the Company's fair value hedging strategy.
	Investments in Trading and Available-for-Sale Securities
	The fair values of our investments in trading and available-for-sale securities using quoted market prices from daily exchange traded markets are based on the closing price as of the balance sheet date and are classified as Level 1. The fair values of our investments in trading and available-for-sale securities classified as Level 2 are priced using quoted market prices for similar instruments or nonbinding market prices that are corroborated by observable market data. Inputs into these valuation techniques include actual trade data, benchmark yields, broker/dealer quotes and other similar data. These inputs are obtained from quoted market prices, independent pricing vendors or other sources.
	Derivative Financial Instruments
	The fair values of our futures contracts are primarily determined using quoted contract prices on futures exchange markets. The fair values of these instruments are based on the closing contract price as of the balance sheet date and are classified as Level 1.
	The fair values of our derivative instruments other than futures are determined using standard valuation models. The significant inputs used in these models are readily available in public markets, or can be derived from observable market transactions, and therefore have been classified as Level 2. Inputs used in these standard valuation models for derivative instruments other than futures include the applicable exchange rates, forward rates, interest rates, discount rates and commodity prices. The standard valuation model for options also uses implied volatility as an additional input. The discount rates are based on the historical U.S. Deposit or U.S. Treasury rates, and the implied volatility specific to options is based on quoted rates from financial institutions.
	Included in the fair value of derivative instruments is an adjustment for nonperformance risk. The adjustment is based on current credit default swap ("CDS") rates applied to each contract, by counterparty. We use our counterparty's CDS rate when we are in an asset position and our own CDS rate when we are in a liability position. The adjustment for nonperformance risk did not have a significant impact on the estimated fair value of our derivative instruments.
	The following tables summarize those assets and liabilities measured at fair value on a recurring basis (in millions):


		December 31, 2014
		Level 1				Level 2				Level 3				Netting				Fair Value
														Adjustment1				Measurements
	Assets:
	Trading securities2	$	228			$	177			$	4			$	—			$	409

	Available-for-sale securities2	4,116				3,627				136			3	—				7,879

	Derivatives4	9				1,721				—				(437		)		1,293		5

	Total assets	$	4,353			$	5,525			$	140			$	(437	)		$	9,581

	Liabilities:
	Derivatives4	$	2			$	558			$	—			$	(437	)		$	123	5

	Total liabilities	$	2			$	558			$	—			$	(437	)		$	123


	1	Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with the same counterparties. There are no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 5.

	2	Refer to Note 3 for additional information related to the composition of our trading securities and available-for-sale securities.

	3	Primarily related to long-term debt securities that mature in 2018.

	4	Refer to Note 5 for additional information related to the composition of our derivative portfolio.

	5	The Company's derivative financial instruments are recorded at fair value in our consolidated balance sheet as follows: $567 million in the line item prepaid expenses and other assets; $726 million in the line item other assets; $14 million in the line item accounts payable and accrued expenses; and $109 million in the line item other liabilities. Refer to Note 5 for additional information related to the composition of our derivative portfolio.


		December 31, 2013
		Level 1				Level 2				Level 3				Netting				Fair Value
														Adjustment1				Measurements
	Assets:
	Trading securities2	$	206			$	163			$	3			$	—			$	372

	Available-for-sale securities2	1,453				3,281				108			3	—				4,842

	Derivatives4	17				822				—				(150		)		689		5

	Total assets	$	1,676			$	4,266			$	111			$	(150	)		$	5,903

	Liabilities:
	Derivatives4	$	10			$	165			$	—			$	(151	)		$	24	5

	Total liabilities	$	10			$	165			$	—			$	(151	)		$	24


1	Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with the same counterparties. There are no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 5.

2	Refer to Note 3 for additional information related to the composition of our trading securities and available-for-sale securities.

3	Primarily related to long-term debt securities that mature in 2018.

4	Refer to Note 5 for additional information related to the composition of our derivative portfolio.

5	The Company's derivative financial instruments are recorded at fair value in our consolidated balance sheet as follows: $129 million in the line item prepaid expenses and other assets; $560 million in the line item other assets; $12 million in the line item accounts payable and accrued expenses; and $12 million in the line item other liabilities. Refer to Note 5 for additional information related to the composition of our derivative portfolio.
Gross realized and unrealized gains and losses on Level 3 assets and liabilities were not significant for the years ended December 31, 2014 and 2013.
The Company recognizes transfers between levels within the hierarchy as of the beginning of the reporting period. Gross transfers between levels within the hierarchy were not significant for the years ended December 31, 2014 and 2013.
Nonrecurring Fair Value Measurements
In addition to assets and liabilities that are recorded at fair value on a recurring basis, the Company records assets and liabilities at fair value on a nonrecurring basis as required by accounting principles generally accepted in the United States. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges.
Assets measured at fair value on a nonrecurring basis for the years ended December 31, 2014 and 2013, are summarized below (in millions):


	Gains (Losses)
December 31,	2014				2013

Assets held for sale	$	(494	)	1	$	—

Intangible assets	(18		)	2	(195		)	2
Exchange of investment in equity securities	—				(114		)	4

Valuation of shares in equity method investee	(32		)	3	139			3

Total	$	(544	)		$	(170	)

1	As of December 31, 2014, the Company had entered into agreements to refranchise additional territories in North America. These operations met the criteria to be classified as held for sale in our consolidated balance sheet as of December 31, 2014, and we were required to record their assets and liabilities at the lower of carrying value or fair value less any costs to sell based on the agreed-upon sale price. The Company recognized a noncash loss of $494 million during the year ended December 31, 2014 as a result of writing down the assets to their fair value less costs to sell. The loss was calculated based on Level 3 inputs. Refer to Note 2.

2	The Company recognized losses of $18 million and $195 million during years ended December 31, 2014 and 2013, respectively, due to impairment charges on certain intangible assets. The charges were primarily determined by comparing the fair value of the assets to the current carrying value. The fair value of the assets was derived using discounted cash flow analyses based on Level 3 inputs. Refer to Note 1 and Note 17.

3	In 2014, the Company recognized a loss of $32 million as a result of the owners of the majority interest in certain Brazilian bottling operations exercising their option to acquire from us a 10 percent interest in the entity's outstanding shares. The exercise price was lower than our carrying value. This loss was determined using Level 3 inputs. In 2013, the Company recognized a gain of $139 million as a result of Coca-Cola FEMSA, an equity method investee, issuing additional shares of its own stock at a per share amount greater than the carrying value of the Company's per share investment. Accordingly, the Company is required to treat this type of transaction as if the Company had sold a proportionate share of its investment in Coca-Cola FEMSA. This gain was determined using Level 1 inputs. Refer to Note 17.

4	The Company recognized a net loss of $114 million on the exchange of shares it previously owned in certain equity method investees for shares in the newly formed entity CCEJ. CCEJ is also an equity method investee. The net loss represents the difference between the carrying value of the shares the Company relinquished and the fair value of the CCEJ shares received as a result of the transaction. The net loss and the initial carrying value of the Company's investment were calculated based on Level 1 inputs. Refer to Note 17.
Fair Value Measurements for Pension and Other Postretirement Benefit Plans
The fair value hierarchy discussed above is not only applicable to assets and liabilities that are included in our consolidated balance sheets, but is also applied to certain other assets that indirectly impact our consolidated financial statements. For example, our Company sponsors and/or contributes to a number of pension and other postretirement benefit plans. Assets contributed by the Company become the property of the individual plans. Even though the Company no longer has control over these assets, we are indirectly impacted by subsequent fair value adjustments to these assets. The actual return on these assets impacts the Company's future net periodic benefit cost, as well as amounts recognized in our consolidated balance sheets. Refer to Note 13. The Company uses the fair value hierarchy to measure the fair value of assets held by our various pension and other postretirement benefit plans.
Pension Plan Assets
The following table summarizes the levels within the fair value hierarchy for our pension plan assets as of December 31, 2014 and 2013 (in millions):


	December 31, 2014																December 31, 2013
	Level 1				Level 2				Level 3				Total				Level 1			Level 2				Level 3				Total

Cash and cash equivalents	$	161			$	100			$	—			$	261			$	331		$	183			$	—			$	514

Equity securities:
U.S.-based companies	1,793				6				17				1,816				1,680			7				15				1,702

International-based companies	1,050				13				—				1,063				1,271			13				—				1,284

Fixed-income securities:
Government bonds	—				863				3				866				—			719				49				768

Corporate bonds and debt securities	—				1,533				33				1,566				—			1,466				40				1,506

Mutual, pooled and commingled funds	98				1,134				31				1,263				56			1,531				—				1,587

Hedge funds/limited partnerships	—				215				584				799				—			190				353				543

Real estate	—				16				392				408				—			—				251				251

Other	—				14				846			1	860				—			7				584			1	591

Total	$	3,102			$	3,894			$	1,906			$	8,902			$	3,338		$	4,116			$	1,292			$	8,746


1	Includes purchased annuity contracts and insurance-linked securities.
The following table provides a reconciliation of the beginning and ending balance of Level 3 assets for our U.S. and non-U.S. pension plans for the years ended December 31, 2014 and 2013 (in millions):


	Fixed-Income Securities				Hedge				Real Estate				Equity				Mutual,			Other				Total
					Funds/Limited								Securities				Pooled and
					Partnerships												Commingled
																	Funds
2013
Balance at beginning of year	$	—			$	400			$	257			$	14			$	—		$	510			$	1,181

Actual return on plan assets:
Related to assets still held at the reporting date	(4		)		(6		)		13				—				—			39				42

Related to assets sold during the year	(2		)		24				6				—				—			—				28

Purchases, sales and settlements — net	95				14				(24		)		1				—			193				279

Transfers in or out of Level 3 — net	—				(78		)		—				—				—			(172		)		(250		)

Foreign currency translation	—				(1		)		(1		)		—				—			14				12

Balance at end of year	$	89			$	353			$	251			$	15			$	—		$	584		1	$	1,292

2014
Balance at beginning of year	$	89			$	353			$	251			$	15			$	—		$	584			$	1,292

Actual return on plan assets:
Related to assets still held at the reporting date	17				(17		)		29				1				—			50				80

Related to assets sold during the year	(2		)		42				7				—				—			—				47

Purchases, sales and settlements — net	(41		)		198				106				1				31			241				536

Transfers in or out of Level 3 — net	(27		)		9				—				—				—			—				(18		)

Foreign currency translation	—				(1		)		(1		)		—				—			(29		)		(31		)

Balance at end of year	$	36			$	584			$	392			$	17			$	31		$	846		1	$	1,906


1	Includes purchased annuity contracts and insurance-linked securities.
Other Postretirement Benefit Plan Assets
The following table summarizes the levels within the fair value hierarchy for our other postretirement benefit plan assets as of December 31, 2014 and 2013 (in millions):


	December 31, 2014																December 31, 2013
	Level 1				Level 2				Level 3 1				Total				Level 1			Level 2				Level 3 1				Total

Cash and cash equivalents	$	9			$	1			$	—			$	10			$	—		$	10			$	—			$	10

Equity securities:
U.S.-based companies	114				—				—				114				112			—				—				112

International-based companies	7				—				—				7				8			—				—				8

Fixed-income securities:
Government bonds	76				3				—				79				76			3				—				79

Corporate bonds and debt securities	—				9				—				9				—			9				—				9

Mutual, pooled and commingled funds	10				6				—				16				11			7				—				18

Hedge funds/limited partnerships	—				1				4				5				—			1				2				3

Real estate	—				—				3				3				—			—				2				2

Other	—				—				3				3				—			—				2				2

Total	$	216			$	20			$	10			$	246			$	207		$	30			$	6			$	243


1	Level 3 assets are not a significant portion of other postretirement benefit plan assets.
Other Fair Value Disclosures
The carrying amounts of cash and cash equivalents; short-term investments; receivables; accounts payable and accrued expenses; and loans and notes payable approximate their fair values because of the relatively short-term maturities of these financial instruments.
The fair value of our long-term debt is estimated using Level 2 inputs based on quoted prices for those instruments. Where quoted prices are not available, fair value is estimated using discounted cash flows and market-based expectations for interest rates, credit risk and the contractual terms of the debt instruments. As of December 31, 2014, the carrying amount and fair value of our long-term debt, including the current portion, were $22,615 million and $23,411 million, respectively. As of December 31, 2013, the carrying amount and fair value of our long-term debt, including the current portion, were $20,178 million and $20,352 million, respectively.

SIGNIFICANT_OPERATING_AND_NONO

SIGNIFICANT OPERATING AND NONOPERATING ITEMS	12 Months Ended
SIGNIFICANT OPERATING AND NONOPERATING ITEMS	Dec. 31, 2014
Significant Operating and Nonoperating Items disclosure [Abstract]
SIGNIFICANT OPERATING AND NONOPERATING ITEMS	SIGNIFICANT OPERATING AND NONOPERATING ITEMS
	Other Operating Charges
	In 2014, the Company incurred other operating charges of $1,183 million. These charges primarily consisted of $601 million due to the Company's productivity and reinvestment program and $208 million due to the integration of our German bottling and distribution operations. In addition, the Company incurred a charge of $314 million due to a write-down we recorded related to our concentrate sales receivables from our bottling partner in Venezuela and an impairment of a Venezuelan trademark primarily due to changes in exchange rates. The write-down was recorded as a result of our revised assessment of the U.S. dollar value we expect to realize upon the conversion of the Venezuelan bolivar into U.S. dollars by our bottling partner to pay our concentrate sales receivables. The Company also recorded a loss of $36 million as a result of the restructuring and transition of the Company's Russian juice operations to an existing joint venture with an unconsolidated bottling partner. Refer to Note 18 for additional information on our productivity and reinvestment program as well as the Company's other productivity, integration and restructuring initiatives. Refer to Note 1 for additional information on the Venezuelan currency change. Refer to Note 19 for the impact these charges had on our operating segments.
	In 2013, the Company incurred other operating charges of $895 million, which primarily consisted of $494 million associated with the Company's productivity and reinvestment program; $195 million due to the impairment of certain intangible assets described below; $188 million due to the Company's other restructuring and integration initiatives; and $22 million due to charges associated with certain of the Company's fixed assets. Refer to Note 18 for additional information on our productivity and reinvestment program as well as the Company's other productivity, integration and restructuring initiatives. Refer to Note 19 for the impact these charges had on our operating segments.
	During the year ended December 31, 2013, the Company recorded charges of $195 million related to certain intangible assets. These charges included $113 million related to the impairment of trademarks recorded in our Bottling Investments and Asia Pacific operating segments. These impairments were primarily due to a strategic decision to phase out certain local-market value brands, which resulted in a change in the expected useful life of the intangible assets. The charges were determined by comparing the fair value of the trademarks, derived using discounted cash flow analyses, to the current carrying value. Additionally, the remaining charge of $82 million was related to goodwill recorded in our Bottling Investments operating segment. This charge was primarily the result of management's revised outlook on market conditions and volume performance.
	In 2012, the Company incurred other operating charges of $447 million, which primarily consisted of $270 million associated with the Company's productivity and reinvestment program; $163 million related to the Company's other restructuring and integration initiatives; $20 million due to changes in the Company's ready-to-drink tea strategy as a result of our U.S. license agreement with Nestlé S.A. ("Nestlé") terminating at the end of 2012; and $8 million due to costs associated with the Company detecting carbendazim in orange juice imported from Brazil for distribution in the United States. These charges were partially offset by reversals of $10 million associated with the refinement of previously established accruals related to the Company's 2008–2011 productivity initiatives as well as reversals of $6 million associated with the refinement of previously established accruals related to the Company's integration of CCE's former North America business. Refer to Note 18 for additional information on our productivity and reinvestment program as well as the Company's other productivity, integration and restructuring initiatives. Refer to Note 19 for the impact these charges had on our operating segments.
	Other Nonoperating Items
	Equity Income (Loss) — Net
	The Company recorded net charges of $18 million and $159 million and a net gain of $8 million in equity income (loss) — net during the years ended December 31, 2014, 2013 and 2012, respectively. These amounts primarily represent the Company's proportionate share of unusual or infrequent items recorded by certain of our equity method investees.
	In 2012, the Company also recorded a charge of $11 million related to changes in the structure of Beverage Partners Worldwide ("BPW"), our 50/50 joint venture with Nestlé in the ready-to-drink tea category. These changes resulted in the joint venture focusing its geographic scope primarily on Europe and Canada. The Company accounts for our investment in BPW under the equity method of accounting.
	Refer to Note 19 for the impact these items had on our operating segments.
	Other Income (Loss) — Net
	In 2014, the Company recorded charges of $799 million due to the refranchising of certain territories in North America. The Company also incurred a charge of $372 million due to the remeasurement of the net monetary assets of our Venezuelan subsidiary using the SICAD 2 exchange rate. Refer to Note 2 for more information related to the North America refranchising, Note 1 for more information related to the charge due to the remeasurement in Venezuela and Note 19 for the impact these charges had on our operating segments.
	In 2013, the Company recorded a gain of $615 million due to the deconsolidation of our Brazilian bottling operations as a result of their combination with an independent bottling partner. Subsequent to this transaction, the Company accounts for our investment in the newly combined Brazilian bottling operations under the equity method of accounting. The owners of the majority interest received the option to acquire from us up to 24 percent of the new entity's outstanding shares at any time for a period of six years beginning December 31, 2013. In December 2014, the Company received notification that the owners of the majority interest had exercised their option to acquire from us a 10 percent interest in the entity's outstanding shares. During the year ended December 31, 2014, we recorded a loss of $32 million as a result of the exercise price being lower than our carrying value. Refer to Note 2 for additional information on this transaction. Refer to Note 19 for the impact these items had on our operating segments.
	Effective July 1, 2013, four of the Company's Japanese bottling partners merged as CCEJ, a publicly traded entity, through a share exchange. The terms of the agreement included the issuance of new shares of one of the publicly traded bottlers in exchange for 100 percent of the outstanding shares of the remaining three bottlers according to an agreed-upon share exchange ratio. As a result, the Company recorded a net charge of $114 million for those investments in which the Company's carrying value was greater than the fair value of the shares received. Refer to Note 19 for the impact this loss had on our operating segments.
	In 2013, the Company recorded a charge of $140 million due to the Venezuelan government announcing a currency devaluation. As a result of this devaluation, the Company remeasured the net monetary assets related to its operations in Venezuela. Refer to Note 19 for the impact this charge had on our operating segments. The Company also recognized a gain of $139 million due to Coca-Cola FEMSA issuing additional shares of its own stock at a per share amount greater than the carrying value of the Company's per share investment. Accordingly, the Company is required to treat this type of transaction as if the Company sold a proportionate share of its investment in Coca-Cola FEMSA. Refer to Note 16 for additional information on the measurement of the gain and Note 19 for the impact this gain had on our operating segments.
	In 2012, the Company recognized a gain of $185 million as a result of the merger of Andina and Polar, with Andina being the acquiring company. Prior to this transaction, the Company held an investment in Andina that we accounted for as an available-for-sale security as well as an investment in Polar that we accounted for under the equity method of accounting. The merger of the two companies was a noncash transaction that resulted in Polar shareholders exchanging their existing Polar shares for newly issued shares of Andina at a specified exchange rate. As a result, the Company now holds an investment in Andina that we account for as an equity method investment. Refer to Note 19 for the impact this gain had on our operating segments.
	On December 13, 2012, the Company and Coca-Cola FEMSA executed a share purchase agreement for the sale of a majority ownership interest in our consolidated Philippine bottling operations. This transaction was completed on January 25, 2013. As a result of this agreement, the Company was required to classify our Philippine bottling operations as held for sale in our consolidated balance sheet as of December 31, 2012. We also recognized a loss of $108 million during the year ended December 31, 2012, based on the agreed-upon sale price and related transaction costs. Refer to Note 19 for the impact this loss had on our operating segments.
	The Company also recognized a gain of $92 million in 2012 as a result of Coca-Cola FEMSA issuing additional shares of its own stock at a per share amount greater than the carrying value of the Company's investment. Accordingly, the Company is required to treat this type of transaction as if we sold a proportionate share of our investment in Coca-Cola FEMSA. Refer to Note 19 for the impact this gain had on our operating segments.
	During the year ended December 31, 2012, the Company recorded a charge of $82 million due to the acquisition of an ownership interest in Mikuni for which we paid a premium over the publicly traded market price. Although the Company paid this premium to obtain specific rights that have an economic and strategic value to the Company, they do not qualify as an asset and were recorded as expense on the acquisition date. For the impact that this charge had on our operating segments, refer to Note 19. The Company accounted for our investment in Mikuni under the equity method of accounting prior to the merger of the four bottlers into CCEJ discussed above.
	The Company also recognized charges of $16 million during the year ended December 31, 2012, due to other-than-temporary declines in the fair values of certain cost method investments. Refer to Note 19 for the impact these charges had on our operating segments.

PRODUCTIVITY_INTEGRATION_AND_R

PRODUCTIVITY, INTEGRATION AND RESTRUCTURING INITIATIVES	12 Months Ended
	Dec. 31, 2014
Restructuring and Related Activities [Abstract]
PRODUCTIVITY, INTEGRATION AND RESTRUCTURING INITIATIVES	PRODUCTIVITY, INTEGRATION AND RESTRUCTURING INITIATIVES
	Productivity and Reinvestment
	In February 2012, the Company announced a four-year productivity and reinvestment program which is designed to assist us in strengthening our brands and reinvesting our resources to drive long-term profitable growth. This program is focused on the following initiatives: global supply chain optimization; global marketing and innovation effectiveness; operating expense leverage and operational excellence; data and information technology systems standardization; and further integration of CCE's former North America business.
	In February 2014, the Company announced the expansion of our productivity and reinvestment program to drive incremental productivity by 2016 that will primarily be redirected into increased media investments. Our incremental productivity goal consists of two relatively equal components. First, we will expand savings through global supply chain optimization, data and information technology systems standardization, and resource and cost reallocation. Second, we will increase the effectiveness of our marketing investments by transforming our marketing and commercial model to redeploy resources into more consumer-facing marketing investments to accelerate growth.
	In October 2014, the Company announced that we are further expanding our productivity and reinvestment program through 2019. The expansion of the productivity initiatives will focus on four key areas: restructuring the Company's global supply chain, including manufacturing in North America; implementing zero-based budgeting across the organization; streamlining and simplifying the Company's operating model; and further driving increased discipline and efficiency in direct marketing investments.
	The Company has incurred total pretax expenses of $1,365 million related to this program since it commenced. These expenses were recorded in the line item other operating charges in our consolidated statement of income. Refer to Note 19 for the impact these charges had on our operating segments. Outside services reported in the table below primarily relate to expenses in connection with legal, outplacement and consulting activities. Other direct costs reported in the table below include, among other items, internal and external costs associated with the development, communication, administration and implementation of these initiatives; accelerated depreciation on certain fixed assets; contract termination fees; and relocation costs.
	The following table summarizes the balance of accrued expenses related to these productivity and reinvestment initiatives and the changes in the accrued amounts since the commencement of the plan (in millions):


		Severance Pay			Outside Services			Other			Total
		and Benefits						Direct Costs
	2012
	Costs incurred	$	21		$	61		$	188		$	270

	Payments	(8		)	(55		)	(167		)	(230		)
	Noncash and exchange	(1		)	—			(13		)	(14		)

	Accrued balance as of December 31	$	12		$	6		$	8		$	26

	2013
	Costs incurred	$	188		$	59		$	247		$	494

	Payments	(113		)	(59		)	(209		)	(381		)
	Noncash and exchange	1			—			(28		)	(27		)

	Accrued balance as of December 31	$	88		$	6		$	18		$	112

	2014
	Costs incurred	$	277		$	77		$	247		$	601

	Payments	(103		)	(79		)	(220		)	(402		)
	Noncash and exchange	(2		)	—			(24		)	(26		)

	Accrued balance as of December 31	$	260		$	4		$	21		$	285

	Integration Initiatives
	Integration of Our German Bottling and Distribution Operations
	In 2008, the Company began an integration initiative related to the 18 German bottling and distribution operations acquired in 2007. The Company incurred $208 million, $187 million and $148 million of expenses related to this initiative in 2014, 2013 and 2012, respectively, and has incurred total pretax expenses of $835 million related to this initiative since it commenced. These expenses were recorded in the line item other operating charges in our consolidated statements of income and impacted the Bottling Investments operating segment. The expenses recorded in connection with these integration activities have been primarily due to involuntary terminations. The Company had $101 million and $127 million accrued related to these integration costs as of December 31, 2014 and 2013, respectively.
	The Company is currently reviewing other restructuring opportunities within the German bottling and distribution operations, which if implemented will result in additional charges in future periods. However, as of December 31, 2014, the Company had not finalized any additional plans.

OPERATING_SEGMENTS

OPERATING SEGMENTS	12 Months Ended
OPERATING SEGMENTS	Dec. 31, 2014
Operations, Reportable Information, by Operating Segment
OPERATING SEGMENTS	OPERATING SEGMENTS
	As of December 31, 2014, our organizational structure consisted of the following operating segments: Eurasia and Africa; Europe; Latin America; North America; Asia Pacific; Bottling Investments; and Corporate.
	Segment Products and Services
	The business of our Company is nonalcoholic beverages. With the exception of North America, our geographic operating segments (Eurasia and Africa; Europe; Latin America; North America; and Asia Pacific) derive a majority of their revenues from the manufacture and sale of beverage concentrates and syrups and, in some cases, the sale of finished beverages. The North America operating segment derives the majority of its revenues from the sale of finished beverages. Our Bottling Investments operating segment is composed of our Company-owned or consolidated bottling operations outside of North America, regardless of the geographic location of the bottler, and equity income from the majority of our equity method investments. Company-owned or consolidated bottling operations derive the majority of their revenues from the sale of finished beverages. Generally, bottling and finished product operations produce higher net revenues but lower gross profit margins compared to concentrate and syrup operations.
	The following table sets forth the percentage of total net operating revenues related to concentrate operations and finished product operations:


	Year Ended December 31,	2014		2013			2012
	Year Ended December 31,	2014		2013			2012
	Concentrate operations1	38	%	38	%		38	%
	Finished product operations2	62		62			62
	Finished product operations2	62		62			62
	Net operating revenues	100	%	100	%		100	%

	1	Includes concentrates sold by the Company to authorized bottling partners for the manufacture of fountain syrups. The bottlers then typically sell the fountain syrups to wholesalers or directly to fountain retailers.

	2	Includes fountain syrups manufactured by the Company, including consolidated bottling operations, and sold to fountain retailers or to authorized fountain wholesalers or bottling partners who resell the fountain syrups to fountain retailers.
	Method of Determining Segment Income or Loss
	Management evaluates the performance of our operating segments separately to individually monitor the different factors affecting financial performance. Our Company manages income taxes and certain treasury-related items, such as interest income and expense, on a global basis within the Corporate operating segment. We evaluate segment performance based on income or loss before income taxes.
	Geographic Data
	The following table provides information related to our net operating revenues (in millions):


	Year Ended December 31,	2014			2013				2012
	Year Ended December 31,	2014			2013				2012
	United States	$	19,763		$	19,820			$	19,732
	United States	$	19,763		$	19,820			$	19,732
	International	26,235			27,034				28,285
	International	26,235			27,034				28,285
	Net operating revenues	$	45,998		$	46,854			$	48,017
	Net operating revenues	$	45,998		$	46,854			$	48,017
	The following table provides information related to our property, plant and equipment — net (in millions):


	Year Ended December 31,	2014			2013				2012
	Year Ended December 31,	2014			2013				2012
	United States	$	8,683		$	8,841			$	8,509
	United States	$	8,683		$	8,841			$	8,509
	International	5,950			6,126				5,967
	International	5,950			6,126				5,967
	Property, plant and equipment — net	$	14,633		$	14,967			$	14,476
	Property, plant and equipment — net	$	14,633		$	14,967			$	14,476
	Information about our Company's operations by operating segment for the years ended December 31, 2014, 2013 and 2012, is as follows (in millions):


		Eurasia &			Europe				Latin			North				Asia Pacific			Bottling				Corporate				Eliminations				Consolidated
		Africa			Europe				America			America				Asia Pacific			Investments				Corporate				Eliminations				Consolidated
	2014
	Net operating revenues:
	Third party	$	2,730		$	4,844			$	4,597		$	21,462			$	5,257		$	6,972			$	136			$	—			$	45,998
	Third party	$	2,730		$	4,844			$	4,597		$	21,462			$	5,257		$	6,972			$	136			$	—			$	45,998
	Intersegment	—			692				60			17				489			67				—				(1,325		)		—
	Intersegment	—			692				60			17				489			67				—				(1,325		)		—
	Total net revenues	2,730			5,536				4,657			21,479				5,746			7,039				136				(1,325		)		45,998
	Total net revenues	2,730			5,536				4,657			21,479				5,746			7,039				136				(1,325		)		45,998
	Operating income (loss)	1,084			2,852				2,316			2,447				2,448			9				(1,448		)		—				9,708
	Operating income (loss)	1,084			2,852				2,316			2,447				2,448			9				(1,448		)		—				9,708
	Interest income	—			—				—			—				—			—				594				—				594
	Interest income	—			—				—			—				—			—				594				—				594
	Interest expense	—			—				—			—				—			—				483				—				483
	Interest expense	—			—				—			—				—			—				483				—				483
	Depreciation and amortization	47			75				56			1,195				96			315				192				—				1,976
	Depreciation and amortization	47			75				56			1,195				96			315				192				—				1,976
	Equity income (loss) — net	35			31				10			(16		)		12			691				6				—				769
	Equity income (loss) — net	35			31				10			(16		)		12			691				6				—				769
Income (loss) before income taxes	1,125			2,892				2,319			1,633				2,464			715				(1,823		)		—				9,325
Income (loss) before income taxes	1,125			2,892				2,319			1,633				2,464			715				(1,823		)		—				9,325
Identifiable operating assets1	1,298			3,358			2	2,426			33,066				1,793			6,975			2	29,482				—				78,398
Identifiable operating assets1	1,298			3,358			2	2,426			33,066				1,793			6,975			2	29,482				—				78,398
Investments3	1,081			90				757			48				157			8,781				2,711				—				13,625
Investments3	1,081			90				757			48				157			8,781				2,711				—				13,625
Capital expenditures	30			54				55			1,293				76			628				270				—				2,406
Capital expenditures	30			54				55			1,293				76			628				270				—				2,406
2013
Net operating revenues:
Third party	$	2,763		$	4,645			$	4,748		$	21,574			$	5,372		$	7,598			$	154			$	—			$	46,854
Third party	$	2,763		$	4,645			$	4,748		$	21,574			$	5,372		$	7,598			$	154			$	—			$	46,854
Intersegment	—			689				191			16				497			78				—				(1,471		)		—
Intersegment	—			689				191			16				497			78				—				(1,471		)		—
Total net revenues	2,763			5,334				4,939			21,590				5,869			7,676				154				(1,471		)		46,854
Total net revenues	2,763			5,334				4,939			21,590				5,869			7,676				154				(1,471		)		46,854
Operating income (loss)	1,087			2,859				2,908			2,432				2,478			115				(1,651		)		—				10,228
Operating income (loss)	1,087			2,859				2,908			2,432				2,478			115				(1,651		)		—				10,228
Interest income	—			—				—			—				—			—				534				—				534
Interest income	—			—				—			—				—			—				534				—				534
Interest expense	—			—				—			—				—			—				463				—				463
Interest expense	—			—				—			—				—			—				463				—				463
Depreciation and amortization	42			86				58			1,192				130			335				134				—				1,977
Depreciation and amortization	42			86				58			1,192				130			335				134				—				1,977
Equity income (loss) — net	22			24				13			2				19			524				(2		)		—				602
Equity income (loss) — net	22			24				13			2				19			524				(2		)		—				602
Income (loss) before income taxes	1,109			2,923				2,920			2,434				2,494			679				(1,082		)		—				11,477
Income (loss) before income taxes	1,109			2,923				2,920			2,434				2,494			679				(1,082		)		—				11,477
Identifiable operating assets1	1,273			3,713			2	2,918			33,964				1,922			7,011			2	27,742				—				78,543
Identifiable operating assets1	1,273			3,713			2	2,918			33,964				1,922			7,011			2	27,742				—				78,543
Investments3	1,157			106				545			49				143			9,424				88				—				11,512
Investments3	1,157			106				545			49				143			9,424				88				—				11,512
Capital expenditures	40			34				63			1,374				117			643				279				—				2,550
Capital expenditures	40			34				63			1,374				117			643				279				—				2,550
2012
Net operating revenues:
Third party	$	2,697		$	4,481			$	4,560		$	21,665			$	5,680		$	8,807			$	127			$	—			$	48,017
Third party	$	2,697		$	4,481			$	4,560		$	21,665			$	5,680		$	8,807			$	127			$	—			$	48,017
Intersegment	—			642				271			15				628			88				—				(1,644		)		—
Intersegment	—			642				271			15				628			88				—				(1,644		)		—
Total net revenues	2,697			5,123				4,831			21,680				6,308			8,895				127				(1,644		)		48,017
Total net revenues	2,697			5,123				4,831			21,680				6,308			8,895				127				(1,644		)		48,017
Operating income (loss)	1,078			2,960				2,879			2,597				2,516			140				(1,391		)		—				10,779
Operating income (loss)	1,078			2,960				2,879			2,597				2,516			140				(1,391		)		—				10,779
Interest income	—			—				—			—				—			—				471				—				471
Interest income	—			—				—			—				—			—				471				—				471
Interest expense	—			—				—			—				—			—				397				—				397
Interest expense	—			—				—			—				—			—				397				—				397
Depreciation and amortization	33			100				70			1,083				119			406				171				—				1,982
Depreciation and amortization	33			100				70			1,083				119			406				171				—				1,982
Equity income (loss) — net	20			45				4			13				2			732				3				—				819
Equity income (loss) — net	20			45				4			13				2			732				3				—				819
Income (loss) before income taxes	1,101			3,015				2,882			2,624				2,523			904				(1,240		)		—				11,809
Income (loss) before income taxes	1,101			3,015				2,882			2,624				2,523			904				(1,240		)		—				11,809
Identifiable operating assets1	1,299			2,976			2	2,759			34,114				2,163			9,648			2	22,767				—				75,726
Identifiable operating assets1	1,299			2,976			2	2,759			34,114				2,163			9,648			2	22,767				—				75,726
Investments3	1,155			271				539			39				127			8,253				64				—				10,448
Investments3	1,155			271				539			39				127			8,253				64				—				10,448
Capital expenditures	51			30				88			1,447				107			867				190				—				2,780
Capital expenditures	51			30				88			1,447				107			867				190				—				2,780

1	Principally cash and cash equivalents, short-term investments, marketable securities, trade accounts receivable, inventories, goodwill, trademarks and other intangible assets and property, plant and equipment — net.

2	Property, plant and equipment — net in Germany represented 10 percent of consolidated property, plant and equipment — net in 2014, 11 percent in 2013 and 10 percent in 2012.

3	Principally equity method investments, available-for-sale securities and nonmarketable investments in bottling companies.
In 2014, the results of our operating segments were impacted by the following items:

•	Operating income (loss) and income (loss) before income taxes were reduced by $26 million for Eurasia and Africa, $111 million for Europe, $20 million for Latin America, $281 million for North America, $36 million for Asia Pacific, $211 million for Bottling Investments and $124 million for Corporate due to charges related to the Company's productivity and reinvestment program as well as other restructuring initiatives. Refer to Note 18.

•	Operating income (loss) and income (loss) before income taxes were reduced by $42 million for Bottling Investments as a result of the restructuring and transition of the Company's Russian juice operations to an existing joint venture with an unconsolidated bottling partner. Refer to Note 17.

•	Income (loss) before income taxes was reduced by $2 million for Europe and $16 million for Bottling Investments due to the Company's proportionate share of unusual or infrequent items recorded by certain of our equity method investees. Refer to Note 17.

•	Income (loss) before income taxes was reduced by $799 million for North America due to the refranchising of certain territories. Refer to Note 2 and Note 17.

•	Income (loss) before income taxes was reduced by $275 million for Latin America and $411 million for Corporate due to the remeasurement of the net monetary assets of our local Venezuelan subsidiary into U.S. dollars using the SICAD 2 exchange rate, an impairment of a Venezuelan trademark, and a write-down the Company recorded on the concentrate sales receivables from our bottling partner in Venezuela. Refer to Note 1 and Note 17.

•	Income (loss) before income taxes was increased by $25 million for Bottling Investments due to the elimination of intercompany profits resulting from a write-down we recorded on the concentrate sales receivables from our bottling partner in Venezuela, an equity method investee, partially offset by our proportionate share of their remeasurement loss. Refer to Note 1.

•	Income (loss) before income taxes was reduced by $32 million for Corporate as a result of a Brazilian bottling entity's majority interest owners exercising their option to acquire from us an additional equity interest at an exercise price less than that of our carrying value. Refer to Note 2 and Note 17.
In 2013, the results of our operating segments were impacted by the following items:

•	Operating income (loss) and income (loss) before income taxes were reduced by $2 million for Eurasia and Africa, $57 million for Europe, $282 million for North America, $26 million for Asia Pacific, $194 million for Bottling Investments and $121 million for Corporate due to charges related to the Company's productivity and reinvestment program as well as other restructuring initiatives. Refer to Note 18.

•	Operating income (loss) and income (loss) before income taxes were reduced by $195 million for Corporate due to impairment charges recorded on certain of the Company's intangible assets. Refer to Note 8 and Note 17.

•	Operating income (loss) and income (loss) before income taxes were reduced by $22 million for Asia Pacific due to charges associated with certain of the Company's fixed assets. Refer to Note 17.

•	Income (loss) before income taxes was increased by $615 million for Corporate due to a gain the Company recognized on the deconsolidation of our Brazilian bottling operations as a result of their combination with an independent bottling partner. Refer to Note 2.

•	Income (loss) before income taxes was reduced by $9 million for Bottling Investments and $140 million for Corporate due to the devaluation of the Venezuelan bolivar, including our proportionate share of the charge incurred by an equity method investee that has operations in Venezuela. Refer to Note 1 and Note 17.

•	Income (loss) before income taxes was reduced by a net $114 million for Corporate due to the merger of four of the Company's Japanese bottling partners in which we held equity method investments prior to their merger into CCEJ. Refer to Note 2 and Note 17.

•	Income (loss) before income taxes was increased by $139 million for Corporate due to a gain the Company recognized as a result of Coca-Cola FEMSA issuing additional shares of its own stock during the year at a per share amount greater than the carrying value of the Company's per share investment. Refer to Note 16 and Note 17.

•	Income (loss) before income taxes was reduced by a net $159 million for Bottling Investments due to the Company’s proportionate share of unusual or infrequent items recorded by certain of our equity method investees. Refer to Note 17.

•	Income (loss) before income taxes was reduced by $53 million for Corporate due to charges the Company recognized on the early extinguishment of certain long-term debt, including the hedge accounting adjustments reclassified from accumulated other comprehensive income to earnings. Refer to Note 10.
In 2012, the results of our operating segments were impacted by the following items:

•	Operating income (loss) and income (loss) before income taxes were reduced by $1 million for Europe, $227 million for North America, $3 million for Asia Pacific, $164 million for Bottling Investments and $38 million for Corporate due to charges related to the Company's productivity and reinvestment program as well as other restructuring initiatives. Refer to Note 18.

•	Operating income (loss) and income (loss) before income taxes were reduced by $21 million for North America due to costs associated with the Company detecting residues of carbendazim, a fungicide that is not registered in the United States for use on citrus products, in orange juice imported from Brazil for distribution in the United States. As a result, the Company began purchasing additional supplies of Florida orange juice at a higher cost than Brazilian orange juice. Refer to Note 17.

•	Operating income (loss) and income (loss) before income taxes were reduced by $20 million for North America due to changes in the Company's ready-to-drink tea strategy as a result of our U.S. license agreement with Nestlé that terminated at the end of 2012. Refer to Note 17.

•	Equity income (loss) — net and income (loss) before income taxes were increased by $8 million for Bottling Investments due to the Company’s proportionate share of unusual or infrequent items recorded by certain of our equity method investees. Refer to Note 17.

•	Income (loss) before income taxes was increased by $185 million for Corporate due to the gain the Company recognized as a result of the merger of Andina and Polar. Refer to Note 17.

•	Income (loss) before income taxes was reduced by $108 million for Corporate due to the loss the Company recognized on the pending sale of a majority ownership interest in our Philippine bottling operations to Coca-Cola FEMSA, which was completed in January 2013. As of December 31, 2012, the assets and liabilities associated with our Philippine bottling operations were classified as held for sale in our consolidated balance sheets. Refer to Note 17.

•	Income (loss) before income taxes was increased by $92 million for Corporate due to a gain the Company recognized as a result of Coca-Cola FEMSA issuing additional shares of its own stock during the year at a per share amount greater than the carrying amount of the Company's per share investment. Refer to Note 17.

•	Income (loss) before income taxes was reduced by $82 million for Corporate due to the Company acquiring an ownership interest in Mikuni for which we paid a premium over the publicly traded market price. This premium was expensed on the acquisition date. Refer to Note 17.

•	Income (loss) before income taxes was reduced by $16 million for Corporate due to other-than-temporary declines in the fair values of certain cost method investments. Refer to Note 16 and Note 17.

•	Income (loss) before income taxes was reduced by $1 million for Eurasia and Africa, $4 million for Europe, $2 million for Latin America and $4 million for Asia Pacific due to changes in the structure of BPW, our 50/50 joint venture with Nestlé in the ready-to-drink tea category. Refer to Note 17.

NET_CHANGE_IN_OPERATING_ASSETS

NET CHANGE IN OPERATING ASSETS AND LIABILITIES	12 Months Ended
	Dec. 31, 2014
NET CHANGE IN OPERATING ASSETS AND LIABILITIES DISCLOSURE [Abstract]
NET CHANGE IN OPERATING ASSETS AND LIABILITIES	NET CHANGE IN OPERATING ASSETS AND LIABILITIES
	Net cash provided by (used in) operating activities attributable to the net change in operating assets and liabilities is composed of the following (in millions):


	Year Ended December 31,	2014			2013			2012

	(Increase) decrease in trade accounts receivable	$	(253	)	$	28		$	(33	)

	(Increase) decrease in inventories	35			(105		)	(286		)

	(Increase) decrease in prepaid expenses and other assets	194			(163		)	(29		)

	Increase (decrease) in accounts payable and accrued expenses	(250		)	(158		)	(556		)
	Increase (decrease) in accrued taxes	151			22			770

	Increase (decrease) in other liabilities	(316		)	(556		)	(946		)
	Net change in operating assets and liabilities	$	(439	)	$	(932	)	$	(1,080	)

BUSINESS_AND_SUMMARY_OF_SIGNIF1

BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

12 Months Ended

Dec. 31, 2014

Summary of Significant Accounting Policies [Abstract]

Principles of Consolidation

Creditors of our VIEs do not have recourse against the general credit of the Company, regardless of whether they are accounted for as consolidated entities.

Assets and Liabilities Held for Sale

Revenue Recognition

Deductions from Revenue

Advertising Costs

Shipping and Handling Costs

Net Income Per Share

Cash Equivalents

Short-Term Investments

We classify time deposits and other investments that have maturities of greater than three months but less than one year as short-term investments.

Investments in Equity and Debt Securities

Trade Accounts Receivable

Year Ended December 31,

2014

2013

2012

Balance at beginning of year

Net charges to costs and expenses1

308

Write-offs

(13

)

(14

)

(19

)

Other2

(25

)

(16

)

Balance at end of year

331

The increase in 2014 was primarily related to concentrate sales receivables from our bottling partner in Venezuela. See Hyperinflationary Economies discussion below for additional information.

2 Other includes foreign currency translation and the impact of transferring certain assets to assets held for sale. See Note 2.

Inventories

Derivative Instruments

Property, Plant and Equipment

Goodwill, Trademarks and Other Intangible Assets

Contingencies

Stock-Based Compensation

Pension and Other Postretirement Benefit Plans

Income Taxes

Translation and Remeasurement

Hyperinflationary Economies

BUSINESS_AND_SUMMARY_OF_SIGNIF2

BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2014
Summary of Significant Accounting Policies [Abstract]
Activity in allowance for doubtful accounts	Activity in the allowance for doubtful accounts was as follows (in millions):


	Year Ended December 31,	2014			2013			2012

	Balance at beginning of year	$	61		$	53		$	83

	Net charges to costs and expenses1	308			30			5

	Write-offs	(13		)	(14		)	(19		)
	Other2	(25		)	(8		)	(16		)
	Balance at end of year	$	331		$	61		$	53


	1	The increase in 2014 was primarily related to concentrate sales receivables from our bottling partner in Venezuela. See Hyperinflationary Economies discussion below for additional information.
	2 Other includes foreign currency translation and the impact of transferring certain assets to assets held for sale. See Note 2.

ACQUISITIONS_AND_DIVESTITURES_

ACQUISITIONS AND DIVESTITURES (Tables)	12 Months Ended
	Dec. 31, 2014
Acquisitions and Divestitures Disclosure [
Disclosure of Assets and Liabilities Held-for-sale [Table Text Block]	The following table presents information related to the major classes of assets and liabilities that were classified as held for sale in our consolidated balance sheet (in millions):


		31-Dec-14

	Cash, cash equivalents and short-term investments	$	30

	Trade accounts receivable, less allowances	100

	Inventories	54

	Prepaid expenses and other assets	7

	Equity method investments	141

	Other assets	3

	Property, plant and equipment — net	303

	Bottlers' franchise rights with indefinite lives	410

	Trademarks	43

	Goodwill	46

	Other intangible assets	36

	Allowance for reduction of assets held for sale	(494		)
	Total assets	$	679

	Accounts payable and accrued expenses	$	48

	Other liabilities	6

	Deferred income taxes	4

	Total liabilities	$	58

INVESTMENTS_Tables

INVESTMENTS (Tables)	12 Months Ended
	Dec. 31, 2014
Investments Disclosure [Abstract]
Schedule of trading securities	The Company's trading securities were included in the following line items in our consolidated balance sheets (in millions):


	December 31,	2014			2013

	Marketable securities	$	315		$	286

	Other assets	94			86

	Total trading securities	$	409		$	372

Certain Debt and Marketable Equity Securities, Available-for-Sale And Held-To-Maturity Securities, Value and Maturities	As of December 31, 2014 and 2013, the Company did not have any held-to-maturity securities. Available-for-sale securities consisted of the following (in millions):


					Gross Unrealized							Estimated Fair Value
		Cost			Gains			Losses
	2014
	Available-for-sale securities:1
	Equity securities	$	2,687		$	1,463		$	(29	)		$	4,121

	Debt securities	3,796			68			(106		)	2	3,758

		$	6,483		$	1,531		$	(135	)		$	7,879

	2013
	Available-for-sale securities:1
	Equity securities	$	1,097		$	373		$	(17	)		$	1,453

	Debt securities	3,388			24			(23		)		3,389

		$	4,485		$	397		$	(40	)		$	4,842


	1	Refer to Note 16 for additional information related to the estimated fair value.
	2 Includes $101 million recognized in the consolidated income statement line item other income (loss) — net during the year ended December 31, 2014. The amount was primarily offset by changes in the fair value of foreign currency contracts designated as fair value hedges. Refer to Note 5 for additional information.
Schedule of Realized Gain (Loss) [Table Text Block]	The sale and/or maturity of available-for-sale securities resulted in the following activity (in millions):


	Year Ended December 31,	2014			2013			2012

	Gross gains	$	38		$	12		$	41

	Gross losses	(21		)	(24		)	(35		)
	Proceeds	4,157			4,212			5,036

Investments By Balance Sheet Grouping	The Company's available-for-sale securities were included in the following line items in our consolidated balance sheets (in millions):


	December 31,	2014			2013

	Cash and cash equivalents	$	43		$	245

	Marketable securities	3,350			2,861

	Other investments	3,512			958

	Other assets	974			778

		$	7,879		$	4,842

Contractual maturity amounts of the investment securities	The contractual maturities of these investments as of December 31, 2014, were as follows (in millions):


		Available-for-Sale Securities
		Cost			Fair Value

	Within 1 year	$	1,589		$	1,489

	After 1 year through 5 years	1,709			1,747

	After 5 years through 10 years	118			130

	After 10 years	380			392

	Equity securities	2,687			4,121

		$	6,483		$	7,879

INVENTORIES_Tables

INVENTORIES (Tables)	12 Months Ended
	Dec. 31, 2014
Inventories [Abstract]
Inventories [Table Text Block]	Inventories consisted of the following (in millions):


	December 31,	2014		2013

	Raw materials and packaging	$	1,615	$	1,692

	Finished goods	1,134		1,240

	Other	351		345

	Total inventories	$	3,100	$	3,277

HEDGING_TRANSACTIONS_AND_DERIV1

HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS (Tables)	12 Months Ended
	Dec. 31, 2014
Hedging Transactions and Derivative Financial Instruments Disclosures [Abstract]
Derivative instruments, fair value, designated as hedging instruments	The following table presents the fair values of the Company's derivative instruments that were designated and qualified as part of a hedging relationship (in millions):


				Fair Value1,2
	Derivatives Designated as Hedging Instruments	Balance Sheet Location1		December 31,				December 31,
				2014				2013
	Assets:
	Foreign currency contracts	Prepaid expenses and other assets		$	923			$	211

	Foreign currency contracts	Other assets		346				109

	Commodity contracts	Prepaid expenses and other assets		—				1

	Interest rate contracts	Prepaid expenses and other assets		14				—

	Interest rate contracts	Other assets		146				283

	Total assets			$	1,429			$	604

	Liabilities:
	Foreign currency contracts	Accounts payable and accrued expenses		$	24			$	84

	Foreign currency contracts	Other liabilities		249				40

	Commodity contracts	Accounts payable and accrued expenses		1				1

	Interest rate contracts	Accounts payable and accrued expenses		11				—

	Interest rate contracts	Other liabilities		35				—

	Total liabilities			$	320			$	125


	1	All of the Company's derivative instruments are carried at fair value in our consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master netting agreements and cash collateral. Refer to Note 16 for the net presentation of the Company's derivative instruments.

	2	Refer to Note 16 for additional information related to the estimated fair value.
Derivative instruments, fair value, not designated as hedging instruments	The following table presents the fair values of the Company's derivative instruments that were not designated as hedging instruments (in millions):


				Fair Value1,2
	Derivatives Not Designated as Hedging Instruments	Balance Sheet Location1		December 31,				December 31,
				2014				2013
	Assets:
	Foreign currency contracts	Prepaid expenses and other assets		$	44			$	21

	Foreign currency contracts	Other assets		231				171

	Commodity contracts	Prepaid expenses and other assets		9				33

	Commodity contracts	Other assets		1				1

	Other derivative instruments	Prepaid expenses and other assets		14				9

	Other derivative instruments	Other assets		2				—

	Total assets			$	301			$	235

	Liabilities:
	Foreign currency contracts	Accounts payable and accrued expenses		$	33			$	24

	Foreign currency contracts	Other liabilities		21				—

	Commodity contracts	Accounts payable and accrued expenses		156				23

	Commodity contracts	Other liabilities		17				—

	Interest rate contracts	Other liabilities		2				3

	Other derivative instruments	Accounts payable and accrued expenses		11				—

	Total liabilities			$	240			$	50


	1	All of the Company's derivative instruments are carried at fair value in our consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master netting agreements and cash collateral. Refer to Note 16 for the net presentation of the Company's derivative instruments.

	2	Refer to Note 16 for additional information related to the estimated fair value.
Derivative instruments, pretax impact that changes in the fair value of the derivatives designated as hedges had on AOCI and earnings	The following table presents the pretax impact that changes in the fair values of derivatives designated as cash flow hedges had on AOCI and earnings during the years ended December 31, 2014, 2013 and 2012 (in millions):


		Gain (Loss)				Location of Gain (Loss)		Gain (Loss)				Gain (Loss)
		Recognized				Recognized in Income1		Reclassified from				Recognized in Income
		in Other						AOCI into Income				(Ineffective Portion and
		Comprehensive						(Effective Portion)				Amount Excluded from
		Income ("OCI")										Effectiveness Testing)
	2014
	Foreign currency contracts	$	973			Net operating revenues		$	121			$	—		2

	Foreign currency contracts	50				Cost of goods sold		34				—			2

	Foreign currency contracts	(218		)		Other income (loss) — net		(108		)		—

	Interest rate contracts	(180		)		Interest expense		—				—

	Commodity contracts	—				Cost of goods sold		3				—

	Total	$	625					$	50			$	—

	2013
	Foreign currency contracts	$	218			Net operating revenues		$	149			$	1

	Foreign currency contracts	52				Cost of goods sold		32				—			2

	Interest rate contracts	169				Interest expense		(12		)		(3		)

	Commodity contracts	2				Cost of goods sold		(2		)		—

	Total	$	441					$	167			$	(2	)

	2012
	Foreign currency contracts	$	59			Net operating revenues		$	(46	)		$	2

	Foreign currency contracts	34				Cost of goods sold		(23		)		—

	Interest rate contracts	1				Interest expense		(12		)		—			2

	Commodity contracts	(4		)		Cost of goods sold		(1		)		—

	Total	$	90					$	(82	)		$	2


	1	The Company records gains and losses reclassified from AOCI in income for the effective portion and ineffective portion, if any, to the same line items in our consolidated statements of income.

	2	Includes a de minimis amount of ineffectiveness in the hedging relationship.
Derivative instruments, fair value hedges, gain (loss) recognized in income	The following table summarizes the pretax impact that changes in the fair values of derivatives designated as fair value hedges had on earnings during the years ended December 31, 2014, 2013 and 2012 (in millions):


	Hedging Instruments and Hedged Items	Location of Gain (Loss)	Gain (Loss)
		Recognized in Income	Recognized in Income1
	2014
	Interest rate contracts	Interest expense	$	18

	Fixed-rate debt	Interest expense	11

	Net impact to interest expense		$	29

	Foreign currency contracts	Other income (loss) — net	$	132

	Available-for-sale securities	Other income (loss) — net	(165		)
	Net impact to other income (loss) — net		$	(33	)
	Net impact of fair value hedging instruments		$	(4	)
	2013
	Interest rate contracts	Interest expense	$	(193	)
	Fixed-rate debt	Interest expense	240

	Net impact to interest expense		$	47

	Foreign currency contracts	Other income (loss) — net	$	24

	Available-for-sale securities	Other income (loss) — net	(48		)
	Net impact to other income (loss) — net		$	(24	)
	Net impact of fair value hedging instruments		$	23

	2012
	Interest rate contracts	Interest expense	$	89

	Fixed-rate debt	Interest expense	(42		)
	Net impact to interest expense		$	47

	Foreign currency contracts	Other income (loss) — net	$	42

	Available-for-sale securities	Other income (loss) — net	(46		)
	Net impact to other income (loss) — net		$	(4	)
	Net impact of fair value hedging instruments		$	43

	1 The net impacts represent the ineffective portions of the hedge relationships and the amounts excluded from the assessment of hedge effectiveness.
Derivative instruments,fair value of net investment hedges, gain (loss) recognized in AOCI	The following table presents the pretax impact that changes in the fair values of derivatives designated as net investment hedges had on AOCI during the years ended December 31, 2014, 2013 and 2012 (in millions):


		Gain (Loss)
		Recognized in OCI
	Year Ended December 31,	2014				2013				2012

	Foreign currency contracts	$	80			$	61			$	(61	)

Derivative instruments, not designated as hedging instruments, gain (loss) in earnings	The following table presents the pretax impact that changes in the fair values of derivatives not designated as hedging instruments had on earnings during the years ended December 31, 2014, 2013 and 2012 (in millions):


				Gains (Losses)
	Derivatives Not Designated	Location of Gains (Losses)		Year Ended December 31,
	as Hedging Instruments	Recognized in Income		2014				2013				2012

	Foreign currency contracts	Net operating revenues		$	(6	)		$	5			$	(7	)

	Foreign currency contracts	Other income (loss) — net		(85		)		162				24

	Foreign currency contracts	Cost of goods sold		—				2				—

	Commodity contracts	Net operating revenues		(48		)		5				4

	Commodity contracts	Cost of goods sold		(8		)		(122		)		(110		)
	Commodity contracts	Selling, general and administrative expenses		(79		)		7				9

	Interest rate swaps	Interest expense		—				(3		)		—

	Other derivative instruments	Selling, general and administrative expenses		24				55				18

	Other derivative instruments	Other income (loss) — net		39				—				—

	Total			$	(163	)		$	111			$	(62	)

EQUITY_METHOD_INVESTMENTS_Tabl

EQUITY METHOD INVESTMENTS (Tables)	12 Months Ended
	Dec. 31, 2014
EQUITY METHOD INVESTMENTS [Abstract]
Summary of financial information for equity method investees	A summary of financial information for our equity method investees in the aggregate is as follows (in millions):


	Year Ended December 31,	2014		2013		2012

	Net operating revenues	$	52,627	$	53,038	$	47,087

	Cost of goods sold	31,810		32,377		28,821

	Gross profit	$	20,817	$	20,661	$	18,266

	Operating income	$	4,489	$	4,380	$	4,605

	Consolidated net income	$	2,440	$	2,364	$	2,993

	Less: Net income attributable to noncontrolling interests	74		62		89

	Net income attributable to common shareowners	$	2,366	$	2,302	$	2,904

	Equity income (loss) — net	$	769	$	602	$	819



	December 31,	2014		2013

	Current assets	$	16,184	$	19,229

	Noncurrent assets	40,080		40,427

	Total assets	$	56,264	$	59,656

	Current liabilities	$	12,477	$	14,386

	Noncurrent liabilities	16,657		17,779

	Total liabilities	$	29,134	$	32,165

	Equity attributable to shareowners of investees	$	26,363	$	26,668

	Equity attributable to noncontrolling interests	767		823

	Total equity	$	27,130	$	27,491

	Company equity investment	$	9,947	$	10,393

PROPERTY_PLANT_AND_EQUIPMENT_T

PROPERTY, PLANT AND EQUIPMENT (Tables)	12 Months Ended
	Dec. 31, 2014
Property Plant and Equipament [Abstract]
Property, Plant and Equipment [Table Text Block]	The following table summarizes our property, plant and equipment (in millions):


	December 31,	2014		2013

	Land	$	972	$	1,011

	Buildings and improvements	5,539		5,605

	Machinery, equipment and vehicle fleet	18,225		17,551

	Construction in progress	522		865

		$	25,258	$	25,032

	Less accumulated depreciation	10,625		10,065

	Property, plant and equipment — net	$	14,633	$	14,967

INTANGIBLE_ASSETS_Tables

INTANGIBLE ASSETS (Tables)	12 Months Ended
	Dec. 31, 2014
INTANGIBLE ASSETS [Abstract]
Indefinite-lived intangible assets	The following table summarizes information related to indefinite-lived intangible assets (in millions):


	December 31,	2014				2013

	Trademarks1	$	6,533			$	6,744

	Bottlers' franchise rights2,3	6,689				7,415

	Goodwill	12,100				12,312

	Other	170				171

	Indefinite-lived intangible assets	$	25,492			$	26,642

	1 The decrease in 2014 was primarily the result of changes in brand strategies causing certain trademarks to become definite-lived, the transfer of the Company's energy brands to assets held for sale and the effect of translation adjustments. This decrease was partially offset by the finalization of purchase accounting related to the Company's consolidation of innocent in 2013. Refer to Note 2 for additional information.

	2	The decrease in 2014 was primarily related to North America refranchising. Refer to Note 2 for additional information.
	3 The Company has agreements with Dr Pepper Snapple Group, Inc. ("DPSG") to distribute Dr Pepper trademark brands in the United States, Canada Dry in the Northeastern United States, and Canada Dry and C' Plus in Canada. As of December 31, 2014, the agreements have remaining terms of 16 years, with automatic 20-year renewal periods unless otherwise terminated under the terms of the agreements and there are no significant costs to renew the agreements. The Company anticipates using the assets indefinitely. The distribution rights acquired from DPSG are the only significant indefinite-lived intangible assets subject to renewal or extension arrangements.
Carrying value of goodwill by operating segment	The following table provides information related to the carrying value of our goodwill by operating segment (in millions):


		Eurasia &				Europe				Latin				North				Asia Pacific			Bottling			Total
		Africa								America				America							Investments
	2013
	Balance as of January 1	$	34			$	691			$	168			$	10,577			$	123		$	662		$	12,255

	Effect of foreign currency translation	(3		)		29				(12		)		—				(6		)	10			18

	Acquisitions1	5				102				—				—				—			20			127

	Adjustments related to the finalization	—				—				—				(4		)		—			(1		)	(5		)
	of purchase accounting1
	Impairment2	—				—				—				—				—			(82		)	(82		)

	Divestitures, deconsolidations and other	—				—				—				(1		)		—			—			(1		)

	Balance as of December 31	$	36			$	822			$	156			$	10,572			$	117		$	609		$	12,312

	2014
	Balance as of January 1	$	36			$	822			$	156			$	10,572			$	117		$	609		$	12,312

	Effect of foreign currency translation	(2		)		(60		)		(9		)		—				(2		)	(26		)	(99		)

	Acquisitions1	—				—				—				11				16			3			30

	Adjustments related to the finalization	(4		)		(43		)		—				—				—			(14		)	(61		)
	of purchase accounting1
	Divestitures, deconsolidations and other1	(3		)		—				—				(79		)		—			—			(82		)

	Balance as of December 31	$	27			$	719			$	147			$	10,504			$	131		$	572		$	12,100


	1	Refer to Note 2 for information related to the Company's acquisitions and divestitures.

	2	Refer to Note 17 for information related to the Company's impairment of goodwill.
Definite-lived intangible assets	The following table summarizes information related to definite-lived intangible assets (in millions):


		December 31, 2014										December 31, 2013
		Gross Carrying Amount			Accumulated Amortization			Net				Gross Carrying Amount			Accumulated Amortization			Net

	Customer relationships1	$	597		$	(229	)	$	368			$	642		$	(202	)	$	440

	Bottlers' franchise rights1	664			(375		)	289				722			(317		)	405

	Trademarks2	222			(39		)	183				105			(26		)	79

	Other	96			(56		)	40				128			(83		)	45

	Total	$	1,579		$	(699	)	$	880			$	1,597		$	(628	)	$	969


	1	The decrease in 2014 was primarily due to the derecognition of intangible assets as a result of the North America refranchising. Refer to Note 2 for additional information.

	2	The increase in 2014 was the result of changes in brand strategies causing certain indefinite-lived trademarks to become definite-lived.
Estimated amortization expense for the next five years	Based on the carrying value of definite-lived intangible assets as of December 31, 2014, we estimate our amortization expense for the next five years will be as follows (in millions):


			Amortization
			Expense
	2015		$	156

	2016		149

	2017		121

	2018		61

	2019		59

ACCOUNTS_PAYABLE_AND_ACCRUED_E1

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)	12 Months Ended
	Dec. 31, 2014
ACCOUNTS PAYABLE AND ACCRUED EXPENSES Disclosure [Abstract]
Schedule of Accounts Payable and Accrued Expenses [Table Text Block]	Accounts payable and accrued expenses consisted of the following (in millions):


	December 31,	2014		2013

	Accrued marketing	$	2,103	$	2,407

	Other accrued expenses	3,182		3,515

	Trade accounts payable	2,089		1,933

	Accrued compensation	997		933

	Sales, payroll and other taxes	511		450

	Container deposits	352		339

	Accounts payable and accrued expenses	$	9,234	$	9,577

DEBT_AND_BORROWING_ARRANGEMENT1

DEBT AND BORROWING ARRANGEMENTS (Tables)	12 Months Ended
DEBT AND BORROWING ARRANGEMENTS (Tables)	Dec. 31, 2014
Debt and Borrowing Arrangements Disclosure [Abstract]
Components of long-term debt	The Company's long-term debt consisted of the following (in millions, except average rate data):


		December 31, 2014				December 31, 2013
		Amount		Average		Amount		Average
		Amount		Rate 1		Amount		Rate1
	U.S. dollar notes due 2015–2093	$	17,433	1.8	%	$	17,427	1.8	%
	U.S. dollar notes due 2015–2093	$	17,433	1.8	%	$	17,427	1.8	%
	U.S. dollar debentures due 2017–2098	2,157		3.9		2,191		3.9
	U.S. dollar debentures due 2017–2098	2,157		3.9		2,191		3.9
	U.S. dollar zero coupon notes due 20202	143		8.4		138		8.4
	U.S. dollar zero coupon notes due 20202	143		8.4		138		8.4
	Euro notes due 2022 and 20263	2,468		3.7		—		—
	Euro notes due 2022 and 20263	2,468		3.7		—		—
	Other, due through 20984	380		4		370		4
	Other, due through 20984	380		4		370		4
	Fair value adjustment5	34		N/A		52		N/A
	Fair value adjustment5	34		N/A		52		N/A
	Total6,7	$	22,615	2.2	%	$	20,178	2.2	%
	Total6,7	$	22,615	2.2	%	$	20,178	2.2	%
	Less current portion	3,552				1,024
	Less current portion	3,552				1,024
	Long-term debt	$	19,063			$	19,154
	Long-term debt	$	19,063			$	19,154

	1	These rates represent the weighted-average effective interest rate on the balances outstanding as of year end, as adjusted for the effects of interest rate swap agreements, cross currency swap agreements and fair value adjustments, if applicable. Refer to Note 5 for a more detailed discussion on interest rate management.

	2	This amount is shown net of unamortized discounts of $28 million and $33 million as of December 31, 2014 and 2013, respectively.

	3	This amount includes adjustments recorded due to changes in foreign currency exchange rates.

	4	As of December 31, 2014, the amount shown includes $199 million of debt instruments that are due through 2031.

	5	Refer to Note 5 for additional information about our fair value hedging strategy.

	6	As of December 31, 2014 and 2013, the fair value of our long-term debt, including the current portion, was $23,411 million and $20,352 million, respectively. The fair value of our long-term debt is estimated based on quoted prices for those or similar instruments.

	7	The above notes and debentures include various restrictions, none of which is presently significant to our Company.
Schedule of Maturities of Long-term Debt	Maturities of long-term debt for the five years succeeding December 31, 2014, are as follows (in millions):


		Maturities of
		Long-Term Debt
	2015	$	3,552
	2015	$	3,552
	2016	2,689
	2016	2,689
	2017	1,363
	2017	1,363
	2018	3,308
	2018	3,308
	2019	1,004
	2019	1,004

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Lease payments under noncancelable operating leases	The following table summarizes our minimum lease payments under noncancelable operating leases with initial or remaining lease terms in excess of one year as of December 31, 2014 (in millions):


	Year Ended December 31,	Operating Lease Payments

	2015	$	230

	2016	161

	2017	128

	2018	98

	2019	71

	Thereafter	277

	Total minimum operating lease payments1	$	965


	1	Income associated with sublease arrangements is not significant.

STOCK_COMPENSATION_PLANS_Table

STOCK COMPENSATION PLANS (Tables)	12 Months Ended
	Dec. 31, 2014
STOCK COMPENSATION PLANS [Abstract]
Weighted-average fair value of options granted and the weighted-average assumptions used in the Black Scholes Merton option pricing model for such grants	The weighted-average fair value of options granted during the past three years and the weighted-average assumptions used in the Black-Scholes-Merton option-pricing model for such grants were as follows:


		2014				2013				2012

	Fair value of options at grant date	$	3.91			$	3.73			$	3.8

	Dividend yield1	2.7		%		2.8		%		2.7		%
	Expected volatility2	16		%		17		%		18		%
	Risk-free interest rate3	1.6		%		0.9		%		1		%
	Expected term of the option4	5 years				5 years				5 years


	1	The dividend yield is the calculated yield on the Company's stock at the time of the grant.

	2	Expected volatility is based on implied volatilities from traded options on the Company's stock, historical volatility of the Company's stock and other factors.

	3	The risk-free interest rate for the period matching the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of the grant.

	4	The expected term of the option represents the period of time that options granted are expected to be outstanding and is derived by analyzing historical exercise behavior.
Stock option activity for all stock option plans	Stock option activity for all stock option plans for the year ended December 31, 2014, was as follows:


		Shares			Weighted-Average				Weighted-Average		Aggregate
		(In millions)			Exercise Price				Remaining		Intrinsic Value
									Contractual Life		(In millions)
	Outstanding on January 1, 2014	305			$	29.42

	Granted	68			37.24

	Exercised	(58	)		26.12

	Forfeited/expired	(10	)		35.03

	Outstanding on December 31, 20141	305			$	31.6			6.07 years		$	3,241

	Expected to vest at December 31, 2014	300			$	31.51			6.03 years		$	3,216

	Exercisable on December 31, 2014	173			$	27.85			4.35 years		$	2,480


	1	Includes 1.4 million stock option replacement awards in connection with our acquisition of CCE's former North America business in 2010. These options had a weighted-average exercise price of $16.62 and generally vest over 3 years and expire 10 years from the original date of grant.
Summary of information about performance share units based on the Target Award amounts in the performance share unit agreements	The following table summarizes information about performance share units based on the target award amounts in the performance share unit agreements:


		Share Units			Weighted-Average
		(In thousands)			Grant Date
					Fair Value
	Outstanding on January 1, 2014	17,974			$	30.41

	Granted	6,117			32.33

	Paid in cash equivalent	(5	)		30.59

	Canceled/forfeited	(6,660	)		29.11

	Outstanding on December 31, 20141	17,426			$	31.59


	1	The outstanding performance share units as of December 31, 2014, at the threshold award and maximum award levels were 8.7 million and 26.1 million, respectively.
Summary of conversion of performance share units to restricted stock and restricted stock units	The following table summarizes information about nonvested restricted stock and stock units:


		Restricted Stock and Stock Units			Weighted-Average
		(In thousands)			Grant Date
					Fair Value1
	Nonvested on January 1, 20142	7,014			$	25.17

	Vested and released	(6,774	)		25.17

	Canceled/forfeited	(110	)		25.17

	Nonvested on December 31, 20142	130			$	25.17


	1	The weighted-average grant date fair value is based on the fair values of the performance share units granted.

	2	The nonvested restricted stock and stock units as of January 1, 2014, and December 31, 2014, are presented at the performance share units' certified award level.

PENSION_AND_OTHER_POSTRETIREME1

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS (Tables)	12 Months Ended
PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS (Tables)	Dec. 31, 2014
Pension and Other Postretirement Benefit Plans [Abstract]
Changes in benefit obligations and the fair value of plan assets for our benefit plans	The following table sets forth the changes in benefit obligations and the fair value of plan assets for our benefit plans (in millions):


		Pension Benefits								Other Benefits
		2014				2013				2014			2013
		2014				2013				2014			2013
	Benefit obligation at beginning of year1	$	8,845			$	9,693			$	946		$	1,104
	Benefit obligation at beginning of year1	$	8,845			$	9,693			$	946		$	1,104
	Service cost	261				280				26			36
	Service cost	261				280				26			36
	Interest cost	406				378				43			42
	Interest cost	406				378				43			42
	Foreign currency exchange rate changes	(183		)		(69		)		(4		)	(2		)
	Amendments	—				(1		)		(31		)	(73		)
	Amendments	—				(1		)		(31		)	(73		)
	Actuarial loss (gain)	1,519				(899		)		88			(91		)
	Actuarial loss (gain)	1,519				(899		)		88			(91		)
	Benefits paid2	(522		)		(538		)		(62		)	(77		)
	Business combinations	4				—				—			—
	Business combinations	4				—				—			—
	Settlements	(7		)		(9		)		(1		)	—
	Settlements	(7		)		(9		)		(1		)	—
	Special termination benefits	5				2				—			—
	Special termination benefits	5				2				—			—
	Other	18				8				1			7
	Other	18				8				1			7
	Benefit obligation at end of year1	$	10,346			$	8,845			$	1,006		$	946
	Benefit obligation at end of year1	$	10,346			$	8,845			$	1,006		$	946
	Fair value of plan assets at beginning of year	$	8,746			$	7,584			$	243		$	202
	Fair value of plan assets at beginning of year	$	8,746			$	7,584			$	243		$	202
	Actual return on plan assets	574				1,043				2			40
	Actual return on plan assets	574				1,043				2			40
	Employer contributions	214				639				—			—
	Employer contributions	214				639				—			—
	Foreign currency exchange rate changes	(203		)		(43		)		—			—
	Foreign currency exchange rate changes	(203		)		(43		)		—			—
	Benefits paid	(435		)		(474		)		(3		)	(2		)
	Settlements	(1		)		(5		)		—			—
	Settlements	(1		)		(5		)		—			—
	Other	7				2				4			3
	Other	7				2				4			3
	Fair value of plan assets at end of year	$	8,902			$	8,746			$	246		$	243
	Fair value of plan assets at end of year	$	8,902			$	8,746			$	246		$	243
	Net liability recognized	$	(1,444	)		$	(99	)		$	(760	)	$	(703	)

	1	For pension benefit plans, the benefit obligation is the projected benefit obligation. For other benefit plans, the benefit obligation is the accumulated postretirement benefit obligation. The accumulated benefit obligation for our pension plans was $10,028 million and $8,523 million as of December 31, 2014 and 2013, respectively.

	2	Benefits paid to pension plan participants during 2014 and 2013 included $87 million and $64 million, respectively, in payments related to unfunded pension plans that were paid from Company assets. Benefits paid to participants of other benefit plans during 2014 and 2013 included $59 million and $75 million, respectively, that were paid from Company assets.
Pension and other benefit amounts recognized in consolidated balance sheets	Pension and other benefit amounts recognized in our consolidated balance sheets are as follows (in millions):


		Pension Benefits								Other Benefits
	December 31,	2014				2013				2014			2013
	December 31,	2014				2013				2014			2013
	Noncurrent asset	$	479			$	1,067			$	—		$	—
	Noncurrent asset	$	479			$	1,067			$	—		$	—
	Current liability	(78		)		(76		)		(20		)	(21		)
	Long-term liability	(1,845		)		(1,090		)		(740		)	(682		)
	Net liability recognized	$	(1,444	)		$	(99	)		$	(760	)	$	(703	)
Schedule of pension plans with projected benefit obligation in excess of fair value of plan assets	Certain of our pension plans have projected benefit obligations in excess of the fair value of plan assets. For these plans, the projected benefit obligations and the fair value of plan assets were as follows (in millions):


	December 31,	2014				2013
	December 31,	2014				2013
	Projected benefit obligation	$	8,753			$	1,521
	Projected benefit obligation	$	8,753			$	1,521
	Fair value of plan assets	6,854				374
	Fair value of plan assets	6,854				374
Accumulated benefit obligations in excess of fair value of plan assets	Certain of our pension plans have accumulated benefit obligations in excess of the fair value of plan assets. For these plans, the accumulated benefit obligations and the fair value of plan assets were as follows (in millions):


	December 31,	2014				2013
	December 31,	2014				2013
	Accumulated benefit obligation	$	8,501			$	1,446
	Accumulated benefit obligation	$	8,501			$	1,446
	Fair value of plan assets	6,820				351
	Fair value of plan assets	6,820				351
Total pension assets for U.S. and non-U.S. plans	The following table presents total assets for our U.S. and non-U.S. pension plans (in millions):


		U.S. Plans								Non-U.S. Plans
	December 31,	2014				2013				2014			2013
	December 31,	2014				2013				2014			2013
	Cash and cash equivalents	$	186			$	240			$	75		$	274
	Cash and cash equivalents	$	186			$	240			$	75		$	274
	Equity securities:
	U.S.-based companies	1,274				1,422				542			280
	U.S.-based companies	1,274				1,422				542			280
	International-based companies	558				698				505			586
	International-based companies	558				698				505			586
	Fixed-income securities:
	Government bonds	455				464				411			304
	Government bonds	455				464				411			304
	Corporate bonds and debt securities	1,379				1,369				187			137
	Corporate bonds and debt securities	1,379				1,369				187			137
	Mutual, pooled and commingled funds1	863				1,134				400			453
	Mutual, pooled and commingled funds1	863				1,134				400			453
	Hedge funds/limited partnerships	756				526				43			17
	Hedge funds/limited partnerships	756				526				43			17
	Real estate	391				245				17			6
	Real estate	391				245				17			6
	Other	481				245				379			346
	Other	481				245				379			346
	Total pension plan assets2	$	6,343			$	6,343			$	2,559		$	2,403
	Total pension plan assets2	$	6,343			$	6,343			$	2,559		$	2,403

	1	Mutual, pooled and commingled funds include investments in equity securities, fixed-income securities and combinations of both. There are a significant number of mutual, pooled and commingled funds from which investors can choose. The selection of the type of fund is dictated by the specific investment objectives and needs of a given plan. These objectives and needs vary greatly between plans.

	2	Fair value disclosures related to our pension assets are included in Note 16. Fair value disclosures include, but are not limited to, the levels within the fair value hierarchy in which the fair value measurements in their entirety fall; a reconciliation of the beginning and ending balances of Level 3 assets; and information about the valuation techniques and inputs used to measure the fair value of our pension assets.
Other postretirement benefit plan assets	The following table presents total assets for our other postretirement benefit plans (in millions):


	December 31,	2014				2013
	December 31,	2014				2013
	Cash and cash equivalents	$	10			$	10
	Cash and cash equivalents	$	10			$	10
	Equity securities:
	U.S.-based companies	114				112
	U.S.-based companies	114				112
	International-based companies	7				8
	International-based companies	7				8
	Fixed-income securities:
	Government bonds	79				79
	Government bonds	79				79
	Corporate bonds and debt securities	9				9
	Corporate bonds and debt securities	9				9
	Mutual, pooled and commingled funds	16				18
	Mutual, pooled and commingled funds	16				18
	Hedge funds/limited partnerships	5				3
	Hedge funds/limited partnerships	5				3
	Real estate	3				2
	Real estate	3				2
	Other	3				2
	Other	3				2
	Total other postretirement benefit plan assets1	$	246			$	243
	Total other postretirement benefit plan assets1	$	246			$	243

	1	Fair value disclosures related to our other postretirement benefit plan assets are included in Note 16. Fair value disclosures include, but are not limited to, the levels within the fair value hierarchy in which the fair value measurements in their entirety fall; a reconciliation of the beginning and ending balances of Level 3 assets; and information about the valuation techniques and inputs used to measure the fair value of our other postretirement benefit plan assets.
Net periodic benefit cost for pension and other postretirement benefit plans	Net periodic benefit cost for our pension and other postretirement benefit plans consisted of the following (in millions):


		Pension Benefits											Other Benefits
	Year Ended December 31,	2014				2013				2012			2014				2013			2012
	Year Ended December 31,	2014				2013				2012			2014				2013			2012
	Service cost	$	261			$	280			$	291		$	26			$	36		$	34
	Service cost	$	261			$	280			$	291		$	26			$	36		$	34
	Interest cost	406				378				388			43				42			43
	Interest cost	406				378				388			43				42			43
	Expected return on plan assets1	(713		)		(659		)		(573		)	(11		)		(9		)	(8		)
	Amortization of prior service cost (credit)	(2		)		(2		)		(2		)	(17		)		(10		)	(52		)
	Amortization of actuarial loss	73				197				137			2				13			6
	Amortization of actuarial loss	73				197				137			2				13			6
	Net periodic benefit cost	$	25			$	194			$	241		$	43			$	72		$	23
	Net periodic benefit cost	$	25			$	194			$	241		$	43			$	72		$	23
	Settlement charge	4				1				3			—				—			—
	Settlement charge	4				1				3			—				—			—
	Curtailment charge	—				—				6			—				—			—
	Curtailment charge	—				—				6			—				—			—
	Special termination benefits2	5				2				1			—				—			—
	Special termination benefits2	5				2				1			—				—			—
	Total cost recognized in statements of income	$	34			$	197			$	251		$	43			$	72		$	23
	Total cost recognized in statements of income	$	34			$	197			$	251		$	43			$	72		$	23

	1	The Company has elected to use the actual fair value of plan assets as the market-related value of assets in the determination of the expected return on plan assets.

	2	The special termination benefits were primarily related to the Company's productivity, restructuring and integration initiatives. Refer to Note 18 for additional information related to our productivity, restructuring and integration initiatives.
Changes in AOCI for benefit plans	The following table sets forth the changes in AOCI for our benefit plans (in millions, pretax):


		Pension Benefits								Other Benefits
		2014				2013				2014			2013
		2014				2013				2014			2013
	Beginning balance in AOCI	$	(1,537	)		$	(3,032	)		$	13		$	(186	)
	Beginning balance in AOCI	$	(1,537	)		$	(3,032	)		$	13		$	(186	)
	Recognized prior service cost (credit)	(2		)		(2		)		(17		)	(10		)
	Recognized net actuarial loss (gain)	77				198				2			13
	Recognized net actuarial loss (gain)	77				198				2			13
	Prior service credit (cost) arising in current year	—				1				31			73
	Prior service credit (cost) arising in current year	—				1				31			73
	Net actuarial (loss) gain arising in current year	(1,658		)		1,283				(97		)	122
	Net actuarial (loss) gain arising in current year	(1,658		)		1,283				(97		)	122
	Foreign currency translation gain (loss)	51				15				1			1
	Foreign currency translation gain (loss)	51				15				1			1
	Ending balance in AOCI	$	(3,069	)		$	(1,537	)		$	(67	)	$	13
	Ending balance in AOCI	$	(3,069	)		$	(1,537	)		$	(67	)	$	13
Amounts in AOCI for benefit plans (pretax)	The following table sets forth amounts in AOCI for our benefit plans (in millions, pretax):


		Pension Benefits								Other Benefits
	December 31,	2014				2013				2014			2013
	December 31,	2014				2013				2014			2013
	Prior service credit (cost)	$	10			$	12			$	100		$	86
	Prior service credit (cost)	$	10			$	12			$	100		$	86
	Net actuarial loss	(3,079		)		(1,549		)		(167		)	(73		)
	Ending balance in AOCI	$	(3,069	)		$	(1,537	)		$	(67	)	$	13
	Ending balance in AOCI	$	(3,069	)		$	(1,537	)		$	(67	)	$	13
Amounts in AOCI expected to be recognized as components of net periodic pension cost in next fiscal year	Amounts in AOCI expected to be recognized as components of net periodic pension cost in 2015 are as follows (in millions, pretax):


		Pension Benefits				Other Benefits
	Amortization of prior service cost (credit)	$	(2	)		$	(19	)
	Amortization of actuarial loss	203				10
	Amortization of actuarial loss	203				10
		$	201			$	(9	)
		$	201			$	(9	)
Certain weighted average assumptions used in computing the benefit obligations and net periodic benefit cost	Certain weighted-average assumptions used in computing the benefit obligations are as follows:


		Pension Benefits						Other Benefits
	December 31,	2014			2013			2014			2013
	December 31,	2014			2013			2014			2013
	Discount rate	3.75	%		4.75	%		3.75	%		4.75	%
	Rate of increase in compensation levels	3.5	%		3.5	%		N/A			N/A
	Rate of increase in compensation levels	3.5	%		3.5	%		N/A			N/A
	Certain weighted-average assumptions used in computing net periodic benefit cost are as follows:


		Pension Benefits									Other Benefits
	Year Ended December 31,	2014			2013			2012			2014		2013			2012
	Year Ended December 31,	2014			2013			2012			2014		2013			2012
	Discount rate	4.75	%		4	%		4.75	%		4.75	%	4	%		4.75	%
	Rate of increase in compensation levels	3.5	%		3.5	%		3.25	%		N/A		N/A			N/A
	Rate of increase in compensation levels	3.5	%		3.5	%		3.25	%		N/A		N/A			N/A
	Expected long-term rate of return on plan assets	8.25	%		8.25	%		8.25	%		4.75	%	4.75	%		4.75	%
Assumed health care cost trend rates	The assumed health care cost trend rates are as follows:


	December 31,	2014			2013
	December 31,	2014			2013
	Health care cost trend rate assumed for next year	7.5	%		8	%
	Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)	5	%		5	%
	Year that the rate reaches the ultimate trend rate	2020			2020
	Year that the rate reaches the ultimate trend rate	2020			2020
Estimated future benefit payments for funded and unfunded plans	Our estimated future benefit payments for funded and unfunded plans are as follows (in millions):


	Year Ended December 31,	2015				2016				2017			2018				2019			2020-2024
	Year Ended December 31,	2015				2016				2017			2018				2019			2020-2024
	Pension benefit payments	$	494			$	518			$	551		$	560			$	584		$	3,137
	Pension benefit payments	$	494			$	518			$	551		$	560			$	584		$	3,137
	Other benefit payments1	61				65				67			67				68			343
	Other benefit payments1	61				65				67			67				68			343
	Total estimated benefit payments	$	555			$	583			$	618		$	627			$	652		$	3,480
	Total estimated benefit payments	$	555			$	583			$	618		$	627			$	652		$	3,480

	1	The expected benefit payments for our other postretirement benefit plans are net of estimated federal subsidies expected to be received under the Medicare Prescription Drug, Improvement and Modernization Act of 2003. Federal subsidies are estimated to be approximately $5 million for the period 2015–2019, and $4 million for the period 2020–2024.

INCOME_TAXES_Tables

INCOME TAXES (Tables)	12 Months Ended
INCOME TAXES (Tables)	Dec. 31, 2014
Income Taxes [Abstract]
Schedule of income before income taxes	Income before income taxes consisted of the following (in millions):


	Year Ended December 31,	2014				2013				2012
	Year Ended December 31,	2014				2013				2012
	United States	$	1,567			$	2,451			$	3,526
	United States	$	1,567			$	2,451			$	3,526
	International	7,758				9,026				8,283
	International	7,758				9,026				8,283
	Total	$	9,325			$	11,477			$	11,809
	Total	$	9,325			$	11,477			$	11,809
Schedule of income tax expense (benefit)	Income tax expense consisted of the following for the years ended December 31, 2014, 2013 and 2012 (in millions):


		United States				State and Local				International			Total
		United States				State and Local				International			Total
	2014
	Current	$	867			$	81			$	1,293		$	2,241
	Current	$	867			$	81			$	1,293		$	2,241
	Deferred	(97		)		(21		)		78			(40		)
	Deferred	(97		)		(21		)		78			(40		)
	2013
	Current	$	713			$	102			$	1,388		$	2,203
	Current	$	713			$	102			$	1,388		$	2,203
	Deferred	305				38				305			648
	Deferred	305				38				305			648
	2012
	Current	$	602			$	74			$	1,415		$	2,091
	Current	$	602			$	74			$	1,415		$	2,091
	Deferred	936				33				(337		)	632
	Deferred	936				33				(337		)	632
Reconciliation of the statutory U.S. federal tax rate and effective tax rates	A reconciliation of the statutory U.S. federal tax rate and our effective tax rate is as follows:


	Year Ended December 31,	2014			2013			2012
	Year Ended December 31,	2014			2013			2012
	Statutory U.S. federal tax rate	35	%		35	%		35	%
	State and local income taxes — net of federal benefit	1			1			1.1
	State and local income taxes — net of federal benefit	1			1			1.1
	Earnings in jurisdictions taxed at rates different from the statutory U.S. federal rate	(11.5	)	1,2	(10.3	)	5,6,7	(9.5	)	10,11
	Reversal of valuation allowances	—			—			(2.4	)	12
	Reversal of valuation allowances	—			—			(2.4	)	12
	Equity income or loss	(2.2	)		(1.4	)	8	(2.0	)
	Other operating charges	2.9		3,4	1.2		9	0.4		13
	Other operating charges	2.9		3,4	1.2		9	0.4		13
	Other — net	(1.6	)		(0.7	)		0.5
	Other — net	(1.6	)		(0.7	)		0.5
	Effective tax rate	23.6	%		24.8	%		23.1	%

	1	Includes a $6 million tax expense on a pretax net charge of $372 million (or a 1.5 percent impact on our effective tax rate) due to the remeasurement of the net monetary assets of our local Venezuelan subsidiary into U.S. dollars using the SICAD 2 exchange rate. Refer to Note 1.

	2	Includes a tax expense of $18 million (or a 0.2 percent impact on our effective tax rate) related to amounts required to be recorded for changes to our uncertain tax positions, including interest and penalties, in various international jurisdictions.

	3	Includes a tax expense of $55 million on a pretax charge of $352 million (or a 1.9 percent impact on our effective tax rate) primarily due to an impairment of a Venezuelan trademark, a write-down the Company recorded on the concentrate sales receivables from our bottling partner in Venezuela, a charge associated with certain of the Company's fixed assets, and as a result of the restructuring and transition of the Company's Russian juice operations to an existing joint venture with an unconsolidated bottling partner. Refer to Note 1 and Note 17.

	4	Includes a tax benefit of $191 million on pretax charges of $809 million (or a 1 percent impact on our effective tax rate) primarily related to the Company's productivity and reinvestment program as well as other restructuring initiatives. Refer to Note 18.

	5	Includes a tax benefit of $26 million (or a 0.2 percent impact on our effective tax rate) related to amounts required to be recorded for changes to our uncertain tax positions, including interest and penalties, in various international jurisdictions.

	6	Includes a tax expense of $279 million on pretax net gains of $501 million (or a 0.9 percent impact on our effective tax rate) related to the deconsolidation of our Brazilian bottling operations upon their combination with an independent bottler and a loss due to the merger of four of the Company's Japanese bottling partners. Refer to Note 2 and Note 17.

	7	Includes a tax expense of $3 million (or a 0.5 percent impact on our effective tax rate) related to a charge of $149 million due to the devaluation of the Venezuelan bolivar. Refer to Note 19.

	8	Includes an $8 million tax benefit on a pretax charge of $159 million (or a 0.4 percent impact on our effective tax rate) related to our proportionate share of unusual or infrequent items recorded by our equity method investees. Refer to Note 17.

	9	Includes a tax benefit of $175 million on pretax charges of $877 million (or a 1.2 percent impact on our effective tax rate) primarily related to impairment charges recorded on certain of the Company's intangible assets and charges related to the Company's productivity and reinvestment program as well as other restructuring initiatives. Refer to Note 17 and Note 18.

	10	Includes a tax expense of $133 million (or a 1.1 percent impact on our effective tax rate) related to amounts required to be recorded for changes to our uncertain tax positions, including interest and penalties, in various international jurisdictions.

	11	Includes a tax expense of $57 million on pretax net gains of $76 million (or a 0.3 percent impact on our effective tax rate) related to the following: a gain recognized as a result of the merger of Embotelladora Andina S.A. ("Andina") and Embotelladoras Coca-Cola Polar S.A. ("Polar"); a gain recognized as a result of Coca-Cola FEMSA, an equity method investee, issuing additional shares of its own stock at a per share amount greater than the carrying value of the Company's per share investment; the loss recognized on the then pending sale of a majority ownership interest in our consolidated Philippine bottling operations to Coca-Cola FEMSA; and the expense recorded for the premium the Company paid over the publicly traded market price to acquire an ownership interest in Mikuni. Refer to Note 17.

	12	Relates to a net tax benefit of $283 million associated with the reversal of valuation allowances in certain of the Company's foreign jurisdictions.

	13	Includes a tax benefit of $95 million on pretax charges of $416 million (or a 0.4 percent impact on our effective tax rate) primarily related to the Company's productivity and reinvestment program as well as other restructuring initiatives; the refinement of previously established accruals related to the Company's 2008–2011 productivity initiatives; and the refinement of previously established accruals related to the Company's integration of CCE's former North America business. Refer to Note 18.
Reconciliation of the gross balance of unrecognized tax benefit	A reconciliation of the changes in the gross balance of unrecognized tax benefit amounts is as follows (in millions):


	Year Ended December 31,	2014				2013				2012
	Year Ended December 31,	2014				2013				2012
	Beginning balance of unrecognized tax benefits	$	230			$	302			$	320
	Beginning balance of unrecognized tax benefits	$	230			$	302			$	320
	Increases related to prior period tax positions	13				1				69
	Increases related to prior period tax positions	13				1				69
	Decreases related to prior period tax positions	(2		)		(7		)		(15		)
	Increases related to current period tax positions	11				8				23
	Increases related to current period tax positions	11				8				23
	Decreases related to settlements with taxing authorities	(5		)		(4		)		(45		)
	Reductions as a result of a lapse of the applicable statute of limitations	(32		)		(59		)		(36		)
	Increases (decreases) from effects of foreign currency exchange rates	(4		)		(11		)		(14		)
	Ending balance of unrecognized tax benefits	$	211			$	230			$	302
	Ending balance of unrecognized tax benefits	$	211			$	230			$	302
Deferred tax assets and liabilities	The tax effects of temporary differences and carryforwards that give rise to deferred tax assets and liabilities consist of the following (in millions):


	December 31,	2014				2013
	December 31,	2014				2013
	Deferred tax assets:
	Property, plant and equipment	$	96			$	102
	Property, plant and equipment	$	96			$	102
	Trademarks and other intangible assets	68				63
	Trademarks and other intangible assets	68				63
	Equity method investments (including foreign currency translation adjustment)	462				243
		462				243
	Derivative financial instruments	134				50
	Derivative financial instruments	134				50
	Other liabilities	1,082				1,102
	Other liabilities	1,082				1,102
	Benefit plans	1,673				1,237
	Benefit plans	1,673				1,237
	Net operating/capital loss carryforwards	729				790
	Net operating/capital loss carryforwards	729				790
	Other	196				225
	Other	196				225
	Gross deferred tax assets	$	4,440			$	3,812
	Gross deferred tax assets	$	4,440			$	3,812
	Valuation allowances	(649		)		(586		)
	Total deferred tax assets1,2	$	3,791			$	3,226
	Total deferred tax assets1,2	$	3,791			$	3,226
	Deferred tax liabilities:
	Property, plant and equipment	$	(2,342	)		$	(2,417	)
	Trademarks and other intangible assets	(4,020		)		(4,192		)
	Equity method investments (including foreign currency translation adjustment)	(1,038		)		(1,070		)
	Derivative financial instruments	(457		)		(147		)
	Other liabilities	(110		)		(69		)
	Benefit plans	(487		)		(473		)
	Other	(944		)		(810		)
	Total deferred tax liabilities3	$	(9,398	)		$	(9,178	)
	Net deferred tax liabilities	$	(5,607	)		$	(5,952	)

	1	Noncurrent deferred tax assets of $319 million and $328 million were included in the line item other assets in our consolidated balance sheets as of December 31, 2014 and 2013, respectively.

	2	Current deferred tax assets of $160 million and $211 million were included in the line item prepaid expenses and other assets in our consolidated balance sheets as of December 31, 2014 and 2013, respectively.

	3	Current deferred tax liabilities of $450 million and $339 million were included in the line item accounts payable and accrued expenses in our consolidated balance sheets as of December 31, 2014 and 2013, respectively.
Deferred tax asset valuation allowances	An analysis of our deferred tax asset valuation allowances is as follows (in millions):


	Year Ended December 31,	2014				2013				2012
	Year Ended December 31,	2014				2013				2012
	Balance at beginning of year	$	586			$	487			$	859
	Balance at beginning of year	$	586			$	487			$	859
	Additions	104				169				126
	Additions	104				169				126
	Decrease due to transfer to assets held for sale	—				—				(146		)
	Decrease due to transfer to assets held for sale	—				—				(146		)
	Deductions	(41		)		(70		)		(352		)
	Balance at end of year	$	649			$	586			$	487
	Balance at end of year	$	649			$	586			$	487

OTHER_COMPREHENSIVE_INCOME_Tab

OTHER COMPREHENSIVE INCOME (Tables)	12 Months Ended
	Dec. 31, 2014
OTHER COMPREHENSIVE INCOME [Abstract]
AOCI attributable to the shareowners of The Coca-Cola Company	AOCI attributable to shareowners of The Coca-Cola Company consisted of the following (in millions):


	December 31,	2014				2013

	Foreign currency translation adjustment	$	(5,226	)		$	(2,849	)
	Accumulated derivative net gains (losses)	554				197

	Unrealized net gains (losses) on available-for-sale securities	972				258

	Adjustments to pension and other benefit liabilities	(2,077		)		(1,038		)
	Accumulated other comprehensive income (loss)	$	(5,777	)		$	(3,432	)
Allocation of total comprehensive income or Loss between shareowners of the The Coca-Cola Company and noncontrolling interests [Text Block]	The following table summarizes the allocation of total comprehensive income between shareowners of The Coca-Cola Company and noncontrolling interests (in millions):


		Year Ended December 31, 2014
		Shareowners of			Noncontrolling			Total
		The Coca-Cola Company			Interests
	Consolidated net income	$	7,098		$	26		$	7,124

	Other comprehensive income:
	Net foreign currency translation adjustment	(2,377		)	(5		)	(2,382		)
	Net gain (loss) on derivatives1	357			—			357

	Net unrealized gain (loss) on available-for-sale securities2	714			—			714

	Net change in pension and other benefit liabilities3	(1,039		)	—			(1,039		)

	Total comprehensive income	$	4,753		$	21		$	4,774


	1	Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments.

	2	Refer to Note 3 for information related to the net unrealized gain or loss on available-for-sale securities.

	3	Refer to Note 13 for additional information related to the Company's pension and other postretirement benefit liabilities.
OCI attributable to shareowners of The Coca-Cola Company, including our proportionate share of equity method investees' OCI	OCI attributable to shareowners of The Coca-Cola Company, including our proportionate share of equity method investees' OCI, for the years ended December 31, 2014, 2013 and 2012, is as follows (in millions):


		Before-Tax Amount				Income Tax				After-Tax Amount

	2014
	Foreign currency translation adjustments:
	Translation adjustment arising in the period	$	(2,560	)		$	183			$	(2,377	)

	Net foreign currency translation adjustment	(2,560		)		183				(2,377		)

	Derivatives:
	Unrealized gains (losses) arising during the year	620				(231		)		389

	Reclassification adjustments recognized in net income	(50		)		18				(32		)

	Net gain (loss) on derivatives1	570				(213		)		357

	Available-for-sale securities:
	Unrealized gains (losses) arising during the year	1,139				(412		)		727

	Reclassification adjustments recognized in net income	(17		)		4				(13		)

	Net change in unrealized gain (loss) on available-for-sale securities2	1,122				(408		)		714

	Pension and other benefit liabilities:
	Net pension and other benefits arising during the year	(1,666		)		588				(1,078		)

	Reclassification adjustments recognized in net income	60				(21		)		39

	Net change in pension and other benefit liabilities3	(1,606		)		567				(1,039		)

	Other comprehensive income (loss) attributable to The Coca-Cola Company	$	(2,474	)		$	129			$	(2,345	)


	1	Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments.

	2	Includes reclassification adjustments related to divestitures of certain available-for-sale securities. Refer to Note 3 for additional information related to these divestitures.

	3	Refer to Note 13 for additional information related to the Company's pension and other postretirement benefit liabilities.


		Before-Tax Amount				Income Tax				After-Tax Amount

	2013
	Foreign currency translation adjustments:
	Translation adjustment arising in the period	$	(1,046	)		$	56			$	(990	)

	Reclassification adjustments recognized in net income	(194		)		—				(194		)

	Net foreign currency translation adjustment	(1,240		)		56				(1,184		)

	Derivatives:
	Unrealized gains (losses) arising during the year	425				(173		)		252

	Reclassification adjustments recognized in net income	(167		)		66				(101		)

	Net gain (loss) on derivatives1	258				(107		)		151

	Available-for-sale securities:
	Unrealized gains (losses) arising during the year	(134		)		42				(92		)

	Reclassification adjustments recognized in net income	12				—				12

Net change in unrealized gain (loss) on available-for-sale securities2	(122		)		42				(80		)

Pension and other benefit liabilities:
Net pension and other benefits arising during the year	1,490				(550		)		940

Reclassification adjustments recognized in net income	198				(72		)		126

Net change in pension and other benefit liabilities3	1,688				(622		)		1,066

Other comprehensive income (loss) attributable to The Coca-Cola Company	$	584			$	(631	)		$	(47	)


1	Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments.

2	Includes reclassification adjustments related to divestitures of certain available-for-sale securities. Refer to Note 3 for additional information related to these divestitures.

3	Refer to Note 13 for additional information related to the Company's pension and other postretirement benefit liabilities.


	Before-Tax Amount				Income Tax				After-Tax Amount

2012
Net foreign currency translation adjustment	$	(219	)		$	(1	)		$	(220	)
Derivatives:
Unrealized gains (losses) arising during the year	77				(29		)		48

Reclassification adjustments recognized in net income	82				(31		)		51

Net gain (loss) on derivatives1	159				(60		)		99

Available-for-sale securities:
Unrealized gains (losses) arising during the year	248				(64		)		184

Reclassification adjustments recognized in net income	(6		)		—				(6		)

Net change in unrealized gain (loss) on available-for-sale securities2	242				(64		)		178

Pension and other benefit liabilities:
Net pension and other benefits arising during the year	(1,132		)		405				(727		)

Reclassification adjustments recognized in net income	92				(33		)		59

Net change in pension and other benefit liabilities3	(1,040		)		372				(668		)

Other comprehensive income (loss) attributable to The Coca-Cola Company	$	(858	)		$	247			$	(611	)


1	Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments.

2	Includes reclassification adjustments related to divestitures of certain available-for-sale securities. Refer to Note 3 for additional information related to these divestitures.

3	Refer to Note 13 for additional information related to the Company's pension and other postretirement benefit liabilities.
Disclosure of Reclassification Amount [Text Block]	The following table presents the amounts and line items in our consolidated statements of income where adjustments reclassified from AOCI into income were recorded during the year ended December 31, 2014 (in millions):


	Description of AOCI Component	Financial Statement Line Item	Amount Reclassified from
			AOCI into Income
	Derivatives:
	Foreign currency contracts	Net operating revenues	$	(121	)
	Foreign currency and commodity contracts	Cost of goods sold	(37		)
	Foreign currency contracts	Other income (loss) — net	108

		Income before income taxes	$	(50	)
		Income taxes	18

		Consolidated net income	$	(32	)
	Available-for-sale securities:
	Sale of securities	Other income (loss) — net	$	(17	)
		Income before income taxes	$	(17	)
		Income taxes	4

		Consolidated net income	$	(13	)
	Pension and other benefit liabilities:
	Amortization of net actuarial loss	*	$	79

	Amortization of prior service cost (credit)	*	(19		)
		Income before income taxes	$	60

		Income taxes	(21		)
		Consolidated net income	$	39


	*	This component of AOCI is included in the Company's computation of net periodic benefit cost and is not reclassified out of AOCI into a single line item in our consolidated statements of income in its entirety. Refer to Note 13 for additional information.

FAIR_VALUE_MEASUREMENTS_Tables

FAIR VALUE MEASUREMENTS (Tables)	12 Months Ended
	Dec. 31, 2014
Fair Value Measurements Disclosure [Abstract]
Assets and liabilities measured at fair value on a recurring basis	The following tables summarize those assets and liabilities measured at fair value on a recurring basis (in millions):


		December 31, 2014
		Level 1				Level 2				Level 3				Netting			Fair Value
														Adjustment1			Measurements
	Assets:
	Trading securities2	$	228			$	177			$	4			$	—		$	409

	Available-for-sale securities2	4,116				3,627				136			3	—			7,879

	Derivatives4	9				1,721				—				(437		)	1,293		5

	Total assets	$	4,353			$	5,525			$	140			$	(437	)	$	9,581

	Liabilities:
	Derivatives4	$	2			$	558			$	—			$	(437	)	$	123	5

	Total liabilities	$	2			$	558			$	—			$	(437	)	$	123


	1	Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with the same counterparties. There are no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 5.

	2	Refer to Note 3 for additional information related to the composition of our trading securities and available-for-sale securities.

	3	Primarily related to long-term debt securities that mature in 2018.

	4	Refer to Note 5 for additional information related to the composition of our derivative portfolio.

	5	The Company's derivative financial instruments are recorded at fair value in our consolidated balance sheet as follows: $567 million in the line item prepaid expenses and other assets; $726 million in the line item other assets; $14 million in the line item accounts payable and accrued expenses; and $109 million in the line item other liabilities. Refer to Note 5 for additional information related to the composition of our derivative portfolio.


		December 31, 2013
		Level 1				Level 2				Level 3				Netting			Fair Value
														Adjustment1			Measurements
	Assets:
	Trading securities2	$	206			$	163			$	3			$	—		$	372

	Available-for-sale securities2	1,453				3,281				108			3	—			4,842

	Derivatives4	17				822				—				(150		)	689		5

	Total assets	$	1,676			$	4,266			$	111			$	(150	)	$	5,903

	Liabilities:
	Derivatives4	$	10			$	165			$	—			$	(151	)	$	24	5

	Total liabilities	$	10			$	165			$	—			$	(151	)	$	24


	1	Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with the same counterparties. There are no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 5.

	2	Refer to Note 3 for additional information related to the composition of our trading securities and available-for-sale securities.

	3	Primarily related to long-term debt securities that mature in 2018.

	4	Refer to Note 5 for additional information related to the composition of our derivative portfolio.

	5	The Company's derivative financial instruments are recorded at fair value in our consolidated balance sheet as follows: $129 million in the line item prepaid expenses and other assets; $560 million in the line item other assets; $12 million in the line item accounts payable and accrued expenses; and $12 million in the line item other liabilities. Refer to Note 5 for additional information related to the composition of our derivative portfolio.
Assets measured at fair value on a nonrecurring basis	Assets measured at fair value on a nonrecurring basis for the years ended December 31, 2014 and 2013, are summarized below (in millions):


		Gains (Losses)
	December 31,	2014				2013

	Assets held for sale	$	(494	)	1	$	—

	Intangible assets	(18		)	2	(195		)	2
	Exchange of investment in equity securities	—				(114		)	4

	Valuation of shares in equity method investee	(32		)	3	139			3

	Total	$	(544	)		$	(170	)

	1	As of December 31, 2014, the Company had entered into agreements to refranchise additional territories in North America. These operations met the criteria to be classified as held for sale in our consolidated balance sheet as of December 31, 2014, and we were required to record their assets and liabilities at the lower of carrying value or fair value less any costs to sell based on the agreed-upon sale price. The Company recognized a noncash loss of $494 million during the year ended December 31, 2014 as a result of writing down the assets to their fair value less costs to sell. The loss was calculated based on Level 3 inputs. Refer to Note 2.

	2	The Company recognized losses of $18 million and $195 million during years ended December 31, 2014 and 2013, respectively, due to impairment charges on certain intangible assets. The charges were primarily determined by comparing the fair value of the assets to the current carrying value. The fair value of the assets was derived using discounted cash flow analyses based on Level 3 inputs. Refer to Note 1 and Note 17.

	3	In 2014, the Company recognized a loss of $32 million as a result of the owners of the majority interest in certain Brazilian bottling operations exercising their option to acquire from us a 10 percent interest in the entity's outstanding shares. The exercise price was lower than our carrying value. This loss was determined using Level 3 inputs. In 2013, the Company recognized a gain of $139 million as a result of Coca-Cola FEMSA, an equity method investee, issuing additional shares of its own stock at a per share amount greater than the carrying value of the Company's per share investment. Accordingly, the Company is required to treat this type of transaction as if the Company had sold a proportionate share of its investment in Coca-Cola FEMSA. This gain was determined using Level 1 inputs. Refer to Note 17.

	4	The Company recognized a net loss of $114 million on the exchange of shares it previously owned in certain equity method investees for shares in the newly formed entity CCEJ. CCEJ is also an equity method investee. The net loss represents the difference between the carrying value of the shares the Company relinquished and the fair value of the CCEJ shares received as a result of the transaction. The net loss and the initial carrying value of the Company's investment were calculated based on Level 1 inputs. Refer to Note 17.
Summary of the fair value of pension plan assets for U.S. and non-U.S. pension plans	The following table summarizes the levels within the fair value hierarchy for our pension plan assets as of December 31, 2014 and 2013 (in millions):


		December 31, 2014															December 31, 2013
		Level 1				Level 2				Level 3				Total			Level 1			Level 2				Level 3				Total

	Cash and cash equivalents	$	161			$	100			$	—			$	261		$	331		$	183			$	—			$	514

	Equity securities:
	U.S.-based companies	1,793				6				17				1,816			1,680			7				15				1,702

	International-based companies	1,050				13				—				1,063			1,271			13				—				1,284

	Fixed-income securities:
	Government bonds	—				863				3				866			—			719				49				768

	Corporate bonds and debt securities	—				1,533				33				1,566			—			1,466				40				1,506

	Mutual, pooled and commingled funds	98				1,134				31				1,263			56			1,531				—				1,587

	Hedge funds/limited partnerships	—				215				584				799			—			190				353				543

	Real estate	—				16				392				408			—			—				251				251

	Other	—				14				846			1	860			—			7				584			1	591

	Total	$	3,102			$	3,894			$	1,906			$	8,902		$	3,338		$	4,116			$	1,292			$	8,746


	1	Includes purchased annuity contracts and insurance-linked securities.
Reconciliation of the beginning and ending balance of Level 3 assets for U.S. and non-U.S. pension plans	The following table provides a reconciliation of the beginning and ending balance of Level 3 assets for our U.S. and non-U.S. pension plans for the years ended December 31, 2014 and 2013 (in millions):


		Fixed-Income Securities				Hedge				Real Estate				Equity			Mutual,			Other				Total
						Funds/Limited								Securities			Pooled and
						Partnerships											Commingled
																	Funds
	2013
	Balance at beginning of year	$	—			$	400			$	257			$	14		$	—		$	510			$	1,181

	Actual return on plan assets:
	Related to assets still held at the reporting date	(4		)		(6		)		13				—			—			39				42

	Related to assets sold during the year	(2		)		24				6				—			—			—				28

	Purchases, sales and settlements — net	95				14				(24		)		1			—			193				279

	Transfers in or out of Level 3 — net	—				(78		)		—				—			—			(172		)		(250		)

	Foreign currency translation	—				(1		)		(1		)		—			—			14				12

	Balance at end of year	$	89			$	353			$	251			$	15		$	—		$	584		1	$	1,292

	2014
	Balance at beginning of year	$	89			$	353			$	251			$	15		$	—		$	584			$	1,292

	Actual return on plan assets:
	Related to assets still held at the reporting date	17				(17		)		29				1			—			50				80

	Related to assets sold during the year	(2		)		42				7				—			—			—				47

	Purchases, sales and settlements — net	(41		)		198				106				1			31			241				536

	Transfers in or out of Level 3 — net	(27		)		9				—				—			—			—				(18		)

	Foreign currency translation	—				(1		)		(1		)		—			—			(29		)		(31		)

	Balance at end of year	$	36			$	584			$	392			$	17		$	31		$	846		1	$	1,906


	1	Includes purchased annuity contracts and insurance-linked securities.
Summary of the fair value of postretirement benefit plan assets	The following table summarizes the levels within the fair value hierarchy for our other postretirement benefit plan assets as of December 31, 2014 and 2013 (in millions):


		December 31, 2014															December 31, 2013
		Level 1				Level 2				Level 3 1				Total			Level 1			Level 2				Level 3 1				Total

	Cash and cash equivalents	$	9			$	1			$	—			$	10		$	—		$	10			$	—			$	10

	Equity securities:
	U.S.-based companies	114				—				—				114			112			—				—				112

	International-based companies	7				—				—				7			8			—				—				8

	Fixed-income securities:
	Government bonds	76				3				—				79			76			3				—				79

	Corporate bonds and debt securities	—				9				—				9			—			9				—				9

	Mutual, pooled and commingled funds	10				6				—				16			11			7				—				18

	Hedge funds/limited partnerships	—				1				4				5			—			1				2				3

	Real estate	—				—				3				3			—			—				2				2

	Other	—				—				3				3			—			—				2				2

	Total	$	216			$	20			$	10			$	246		$	207		$	30			$	6			$	243


	1	Level 3 assets are not a significant portion of other postretirement benefit plan assets.

PRODUCTIVITY_INTEGRATION_AND_R1

PRODUCTIVITY, INTEGRATION AND RESTRUCTURING INITIATIVES (Tables)	12 Months Ended
	Dec. 31, 2014
Restructuring and Related Activities [Abstract]
Productivity and Reinvestment	The following table summarizes the balance of accrued expenses related to these productivity and reinvestment initiatives and the changes in the accrued amounts since the commencement of the plan (in millions):


		Severance Pay			Outside Services			Other			Total
		and Benefits						Direct Costs
	2012
	Costs incurred	$	21		$	61		$	188		$	270

	Payments	(8		)	(55		)	(167		)	(230		)
	Noncash and exchange	(1		)	—			(13		)	(14		)

	Accrued balance as of December 31	$	12		$	6		$	8		$	26

	2013
	Costs incurred	$	188		$	59		$	247		$	494

	Payments	(113		)	(59		)	(209		)	(381		)
	Noncash and exchange	1			—			(28		)	(27		)

	Accrued balance as of December 31	$	88		$	6		$	18		$	112

	2014
	Costs incurred	$	277		$	77		$	247		$	601

	Payments	(103		)	(79		)	(220		)	(402		)
	Noncash and exchange	(2		)	—			(24		)	(26		)

	Accrued balance as of December 31	$	260		$	4		$	21		$	285

OPERATING_SEGMENTS_Tables

OPERATING SEGMENTS (Tables)	12 Months Ended
	Dec. 31, 2014
Segment Reporting Information [Line Items]
Schedule of total net operating revenues related to concentrate and finished products operation	The following table sets forth the percentage of total net operating revenues related to concentrate operations and finished product operations:


	Year Ended December 31,	2014		2013			2012

	Concentrate operations1	38	%	38	%		38	%
	Finished product operations2	62		62			62

	Net operating revenues	100	%	100	%		100	%

	1	Includes concentrates sold by the Company to authorized bottling partners for the manufacture of fountain syrups. The bottlers then typically sell the fountain syrups to wholesalers or directly to fountain retailers.

	2	Includes fountain syrups manufactured by the Company, including consolidated bottling operations, and sold to fountain retailers or to authorized fountain wholesalers or bottling partners who resell the fountain syrups to fountain retailers.
Schedule of net revenue and property plant and equipment by Geography	The following table provides information related to our net operating revenues (in millions):


	Year Ended December 31,	2014			2013				2012

	United States	$	19,763		$	19,820			$	19,732

	International	26,235			27,034				28,285

	Net operating revenues	$	45,998		$	46,854			$	48,017

	The following table provides information related to our property, plant and equipment — net (in millions):


	Year Ended December 31,	2014			2013				2012

	United States	$	8,683		$	8,841			$	8,509

	International	5,950			6,126				5,967

	Property, plant and equipment — net	$	14,633		$	14,967			$	14,476

Schedule of Segment Reporting Information, by Segment [Table Text Block]

		Eurasia &			Europe				Latin			North				Asia Pacific			Bottling				Corporate				Eliminations				Consolidated
		Africa							America			America							Investments
	2014
	Net operating revenues:
	Third party	$	2,730		$	4,844			$	4,597		$	21,462			$	5,257		$	6,972			$	136			$	—			$	45,998

	Intersegment	—			692				60			17				489			67				—				(1,325		)		—

	Total net revenues	2,730			5,536				4,657			21,479				5,746			7,039				136				(1,325		)		45,998

	Operating income (loss)	1,084			2,852				2,316			2,447				2,448			9				(1,448		)		—				9,708

	Interest income	—			—				—			—				—			—				594				—				594

	Interest expense	—			—				—			—				—			—				483				—				483

	Depreciation and amortization	47			75				56			1,195				96			315				192				—				1,976

	Equity income (loss) — net	35			31				10			(16		)		12			691				6				—				769

	Income (loss) before income taxes	1,125			2,892				2,319			1,633				2,464			715				(1,823		)		—				9,325

	Identifiable operating assets1	1,298			3,358			2	2,426			33,066				1,793			6,975			2	29,482				—				78,398

	Investments3	1,081			90				757			48				157			8,781				2,711				—				13,625

	Capital expenditures	30			54				55			1,293				76			628				270				—				2,406

	2013
	Net operating revenues:
	Third party	$	2,763		$	4,645			$	4,748		$	21,574			$	5,372		$	7,598			$	154			$	—			$	46,854

	Intersegment	—			689				191			16				497			78				—				(1,471		)		—

	Total net revenues	2,763			5,334				4,939			21,590				5,869			7,676				154				(1,471		)		46,854

	Operating income (loss)	1,087			2,859				2,908			2,432				2,478			115				(1,651		)		—				10,228

	Interest income	—			—				—			—				—			—				534				—				534

	Interest expense	—			—				—			—				—			—				463				—				463

	Depreciation and amortization	42			86				58			1,192				130			335				134				—				1,977

	Equity income (loss) — net	22			24				13			2				19			524				(2		)		—				602

	Income (loss) before income taxes	1,109			2,923				2,920			2,434				2,494			679				(1,082		)		—				11,477

	Identifiable operating assets1	1,273			3,713			2	2,918			33,964				1,922			7,011			2	27,742				—				78,543

	Investments3	1,157			106				545			49				143			9,424				88				—				11,512

	Capital expenditures	40			34				63			1,374				117			643				279				—				2,550

	2012
	Net operating revenues:
	Third party	$	2,697		$	4,481			$	4,560		$	21,665			$	5,680		$	8,807			$	127			$	—			$	48,017

	Intersegment	—			642				271			15				628			88				—				(1,644		)		—

	Total net revenues	2,697			5,123				4,831			21,680				6,308			8,895				127				(1,644		)		48,017

Operating income (loss)	1,078			2,960				2,879			2,597				2,516			140				(1,391		)		—				10,779

Interest income	—			—				—			—				—			—				471				—				471

Interest expense	—			—				—			—				—			—				397				—				397

Depreciation and amortization	33			100				70			1,083				119			406				171				—				1,982

Equity income (loss) — net	20			45				4			13				2			732				3				—				819

Income (loss) before income taxes	1,101			3,015				2,882			2,624				2,523			904				(1,240		)		—				11,809

Identifiable operating assets1	1,299			2,976			2	2,759			34,114				2,163			9,648			2	22,767				—				75,726

Investments3	1,155			271				539			39				127			8,253				64				—				10,448

Capital expenditures	51			30				88			1,447				107			867				190				—				2,780


1	Principally cash and cash equivalents, short-term investments, marketable securities, trade accounts receivable, inventories, goodwill, trademarks and other intangible assets and property, plant and equipment — net.

2	Property, plant and equipment — net in Germany represented 10 percent of consolidated property, plant and equipment — net in 2014, 11 percent in 2013 and 10 percent in 2012.

3	Principally equity method investments, available-for-sale securities and nonmarketable investments in bottling companies.

NET_CHANGE_IN_OPERATING_ASSETS1

NET CHANGE IN OPERATING ASSETS AND LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2014
NET CHANGE IN OPERATING ASSETS AND LIABILITIES DISCLOSURE [Abstract]
Net change in operating assets and liabilities	Net cash provided by (used in) operating activities attributable to the net change in operating assets and liabilities is composed of the following (in millions):


	Year Ended December 31,	2014			2013			2012

	(Increase) decrease in trade accounts receivable	$	(253	)	$	28		$	(33	)

	(Increase) decrease in inventories	35			(105		)	(286		)

	(Increase) decrease in prepaid expenses and other assets	194			(163		)	(29		)

	Increase (decrease) in accounts payable and accrued expenses	(250		)	(158		)	(556		)
	Increase (decrease) in accrued taxes	151			22			770

	Increase (decrease) in other liabilities	(316		)	(556		)	(946		)
	Net change in operating assets and liabilities	$	(439	)	$	(932	)	$	(1,080	)

BUSINESS_AND_SUMMARY_OF_SIGNIF3

BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	12 Months Ended
Share data in Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Summary of Significant Accounting Policies [Abstract]
Number of brands owned or licensed and marketed by reporting entity	500
Number, of the top five brands in the world, of owned and marketed nonalcoholic sparkling beverage brands	4
Number of countries where finished beverage products bearing our trademarks are sold	200
Beverage servings consumed per day, number	57,000,000,000
Beverage servings consumed per day which bears trademarks owned by or licensed by the entity, number	1,900,000,000
Period of marketing agreement with customers, low end of the range (in years)	4 years
Period of marketing agreement with customers, high end of the range (in years)	10
Amortization expense for infrastructure programs	$72,000,000	$69,000,000	$86,000,000
Aggregate deductions for expenses including amortization expense, incurred in relation to infrastructure programs	7,000,000,000	6,900,000,000	6,100,000,000
Advertising costs included in selling, general and administrative expenses	3,500,000,000	3,300,000,000	3,300,000,000
Advertising and production costs recorded in prepaid expenses and other assets	228,000,000	363,000,000
Shipping and handling costs included in selling, general and administrative expenses	2,700,000,000	2,700,000,000	2,800,000,000
Stock option award excluded from computation of diluted net income per share (in millions of shares)	38	28	34
Investments classified as cash equivalents, maximum maturity period (in months)	3
Investments classified as short term investments maturity period, low end of the range (in months)	3
Investments classified as short term investments maturity period, high end of the range (in years)	1
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	4 years
Property, Plant and Equipment
Depreciation expense	1,716,000,000	1,727,000,000	1,704,000,000
Amortization for leasehold improvements	$20,000,000	$16,000,000	$19,000,000
Goodwill, Trademarks and Other Intangible Assets
Finite Lived Intangible Assets, Minimum Useful Life	1 year
Finite Lived Intangible Assets, Maximum Useful Life	20 years
Indefinite-lived intangible assets, other than goodwill, for which a qualitative assessment was performed on less than percentage	10.00%
Goodwill for which a qualitative assessment was performed on less than percentage	10.00%
Buildings and improvements
Property, Plant and Equipment
Property, Plant and Equipment, Useful Life, Maximum	40 years
Machinery equipment and vehicle fleet
Property, Plant and Equipment
Property, Plant and Equipment, Useful Life, Maximum	20 years

BUSINESS_AND_SUMMARY_OF_SIGNIF4

BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Not primary beneficiary
Variable interest entity
VIEs maximum exposures to loss	$2,274	$2,171
Primary beneficiary
Variable interest entity
VIEs maximum exposures to loss	$266	$284

BUSINESS_AND_SUMMARY_OF_SIGNIF5

BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) (Allowance for doubtful accounts, USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Allowance for doubtful accounts
Activity in the allowance for doubtful accounts
Balance at beginning of year	$61	$53	$83
Net charges to costs and expenses	308	30	5
Write-offs	-13	-14	-19
Other	-25	-8	-16
Balance at end of year	$331	$61	$53

BUSINESS_AND_SUMMARY_OF_SIGNIF6

BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 4) (USD $)	12 Months Ended		3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Mar. 28, 2014
Translation and Remeasurement
Remeasurement Charges on Subsidiary Assets	$372
Venezuelan subsidiary
Translation and Remeasurement
Remeasurement of official exchange rate set by government for nonessential goods (in bolivars per U.S.dollar)				6.3
SCIAD 1 Rate				10.8
SCIAD 2 Rate	49.9883		49.9883	50.9
Remeasurement Charges on Subsidiary Assets	372	140
Accounts Receivable Write-Down	296
Impairment of Intangible Assets (Excluding Goodwill)	18
Net Monetary Assets, Receivables and Intangible Assets	180		180
Cash and Cash equivalents	52		52
Corporate \| Venezuelan subsidiary
Translation and Remeasurement
Remeasurement Charges on Subsidiary Assets		$140	$146	$226

ACQUISITIONS_AND_DIVESTITURES_1

ACQUISITIONS AND DIVESTITURES (Details) (USD $)	12 Months Ended			3 Months Ended	12 Months Ended	60 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014	Dec. 31, 2007	Dec. 31, 2019	Sep. 26, 2014	Mar. 28, 2014	Jun. 27, 2014	1-May-14	Feb. 27, 2014
Significant Acquisitions and Disposals [Line Items]
Acquisitions and Investments, Principally Beverage and Bottling Companies and Trademarks	$389	$353	$1,486
Proceeds from disposals of businesses, equity method investments and nonmarkatable securities	148	872	20
Equity Method Investments	9,947	10,393		9,947
Aujan Industries Trademark owner [Member]
Significant Acquisitions and Disposals [Line Items]
Acquisitions and Investments, Principally Beverage and Bottling Companies and Trademarks			820
Equity Method Investment, Ownership Percentage			50.00%
Aujan bottling and distribution company [Member]
Significant Acquisitions and Disposals [Line Items]
Equity Method Investment, Ownership Percentage			49.00%
Corporate
Significant Acquisitions and Disposals [Line Items]
Equity Method Investment, Realized Gain (Loss) on Disposal	-32
Others [Member]
Significant Acquisitions and Disposals [Line Items]
Disposal Group, Including Discontinued Operation, Assets	80			80
Disposal Groups, Including Discontinued Operations, Name [Domain]
Significant Acquisitions and Disposals [Line Items]
Disposal Group, Including Discontinued Operation, Assets	679			679
Brazilian Bottling Operations
Significant Acquisitions and Disposals [Line Items]
Equity Method Investment, Ownership Percentage	34.00%			34.00%			44.00%
Percentage of shares sold or to be sold through options	24.00%			10.00%
Equity Method Investment, Realized Gain (Loss) on Disposal	-32
North America Territory [Member]
Significant Acquisitions and Disposals [Line Items]
Disposal Group, Including Discontinued Operation, Assets	223			223
Agreement Term	10 years
Agreement Renewal Term	10 years
Proceeds from Sale of Productive Assets	143
Gain (Loss) on Disposition of Assets	-305
Impairment of Long-Lived Assets to be Disposed of	494
Monster Beverage Corporation [Member]
Significant Acquisitions and Disposals [Line Items]
Disposal Group, Including Discontinued Operation, Assets	43			43
Coca-Cola Beverage Africa [Member]
Significant Acquisitions and Disposals [Line Items]
Disposal Group, Including Discontinued Operation, Assets	333			333
CCEAG [Member]
Significant Acquisitions and Disposals [Line Items]
Put Option Exercise Price								503
Ownership Percentage by Parent	100.00%			100.00%
Integration of German Bottling and Distribution Operation [Member]
Significant Acquisitions and Disposals [Line Items]
Number of German bottling and distribution operations for which integration initiatives began in 2008					18
Monster Beverage Corporation [Member]
Significant Acquisitions and Disposals [Line Items]
Equity Method Investment, Ownership Percentage	16.70%			16.70%
Equity Method Investments	2,150			2,150
Green Mountain Coffee Roasters, Inc. [Member]
Significant Acquisitions and Disposals [Line Items]
Available for Sale Securities, Percent									2.00%	16.00%	10.00%
Available for sale security, Shares	6.5			6.5
Available-for-sale Securities, Equity Securities									302		1,265
Business Acquisition, Transaction Costs											14
Agreement Term	10 years
Coca-Cola Bottling Co. [Member]
Significant Acquisitions and Disposals [Line Items]
Proceeds from Sale of Productive Assets	$42
Coca-Cola Beverage Africa [Member]
Significant Acquisitions and Disposals [Line Items]
Equity Method Investment, Ownership Percentage	11.00%			11.00%
Remaining portion of options to be acquired until December 2019, by an equity investment majority owner \| Brazilian Bottling Operations
Significant Acquisitions and Disposals [Line Items]
Percentage of shares sold or to be sold through options						14.00%

ACQUISITIONS_AND_DIVESTITURES_2

ACQUISITIONS AND DIVESTITURES (Details 2) (USD $)	12 Months Ended	3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014	Sep. 26, 2014
Total Bottling Operations Held for Sale
Divestitures
Cash, cash equivalents and short-term investments			$30
Trade Accounts Receivable, less allowances			100
Inventories			54
Prepaid expenses and other assets			7
Equity Method Investments			141
Other Assets			3
Property, plant and equipment - net			303
Bottlers' franchise rights with indefinite lives			410
Trademarks			43
Goodwill			46
Other intangible assets			36
Allowance for reduction of assets held for sale			-494
Total Assets			679
Accounts payable and accrued expenses			48
Other liabilities			6
Deferred income taxes			4
Total liabilities			58
Brazilian Bottling Operations
Divestitures
Deconsolidation, Gain (Loss), Amount	615
Equity Method Investment, Ownership Percentage			34.00%	44.00%
Philippines Bottling Operations
Divestitures
Loss on disposal group held for sale		107
Equity Method Investment, Ownership Percentage			49.00%
Corporate
Divestitures
Deconsolidation, Gain (Loss), Amount	$615

INVESTMENTS_Details

INVESTMENTS (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Trading Securities
Trading securities, net unrealized gains (losses)	$40	$12	$19
Marketable securities	315	286
Other assets	94	86
Trading Securities	$409	$372

INVESTMENTS_Details_2

INVESTMENTS (Details 2) (USD $)	12 Months Ended			3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Mar. 28, 2014
Available-for-sale securities, by type
Available-for-sale securities, cost	$6,483	$4,485
Available-for-sale Securities, Accumulated Gross Unrealized Gain	1,531	397
Available-for-sale Securities, Accumulated Gross Unrealized Loss	-135	-40
Available-for-sale securities, estimated fair value	7,879	4,842
Available-for-sale Securities, Gross Realized Losses	-21	-24	-35
Equity securities
Available-for-sale securities, by type
Available-for-sale securities, cost	2,687	1,097
Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain	1,463	373
Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss	-29	-17
Available-for-sale securities, estimated fair value	4,121	1,453
Debt securities
Available-for-sale securities, by type
Available-for-sale securities, cost	3,796	3,388
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain	68	24
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss,	-106	-23
Available-for-sale securities, estimated fair value	3,758	3,389
Other income (loss) - net
Available-for-sale securities, by type
Available-for-sale Debt Securities, Gross Unrealized Loss				$101

INVESTMENTS_Details_3

INVESTMENTS (Details 3) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Schedule of Available-for-sale Securities [Line Items]
Proceeds from Sale of Available-for-sale Securities	$4,157	$4,212	$5,036
Gross realized gains	38	12	41
Gross realized losses	-21	-24	-35
Available-for-Sale Securities
Schedule of Available-for-sale Securities [Line Items]
Solvency Funds of Insurance Captive	$836	$667

INVESTMENTS_Details_4

INVESTMENTS (Details 4) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Available-for-sale and held-to-maturity securities by balance sheet line item
Cash and cash equivalents	$8,958	$10,414	$8,442	$12,803
Marketable securities	3,665	3,147
OTHER INVESTMENTS	3,678	1,119
OTHER ASSETS	4,407	4,661
Available-for-sale securities	7,879	4,842
Available-for-Sale Securities
Available-for-sale and held-to-maturity securities by balance sheet line item
Cash and cash equivalents	43	245
Marketable securities	3,350	2,861
OTHER INVESTMENTS	3,512	958
OTHER ASSETS	974	778
Available-for-sale securities	$7,879	$4,842

INVESTMENTS_Details_5

INVESTMENTS (Details 5) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, within 1 year, cost	$1,589
Available-for-sale securities, within 1 year, fair value	1,489
Available-for-sale securities, after 1 years through 5 years, cost	1,709
Available-for-sale securities, after 1 years through 5 years, fair value	1,747
Available-for-sale securities, after 5 years through 10 years, cost	118
Available-for-sale securities, after 5 years through 10 years, fair value	130
Available-for-sale securities, after 10 years, cost	380
Available-for-sale securities, after 10 years, fair value	392
Cost Method Investments [Abstract]
Cost method investments, carrying value	$166	$162

INVENTORIES_Details

INVENTORIES (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Inventory balances
Raw materials and packaging	$1,615	$1,692
Finished goods	1,134	1,240
Other	351	345
Total inventories	$3,100	$3,277

HEDGING_TRANSACTIONS_AND_DERIV2

HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Fair Value, Derivatives Designated and Not Designated as Hedges
Maximum length of time over which future cash flow exposures are hedged (in years)	3 years
Derivatives Designated as Hedging Instruments, Assets, at Fair Value	$1,429	$604
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	301	235
Derivatives Designated as Hedging Instruments, Liabilities, at Fair Value	320	125
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	240	50
Anticipated gains (losses) cash flows hedges, estimated reclassification to earnings	416
Increase in the carrying value of long-term debt, in relation to interest rate fair value hedge adjustment	34
Foreign currency contracts \| Prepaid expenses and other assets
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivatives Designated as Hedging Instruments, Assets, at Fair Value	923	211
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	44	21
Foreign currency contracts \| Other assets
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivatives Designated as Hedging Instruments, Assets, at Fair Value	346	109
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	231	171
Foreign currency contracts \| Accounts payable and accrued expenses
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivatives Designated as Hedging Instruments, Liabilities, at Fair Value	24	84
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	33	24
Foreign currency contracts \| Other liabilities
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivatives Designated as Hedging Instruments, Liabilities, at Fair Value	249	40
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	21	0
Commodity contracts \| Prepaid expenses and other assets
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivatives Designated as Hedging Instruments, Assets, at Fair Value	0	1
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	9	33
Commodity contracts \| Other assets
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	1	1
Commodity contracts \| Accounts payable and accrued expenses
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivatives Designated as Hedging Instruments, Liabilities, at Fair Value	1	1
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	156	23
Commodity contracts \| Other liabilities
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	17	0
Interest rate contracts \| Prepaid expenses and other assets
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivatives Designated as Hedging Instruments, Assets, at Fair Value	14	0
Interest rate contracts \| Other assets
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivatives Designated as Hedging Instruments, Assets, at Fair Value	146	283
Interest rate contracts \| Accounts payable and accrued expenses
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivatives Designated as Hedging Instruments, Liabilities, at Fair Value	11	0
Interest rate contracts \| Other liabilities
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivatives Designated as Hedging Instruments, Liabilities, at Fair Value	35	0
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	2	3
Other Derivative Instruments \| Prepaid expenses and other assets
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	14	9
Other Derivative Instruments \| Other assets
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	2	0
Other Derivative Instruments \| Accounts payable and accrued expenses
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	11	0
Cash Flow Hedges \| Foreign currency contracts
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative, Notional Amount	13,224	8,450
Cash Flow Hedges \| Cross Currency Swap
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative, Notional Amount	2,590
Cash Flow Hedges \| Commodity contracts
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative, Notional Amount	9	26
Cash Flow Hedges \| Interest Rate Swap [Member]
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative, Notional Amount	4,328	1,828
Fair Value Hedges \| Available-for-Sale Securities
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative, Notional Amount	1,358	996
Fair Value Hedges \| Interest Rate Swap [Member]
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative, Notional Amount	6,600	5,600
Net Investment Hedges \| Foreign currency contracts
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative, Notional Amount	2,047	2,024
Not Designated as Hedging Instrument [Member] \| Foreign currency contracts
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative, Notional Amount	4,334	3,871
Not Designated as Hedging Instrument [Member] \| Commodity contracts
Fair Value, Derivatives Designated and Not Designated as Hedges
Derivative, Notional Amount	$816	$1,441

HEDGING_TRANSACTIONS_AND_DERIV3

HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS (Details 2) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cash Flow Hedges
Gains and (losses) related to derivative instruments
Gain (Loss) Recognized in OCI	$625	$441	$90
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	50	167	-82
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	-2	2
Cash Flow Hedges \| Interest rate contracts \| Interest expense
Gains and (losses) related to derivative instruments
Gain (Loss) Recognized in OCI	-180	169	1
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	0	-12	-12
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	-3	0
Cash Flow Hedges \| Foreign currency contracts
Gains and (losses) related to derivative instruments
Derivative, Notional Amount	13,224	8,450
Cash Flow Hedges \| Foreign currency contracts \| Net operating revenues
Gains and (losses) related to derivative instruments
Gain (Loss) Recognized in OCI	973	218	59
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	121	149	-46
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	1	2
Cash Flow Hedges \| Foreign currency contracts \| Other income (loss) - net
Gains and (losses) related to derivative instruments
Gain (Loss) Recognized in OCI	-218
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	-108
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0
Cash Flow Hedges \| Foreign currency contracts \| Cost of goods sold
Gains and (losses) related to derivative instruments
Gain (Loss) Recognized in OCI	50	52	34
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	34	32	-23
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	0	0
Cash Flow Hedges \| Interest rate swaps
Gains and (losses) related to derivative instruments
Derivative, Notional Amount	4,328	1,828
Cash Flow Hedges \| Commodity contracts
Gains and (losses) related to derivative instruments
Derivative, Notional Amount	9	26
Cash Flow Hedges \| Commodity contracts \| Cost of goods sold
Gains and (losses) related to derivative instruments
Gain (Loss) Recognized in OCI	0	2	-4
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	3	-2	-1
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	0	0
Fair Value Hedges
Gains and (losses) related to derivative instruments
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	-4	23	43
Fair Value Hedges \| Interest expense
Gains and (losses) related to derivative instruments
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	29	47	47
Fair Value Hedges \| Other income (loss) - net
Gains and (losses) related to derivative instruments
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	-33	-24	-4
Fair Value Hedges \| Interest rate contracts \| Interest expense
Gains and (losses) related to derivative instruments
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	18	-193	89
Fair Value Hedges \| Foreign currency contracts \| Other income (loss) - net
Gains and (losses) related to derivative instruments
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	132	24	42
Fair Value Hedges \| Available-for-Sale Securities
Gains and (losses) related to derivative instruments
Derivative, Notional Amount	1,358	996
Fair Value Hedges \| Available-for-Sale Securities \| Other income (loss) - net
Gains and (losses) related to derivative instruments
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	-165	-48	-46
Fair Value Hedges \| Interest rate swaps
Gains and (losses) related to derivative instruments
Derivative, Notional Amount	6,600	5,600
Fair Value Hedges \| Fixed Rate Debt \| Interest expense
Gains and (losses) related to derivative instruments
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	11	240	-42
Net Investment Hedges \| Foreign currency contracts
Gains and (losses) related to derivative instruments
Derivative, Notional Amount	2,047	2,024
Gain (Loss) Recognized in OCI	80	61	-61
Derivatives Not Designated as Hedging Instruments
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	-163	111	-62
Derivatives Not Designated as Hedging Instruments \| Foreign currency contracts
Gains and (losses) related to derivative instruments
Derivative, Notional Amount	4,334	3,871
Derivatives Not Designated as Hedging Instruments \| Foreign currency contracts \| Net operating revenues
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	-6	5	-7
Derivatives Not Designated as Hedging Instruments \| Foreign currency contracts \| Other income (loss) - net
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	-85	162	24
Derivatives Not Designated as Hedging Instruments \| Foreign currency contracts \| Cost of goods sold
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	0	2	0
Derivatives Not Designated as Hedging Instruments \| Interest rate swaps \| Interest expense
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	0	-3	0
Derivatives Not Designated as Hedging Instruments \| Commodity contracts
Gains and (losses) related to derivative instruments
Derivative, Notional Amount	816	1,441
Derivatives Not Designated as Hedging Instruments \| Commodity contracts \| Net operating revenues
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	-48	5	4
Derivatives Not Designated as Hedging Instruments \| Commodity contracts \| Cost of goods sold
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	-8	-122	-110
Derivatives Not Designated as Hedging Instruments \| Commodity contracts \| Selling, general and administrative expenses
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	-79	7	9
Derivatives Not Designated as Hedging Instruments \| Other Derivative Instruments \| Other income (loss) - net
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	39	0	0
Derivatives Not Designated as Hedging Instruments \| Other Derivative Instruments \| Selling, general and administrative expenses
Gains and (losses) related to derivative instruments
Derivative, Gain (Loss) on Derivative, Net	$24	$55	$18

EQUITY_METHOD_INVESTMENTS_Deta

EQUITY METHOD INVESTMENTS (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Equity method investments, disclosures
Investment in equity method investees in excess of the proportionate share of net assets	$1,671
Summarized financial information - Income statement
Equity income (loss) - net	769	602	819
Summarized financial information - Balance sheet
Equity Method Investments	9,947	10,393
Other Equity Method Investees [Member]
Summarized financial information - Income statement
Net operating revenues	52,627	53,038	47,087
Cost of goods sold	31,810	32,377	28,821
Gross profit	20,817	20,661	18,266
Operating income	4,489	4,380	4,605
Consolidated net income	2,440	2,364	2,993
Less: Net income attributable to noncontrolling interests	74	62	89
Net income attributable to common shareowners	2,366	2,302	2,904
Summarized financial information - Balance sheet
Current Assets	16,184	19,229
Noncurrent assets	40,080	40,427
Total assets	56,264	59,656
Current liabilities	12,477	14,386
Noncurrent liabilities	16,657	17,779
Total liabilities	29,134	32,165
Equity attributable to shareowners of investees	26,363	26,668
Equity attributable to noncontrolling interests	767	823
Total Equity	27,130	27,491
Equity Method Investments	9,947	10,393
Other Equity Method Investments
Summary of significant transactions with equity method investees
Concentrate, syrup and finished product sales	10,063	9,178	7,082
Purchases of finished product	381	415	392
Marketing payments made by us	$1,605	$1,807	$1,587
Coca-Cola FEMSA
Equity method investments, disclosures
Ownership interest in Equity investee (as a percent)	28.00%
Coca-Cola Hellenic
Equity method investments, disclosures
Ownership interest in Equity investee (as a percent)	23.00%
Coca-Cola Amatil
Equity method investments, disclosures
Ownership interest in Equity investee (as a percent)	29.00%

EQUITY_METHOD_INVESTMENTS_Deta1

EQUITY METHOD INVESTMENTS (Details 2) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Schedule of Equity Method Investments [Line Items]
Excess of quoted market value over carrying value	$5,443
Total net receivables due	1,448	1,308
Dividends received	398	401	393
Coca-Cola Hellenic
Schedule of Equity Method Investments [Line Items]
Special dividend included in total dividends			$35

PROPERTY_PLANT_AND_EQUIPMENT_D

PROPERTY, PLANT AND EQUIPMENT (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment
Property, plant and equipment, gross	$25,258	$25,032
Less accumulated depreciation	10,625	10,065
Property, plant and equipment-net	14,633	14,967	14,476
Land
Property, Plant and Equipment
Property, plant and equipment, gross	972	1,011
Buildings and improvements
Property, Plant and Equipment
Property, plant and equipment, gross	5,539	5,605
Machinery equipment and vehicle fleet
Property, Plant and Equipment
Property, plant and equipment, gross	18,225	17,551
Construction in progress
Property, Plant and Equipment
Property, plant and equipment, gross	$522	$865

INTANGIBLE_ASSETS_Details

INTANGIBLE ASSETS (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Indefinite-lived Intangible Assets
Indefinite-lived intangible assets	$25,492	$26,642
Definite-lived Intangible Assets
Gross carrying amount	1,579	1,597
Accumulated amortization	-699	-628
Net definite-lived intangible assets	880	969
Total amortization expense for intangible assets subject to amortization	168	165	173
Amortization Expense
2015	156
2016	149
2017	121
2018	61
2019	59
Trademarks
Indefinite-lived Intangible Assets
Indefinite-lived intangible assets	6,533	6,744
Definite-lived Intangible Assets
Gross carrying amount	222	105
Accumulated amortization	-39	-26
Net definite-lived intangible assets	183	79
Bottlers' Franchise Rights
Indefinite-lived Intangible Assets
Indefinite-lived intangible assets	6,689	7,415
Definite-lived Intangible Assets
Gross carrying amount	664	722
Accumulated amortization	-375	-317
Net definite-lived intangible assets	289	405
Goodwill
Indefinite-lived Intangible Assets
Indefinite-lived intangible assets	12,100	12,312
Other
Indefinite-lived Intangible Assets
Indefinite-lived intangible assets	170	171
Definite-lived Intangible Assets
Gross carrying amount	96	128
Accumulated amortization	-56	-83
Net definite-lived intangible assets	40	45
Customer Relationships
Definite-lived Intangible Assets
Gross carrying amount	597	642
Accumulated amortization	-229	-202
Net definite-lived intangible assets	368	440
Dr Pepper Snapple Group [Member]
Indefinite-lived Intangible Assets
Indefinite-Lived License Agreements	$784	$865
Remaining Term of License Agreement	16
Renewal Period of License Agreement	20

INTANGIBLE_ASSETS_Details_2

INTANGIBLE ASSETS (Details 2) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Goodwill by operating segment
Balance as of January 1	$12,312	$12,255
Effect of foreign currency translation	-99	18
Acquisitions	30	127
Adjustments related to the finalization of purchase accounting	-61	-5
Impairment		-82
Divestitures, deconsolidations and other	-82	-1
Balance as of December 31	12,100	12,312
Eurasia and Africa
Goodwill by operating segment
Balance as of January 1	36	34
Effect of foreign currency translation	-2	-3
Acquisitions	0	5
Adjustments related to the finalization of purchase accounting	-4	0
Impairment		0
Divestitures, deconsolidations and other	-3	0
Balance as of December 31	27	36
Europe
Goodwill by operating segment
Balance as of January 1	822	691
Effect of foreign currency translation	-60	29
Acquisitions	0	102
Adjustments related to the finalization of purchase accounting	-43	0
Impairment		0
Divestitures, deconsolidations and other	0	0
Balance as of December 31	719	822
Latin America
Goodwill by operating segment
Balance as of January 1	156	168
Effect of foreign currency translation	-9	-12
Acquisitions	0	0
Adjustments related to the finalization of purchase accounting	0	0
Impairment		0
Divestitures, deconsolidations and other	0	0
Balance as of December 31	147	156
North America
Goodwill by operating segment
Balance as of January 1	10,572	10,577
Effect of foreign currency translation	0	0
Acquisitions	11	0
Adjustments related to the finalization of purchase accounting	0	-4
Impairment		0
Divestitures, deconsolidations and other	-79	-1
Balance as of December 31	10,504	10,572
Asia Pacific
Goodwill by operating segment
Balance as of January 1	117	123
Effect of foreign currency translation	-2	-6
Acquisitions	16	0
Adjustments related to the finalization of purchase accounting	0	0
Impairment		0
Divestitures, deconsolidations and other	0	0
Balance as of December 31	131	117
Bottling Investments
Goodwill by operating segment
Balance as of January 1	609	662
Effect of foreign currency translation	-26	10
Acquisitions	3	20
Adjustments related to the finalization of purchase accounting	-14	-1
Impairment		-82
Divestitures, deconsolidations and other	0	0
Balance as of December 31	$572	$609

ACCOUNTS_PAYABLE_AND_ACCRUED_E2

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
ACCOUNTS PAYABLE AND ACCRUED EXPENSES Disclosure [Abstract]
Accrued marketing	$2,103	$2,407
Other accrued expenses	3,182	3,515
Trade accounts payable	2,089	1,933
Accrued compensation	997	933
Sales, payroll and other taxes	511	450
Container deposits	352	339
Accounts payable and accrued expenses	$9,234	$9,577

DEBT_AND_BORROWING_ARRANGEMENT2

DEBT AND BORROWING ARRANGEMENTS (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Short-term Debt [Line Items]
Commercial paper borrowings outstanding	$19,010	$16,853
Weighted-average interest rates for commercial paper outstanding (as a percent)	0.20%	0.20%
Line of Credit Facility, Maximum Borrowing Capacity	8,723
Lines of credit and other short-term credit facilities outstanding	120
Lines of credit for general corporate purposes	$7,677

DEBT_AND_BORROWING_ARRANGEMENT3

DEBT AND BORROWING ARRANGEMENTS (Details 2) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Long-term debt
Issuance of long term debt	$3,537	$7,500	$2,750
Debt instrument Average Rate (as a percent)	2.20%	2.20%
Fair value adjustment	34	52
Net charge on exchange, repayment or extinguishment of long-term debt		50
Long-term Debt	22,615	20,178
Less current portion	3,552	1,024
Long-term debt non current	19,063	19,154
Total interest paid	498	498	574
Maturities of Long-Term Debt
2015	3,552
2016	2,689
2017	1,363
2018	3,308
2019	1,004
Total principal notes due September 1, 2015 [Member]
Long-term debt
Issuance of long term debt	1,000
Variable interest rate used	P3M
Basis spread on variable rate used (as a percent)	0.01%
Total principal Euro notes due September 22, 2022 [Member]
Long-term debt
Issuance of long term debt	1,015
Fixed interest rate (as a percent)	1.13%
Total principal Euro notes due September 22, 2026 [Member]
Long-term debt
Issuance of long term debt	1,522
Fixed interest rate (as a percent)	1.88%
Total principal notes due March 5, 2015
Long-term debt
Issuance of long term debt		500
Variable interest rate used		P3M
Basis spread on variable rate used (as a percent)		0.02%
Total principal notes due November 1, 2016
Long-term debt
Issuance of long term debt		500
Variable interest rate used		P3M
Basis spread on variable rate used (as a percent)		0.10%
Fixed interest rate (as a percent)		0.75%
Total principal notes due April 1, 2018
Long-term debt
Issuance of long term debt		1,250
Fixed interest rate (as a percent)		1.15%
Total principal notes due November 1, 2018
Long-term debt
Issuance of long term debt		1,250
Fixed interest rate (as a percent)		1.65%
Total principal notes due November 1, 2020
Long-term debt
Issuance of long term debt		1,250
Fixed interest rate (as a percent)		2.45%
Total principal notes due April 1, 2023
Long-term debt
Issuance of long term debt		750
Fixed interest rate (as a percent)		2.50%
Total principal notes due November 1, 2023
Long-term debt
Issuance of long term debt		1,500
Fixed interest rate (as a percent)		3.20%
Total principal notes due August 15, 2013
Long-term debt
Fixed interest rate (as a percent)		5.00%
Total principal notes due March 3, 2014
Long-term debt
Fixed interest rate (as a percent)		7.38%
Total principal notes due March 15, 2014
Long-term debt
Fixed interest rate (as a percent)		3.63%
Total principal notes due March 1, 2015
Long-term debt
Fixed interest rate (as a percent)		4.25%
Total principal notes due on March 14 2014
Long-term debt
Issuance of long term debt			1,000
Variable interest rate used			3
Basis spread on variable rate used (as a percent)			0.05%
Total principal notes due on March 13 2015
Long-term debt
Issuance of long term debt			1,000
Fixed interest rate (as a percent)			0.75%
Total principal notes due on March 14 2018
Long-term debt
Issuance of long term debt			750
Fixed interest rate (as a percent)			1.65%
U.S. dollar notes due 2015-2093
Long-term debt
Debt instrument Average Rate (as a percent)	1.80%	1.80%
Long-term Debt	17,433	17,427
U.S. dollar debentures due 2017-2098
Long-term debt
Debt instrument Average Rate (as a percent)	3.90%	3.90%
Long-term Debt	2,157	2,191
U.S. dollar zero coupon notes due in 2020
Long-term debt
Debt instrument Average Rate (as a percent)	8.40%	8.40%
Unamortized discounts as of the acquisition date	28	33
Long-term Debt	143	138
Euro notes due 2022 and 2026 [Member]
Long-term debt
Debt instrument Average Rate (as a percent)	3.70%	0.00%
Long-term Debt	2,468	0
Other, due through 2098
Long-term debt
Debt instrument Average Rate (as a percent)	4.00%	4.00%
Long-term Debt	380	370
Other, due through 2031
Long-term debt
Long-term Debt	199
Assumed long term debt \| Coca-Cola Enterprises Inc.
Long-term debt
Fair value adjustment related to the debt assumed	464	514
Fair value adjustments weighted-average amortization period (in years)	20
upon maturity
Long-term debt
Extinguishment of long-term debt	1,000	1,250	1,250
Prior to Maturity
Long-term debt
Extinguishment of long-term debt		2,154
Prior to Maturity \| Total principal notes due August 15, 2013
Long-term debt
Extinguishment of long-term debt		225
Prior to Maturity \| Total principal notes due March 3, 2014
Long-term debt
Extinguishment of long-term debt		675
Prior to Maturity \| Total principal notes due March 15, 2014
Long-term debt
Extinguishment of long-term debt		900
Prior to Maturity \| Total principal notes due March 1, 2015
Long-term debt
Extinguishment of long-term debt		354
Level 2
Long-term debt
Long-term Debt, Fair Value	$23,411	$20,352

COMMITMENTS_AND_CONTINGENCIES_1

COMMITMENTS AND CONTINGENCIES (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Workforce (Unaudited)
Number of associates	129,200
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
2015	$230
2016	161
2017	128
2018	98
2019	71
Thereafter	277
Total minimum operating lease payments	965
North America
Workforce (Unaudited)
Number of associates covered by collective bargaining agreements	18,000
Collective bargaining agreements period, low end of range (in years)	3
Collective bargaining agreements period, high end of range (in years)	5
United States
Workforce (Unaudited)
Number of associates	65,300
Guarantees of indebtedness owed by third parties
Guarantees
Guarantees of indebtedness owed by third parties	565
Guarantees of indebtedness related to VIEs	155
Risk Management Programs
Risk Management Programs
Self-insurance reserves	$530	$537

STOCK_COMPENSATION_PLANS_Detai

STOCK COMPENSATION PLANS (Details) (USD $)	12 Months Ended			3 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2010	Oct. 02, 2010	Dec. 31, 1989	Dec. 31, 1983
STOCK COMPENSATION PLANS [Abstract]
Total stock-based compensation expense	$209	$227	$259
Total income tax benefit recognized in consolidated statements of income for share-based compensation arrangements	57	62	72
Total unrecognized compensation cost related to nonvested share-based compensation arrangements granted	437
Weighted-average period over which the total unrecognized compensation cost is expected to be recognized (in years)	2 years 2 months 17 days
Stock-based compensation awards
Vesting period of stock-based awards (in years)	4 years
Weighted-average assumptions used in the Black Scholes Merton option pricing model
Fair value of options at grant date (in dollars per share)	$3.91	$3.73	$3.80
Dividend yield (as a percent)	2.70%	2.80%	2.70%
Expected volatility (as a percent)	16.00%	17.00%	18.00%
Risk-free interest rate (as a percent)	1.60%	0.90%	1.00%
Expected term of the option (in years)	5 years	5 years	5 years
Share-based compensation disclosure
Granted (in shares)	68,000,000
Exercised (in shares)	-58,000,000	-53,000,000	-61,000,000
Forfeited/expired (in shares)	-10,000,000
Outstanding on December 31, 2014	305,000,000	305,000,000
Expected to vest at December 31, 2014	300,000,000
Granted, Weighted-Average Exercise Price (in dollars per share)	$37.24
Exercised, Weighted-Average Exercise Price (in dollars per share)	$26.12
Forfeited/expired, Weighted-Average Exercise Price (in dollars per share)	$35.03
Outstanding on December 31, Weighted-Average Exercise Price (in dollars per share)	$31.60	$29.42
Expected to vest at December 31, 2014, Weighted-Average Exercise Price (in dollars per share)	$31.51
Expected to Vest, Weighted Average Remaining Contractual Life (in years)	6 years 12 days
Outstanding on December 31, 2014, Weighted-Average Remaining Contractual Life (in years)	6 years 24 days
Outstanding on December 31, 2014, Aggregate Intrinsic Value (in dollars)	3,241
Expected to vest at December 31, 2014, Aggregate Intrinsic Value (in dollars)	3,216
Exercisable on December 31, 2014	173,000,000
Exercisable on December 31, 2014 weighted average exercise price (in dollars per share)	$27.85
Exercisable on December 31, 2014, Weighted-Average Remaining Contractual Life (in years)	4 years 4 months 5 days
Exercisable on December 31, 2014, Aggregate Intrinsic Value (in dollars)	2,480
Total intrinsic value of options exercised	894	815	780
Number of Shares Available for Grant (in shares)	2,700,000
Summary disclosures
Paid in cash equivalent (in shares)	-5,403
Restricted shares units vested and released (in shares)	-6,773,934
Outstanding performance share units at the Threshold Award Level (in shares)	8,700,000
Outstanding performance share units at the Maximum Award Level (in shares)	26,100,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other-than-Options Paid in Cash Equivalent in Period Value	0.2	1.8	0.6
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	3 years
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period Awards, Granted before 2008	2 years
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period Awards Granted 2008 and beyond	1 year
CCE's North American business
Stock-based compensation awards
Vesting period of stock-based awards (in years)	3 years
Share-based compensation disclosure
Outstanding on December 31, 2014	1,400,000
Outstanding on December 31, Weighted-Average Exercise Price (in dollars per share)	$16.62
Expiration period of stock-based awards (in years)	10
Number of Shares Available for Grant (in shares)	1,400,000
1999 Option Plan
Share-based compensation disclosure
Common stock was approved to be issued or transferred through the grant of stock options (in shares)	240,000,000
2002 Option Plan
Share-based compensation disclosure
Common stock was approved to be issued or transferred through the grant of stock options (in shares)	240,000,000
2008 Option Plan
Share-based compensation disclosure
Common stock was approved to be issued or transferred through the grant of stock options (in shares)	280,000,000
2014 Option Plan
Share-based compensation disclosure
Number of Shares Available for Grant (in shares)	500,000,000
Stock options granted in December 2003 and thereafter
Share-based compensation disclosure
Expiration period of stock-based awards (in years)	10
Stock options granted from 1999 through July 2003
Share-based compensation disclosure
Expiration period of stock-based awards (in years)	15 years
Performance share units
Summary disclosures
Granted	6,117,000
Paid in cash equivalent (in shares)	-5,000	-54,999	-16,267
Canceled/forfeited (in shares)	-6,660,000
Outstanding on December 31, 2014	17,426,000	17,974,000
Outstanding on January 1, 2014	$30.41
Grants in Period, Weighted Average Grant Date Fair Value	$32.33	$32.67	$29.95
Paid in cash equivalent, Weighted-Average Grant-Date Fair Value (in dollars per share)	$30.59
Canceled/forfeited, Weighted-Average Grant-Date Fair Value (in dollars per share)	$29.11
Outstanding on December 31, 2014	$31.59	$30.41
Performance share units \| 2012 to 2014 Performance Period
Summary disclosures
Performance share units outstanding based on the target award amounts (in shares)	6,017,000
Performance share units \| Performance Period 2013 to 2015 [Member]
Summary disclosures
Performance share units outstanding based on the target award amounts (in shares)	5,608,000
Performance share units \| Performance Period 2014 to 2016 [Member]
Summary disclosures
Performance share units outstanding based on the target award amounts (in shares)	5,801,000
Performance share units \| CCE's North American business
Stock-based compensation awards
Share-based Compensation Arrangement by Share-based Payment Award Performance Share Unit Projected Payout Percentage					200.00%
Summary disclosures
Grants in Period, Weighted Average Grant Date Fair Value				$29.56
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				3,300,000
Intrinsic value of shares issued due to modification in the performance awards	5	22
1989 Restricted Stock Award Plan
Share-based compensation disclosure
Number of Shares Available for Grant (in shares)						80,000,000
1983 Restricted Stock Award Plan
Share-based compensation disclosure
Number of Shares Available for Grant (in shares)							48,000,000
Time-Based Restricted Stock Unit Awards
Summary disclosures
Performance share units outstanding based on the target award amounts (in shares)	571,399
Time-Based Restricted Stock Unit Awards \| CCE's North American business
Summary disclosures
Performance share units outstanding based on the target award amounts (in shares)	0
Performance-based Restricted Stock Unit Awards
Summary disclosures
Performance share units outstanding based on the target award amounts (in shares)	57,200
Restricted stock award plan [Member]
Share-based compensation disclosure
Number of Shares Available for Grant (in shares)	0
Summary disclosures
Canceled/forfeited (in shares)	-110,000
Outstanding on January 1, 2014	$25.17
Canceled/forfeited, Weighted-Average Grant-Date Fair Value (in dollars per share)	$25.17
Outstanding on December 31, 2014	$25.17	$25.17
Restricted shares units vested and released (in shares)	-6,774,000	-405,963	-4,301,732
Vested and Release, Weighted Average Grant Date Fair Value	$25.17
Restricted shares vested and released under performance share unit awards, total intrinsic value	$255	$16	$148
Performance share units outstanding based on the target award amounts (in shares)	130,000	7,014,000

PENSION_AND_OTHER_POSTRETIREME2

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Defined Benefit Plan Disclosure
Prescription Drug Benefit, Reduction in Accumulated Postretirement Benefit Obligation for Subsidy	$71
Pension benefits
Changes in benefit obligations
Benefit obligation at January 1	8,845	9,693
Service cost	261	280
Interest cost	406	378
Foreign currency exchange rate changes	-183	-69
Amendments	0	-1
Actuarial loss (gain)	1,519	-899
Benefits paid	-522	-538
Business combinations	4	0
Settlements	-7	-9
Special termination benefits	5	2
Other	18	8
Benefit obligation at December 31	10,346	8,845
Fair value of plan assets
Fair value of plan assets at January 1	8,746	7,584
Actual return on plan assets	574	1,043
Employer contributions	214	639
Foreign currency exchange rate changes	-203	-43
Benefits paid	-435	-474
Settlements	-1	-5
Other	7	2
Fair value of plan assets at December 31	8,902	8,746
Net liability recognized	-1,444	-99
Accumulated benefit obligation for pension plans	10,028	8,523
Benefits paid from company assets for unfunded pension plans	87	64
Pension and other benefit amounts recognized in our consolidated balance sheets
Noncurrent asset	479	1,067
Current liability	-78	-76
Long-term liability	-1,845	-1,090
Net liability recognized	-1,444	-99
Projected benefit obligations in excess of the fair value of plan assets
Projected benefit obligation	8,753	1,521
Fair value of plan assets	6,854	374
Accumulated benefit obligations in excess of the fair value of plan assets
Accumulated benefit obligation	8,501	1,446
Fair value of plan assets	6,820	351
U.S. Plan
Defined Benefit Plan Disclosure
Portion of projected pension benefit obligation represented by the defined benefit plan (as a percent)	58.00%
Portion of projected pension plan assets represented by the defined benefit plan (as a percent)	61.00%
Fair value of plan assets
Fair value of plan assets at December 31	6,343	6,343
Non U. S. Plan
Fair value of plan assets
Fair value of plan assets at December 31	2,559	2,403
Other benefits
Changes in benefit obligations
Benefit obligation at January 1	946	1,104
Service cost	26	36
Interest cost	43	42
Foreign currency exchange rate changes	-4	-2
Amendments	-31	-73
Actuarial loss (gain)	88	-91
Benefits paid	-62	-77
Business combinations	0	0
Settlements	-1	0
Special termination benefits	0	0
Other	1	7
Benefit obligation at December 31	1,006	946
Fair value of plan assets
Fair value of plan assets at January 1	243	202
Actual return on plan assets	2	40
Employer contributions	0	0
Foreign currency exchange rate changes	0	0
Benefits paid	-3	-2
Settlements	0	0
Other	4	3
Fair value of plan assets at December 31	246	243
Net liability recognized	-760	-703
Benefits paid from company assets for unfunded pension plans	59	75
Pension and other benefit amounts recognized in our consolidated balance sheets
Noncurrent asset	0	0
Current liability	-20	-21
Long-term liability	-740	-682
Net liability recognized	($760)	($703)

PENSION_AND_OTHER_POSTRETIREME3

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS (Details 2) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Pension benefits
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	$8,902	$8,746	$7,584
Defined Benefit Plan, Benefits Paid for Unfunded Plans	87	64
U.S. Plan
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	6,343	6,343
Non U. S. Plan
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	2,559	2,403
Other Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	246	243	202
Defined Benefit Plan, Benefits Paid for Unfunded Plans	59	75
Cash and cash equivalents \| Pension benefits
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	261	514
Cash and cash equivalents \| U.S. Plan
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	186	240
Cash and cash equivalents \| Non U. S. Plan
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	75	274
Cash and cash equivalents \| Other Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	10	10
Equity securities U.S.-based companies \| Pension benefits
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	1,816	1,702
Equity securities U.S.-based companies \| U.S. Plan
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	1,274	1,422
Equity securities U.S.-based companies \| Non U. S. Plan
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	542	280
Equity securities U.S.-based companies \| Other Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	114	112
Equity securities International-based companies \| Pension benefits
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	1,063	1,284
Equity securities International-based companies \| U.S. Plan
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	558	698
Equity securities International-based companies \| Non U. S. Plan
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	505	586
Equity securities International-based companies \| Other Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	7	8
Government bonds \| Pension benefits
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	866	768
Government bonds \| U.S. Plan
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	455	464
Government bonds \| Non U. S. Plan
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	411	304
Government bonds \| Other Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	79	79
Corporate bonds and debt securities \| Pension benefits
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	1,566	1,506
Corporate bonds and debt securities \| U.S. Plan
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	1,379	1,369
Corporate bonds and debt securities \| Non U. S. Plan
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	187	137
Corporate bonds and debt securities \| Other Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	9	9
Mutual, pooled and commingled funds \| Pension benefits
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	1,263	1,587
Mutual, pooled and commingled funds \| U.S. Plan
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	863	1,134
Mutual, pooled and commingled funds \| Non U. S. Plan
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	400	453
Mutual, pooled and commingled funds \| Other Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	16	18
Hedge funds/limited partnerships \| Pension benefits
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	799	543
Hedge funds/limited partnerships \| U.S. Plan
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	756	526
Hedge funds/limited partnerships \| Non U. S. Plan
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	43	17
Hedge funds/limited partnerships \| Other Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	5	3
Real estate \| Pension benefits
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	408	251
Real estate \| U.S. Plan
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	391	245
Real estate \| Non U. S. Plan
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	17	6
Real estate \| Other Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	3	2
Other \| Pension benefits
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	860	591
Other \| U.S. Plan
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	481	245
Other \| Non U. S. Plan
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	379	346
Other \| Other Postretirement Benefit Plan [Member]
Defined Benefit Plan Disclosure
Fair Value of Plan Assets	$3	$2

PENSION_AND_OTHER_POSTRETIREME4

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS (Details 3)	12 Months Ended
PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS (Details 3)	Dec. 31, 2014
U.S. Plan
Defined Benefit Plan Disclosure
Maximum portion of plan assets for which an investment manager is responsible (as a percent)	10.00%
Target allocation, equity securities (as a percent)	42.00%
Target allocation, fixed-income securities (as a percent)	30.00%
Target allocation, alternative investments (as a percent)	28.00%
Investment in Company common stock (as a percent)	2.00%
Non U. S. Plan
Defined Benefit Plan Disclosure
Investment Strategy Allocation Targets For International Plans	41.00%
Target allocation, equity securities (as a percent)	10.00%
Target allocation, alternative investments (as a percent)	43.00%
Target allocation, fixed income securities (as a percent)	13.00%
Target allocation, mutual, pooled and commingled funds (as a percent)	34.00%
European and Canadian plans
Defined Benefit Plan Disclosure
Investment Strategy Allocation Targets For International Plans	59.00%
Target allocation, equity securities (as a percent)	66.00%
Target allocation, alternative investments (as a percent)	11.00%
Target allocation, fixed income securities (as a percent)	23.00%
Global equities [Member] \| U.S. Plan
Defined Benefit Plan Disclosure
Target allocation, equity securities (as a percent)	60.00%
Investment in Company common stock (as a percent)	5.00%
Emerging market equities \| U.S. Plan
Defined Benefit Plan Disclosure
Target allocation, equity securities (as a percent)	16.00%
Domestic small- and mid-cap equities \| U.S. Plan
Defined Benefit Plan Disclosure
Target allocation, equity securities (as a percent)	24.00%
Long-duration bonds \| U.S. Plan
Defined Benefit Plan Disclosure
Target allocation, fixed-income securities (as a percent)	33.00%
Multi-strategy alternative credit managers \| U.S. Plan
Defined Benefit Plan Disclosure
Target allocation, fixed-income securities (as a percent)	67.00%

PENSION_AND_OTHER_POSTRETIREME5

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS (Details 4) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Pension benefits
Net periodic pension and other Postretirement benefit cost
Service cost	$261	$280	$291
Interest cost	406	378	388
Expected return on plan assets	-713	-659	-573
Amortization of prior service cost (credit)	-2	-2	-2
Amortization of actuarial loss	73	197	137
Net periodic benefit cost	25	194	241
Settlement charge	4	1	3
Curtailment charge	0	0	6
Special termination benefits	5	2	1
Total cost recognized in the statement of income	34	197	251
Changes in AOCI for our benefit plans, pretax
Beginning balance in AOCI	-1,537	-3,032
Recognized prior service cost (credit)	-2	-2
Recognized net actuarial loss (gain)	77	198
Prior service credit (cost) arising in the current year	0	1
Net actuarial (loss) gain arising in the current year	-1,658	1,283
Foreign currency translation gain (loss)	51	15
Ending balance in AOCI	-3,069	-1,537	-3,032
Prior service credit (cost)	10	12
Net actuarial loss	-3,079	-1,549
Defined Benefit Plan, Amount to be Amortized from Accumulated Other Comprehensive Income (Loss) Next Fiscal Year [Abstract]
Amounts in AOCI expected to be recognized as component of net periodic pension cost in next fiscal year	201
Amortization of prior service cost (credit)	-2
Amortization of actuarial loss	203
Weighted average assumptions used in computing the benefit obligations
Discount rate (as a percent)	3.75%	4.75%
Rate of increase in compensation levels (as a percent)	3.50%	3.50%
Weighted-average assumptions used in computing net periodic benefit cost
Discount rate (as a percent)	4.75%	4.00%	4.75%
Rate of increase in compensation levels (as a percent)	3.50%	3.50%	3.25%
Expected long-term rate of return on plan assets (as a percent)	8.25%	8.25%	8.25%
U.S. Plan
Weighted-average assumptions used in computing net periodic benefit cost
Expected long-term rate of return on plan assets (as a percent)	8.50%
The 5-year annualized return on plan assets (as a percent)	10.40%
The 10-year annualized return on plan assets (as a percent)	6.30%
The 15-year annualized return on plan assets (as a percent)	5.50%
Annualized return on plan assets since inception (as a percent)	10.90%
Other benefits
Net periodic pension and other Postretirement benefit cost
Service cost	26	36	34
Interest cost	43	42	43
Expected return on plan assets	-11	-9	-8
Amortization of prior service cost (credit)	-17	-10	-52
Amortization of actuarial loss	2	13	6
Net periodic benefit cost	43	72	23
Settlement charge	0	0	0
Curtailment charge	0	0	0
Special termination benefits	0	0	0
Total cost recognized in the statement of income	43	72	23
Changes in AOCI for our benefit plans, pretax
Beginning balance in AOCI	13	-186
Recognized prior service cost (credit)	-17	-10
Recognized net actuarial loss (gain)	2	13
Prior service credit (cost) arising in the current year	31	73
Net actuarial (loss) gain arising in the current year	-97	122
Foreign currency translation gain (loss)	1	1
Ending balance in AOCI	-67	13	-186
Prior service credit (cost)	100	86
Net actuarial loss	-167	-73
Defined Benefit Plan, Amount to be Amortized from Accumulated Other Comprehensive Income (Loss) Next Fiscal Year [Abstract]
Amounts in AOCI expected to be recognized as component of net periodic pension cost in next fiscal year	-9
Amortization of prior service cost (credit)	-19
Amortization of actuarial loss	$10
Weighted average assumptions used in computing the benefit obligations
Discount rate (as a percent)	3.75%	4.75%
Weighted-average assumptions used in computing net periodic benefit cost
Discount rate (as a percent)	4.75%	4.00%	4.75%
Expected long-term rate of return on plan assets (as a percent)	4.75%	4.75%	4.75%

PENSION_AND_OTHER_POSTRETIREME6

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS (Details 5) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Estimated future benefit payments for funded and unfunded plans
2015	$555
2016	583
2017	618
2018	627
2019	652
2020-2024	3,480
Assumed health care cost trend rates
Health care cost trend rate assumed for the next year (as a percent)	7.50%	8.00%
Rate at which the cost trend rate is assumed to decline, the ultimate trend rate (as a percent)	5.00%	5.00%
Year in which the rate reaches the ultimate trend rate	2020	2020
Pension benefits
Estimated future benefit payments for funded and unfunded plans
2015	494
2016	518
2017	551
2018	560
2019	584
2020-2024	3,137
Other benefits
Estimated future benefit payments for funded and unfunded plans
2015	61
2016	65
2017	67
2018	67
2019	68
2020-2024	343
Estimated federal subsidies expected to be received under the Medicare Prescription Drug, Improvement and Modernization Act of 2003, for the period 2015-2019	5
Estimated federal subsidies expected to be received under the Medicare Prescription Drug, Improvement and Modernization Act of 2003, for the period 2020-2024	4
Non U. S. Plan
Defined Benefit Plan Disclosure
Contributions expected to be made in next fiscal year	$90

PENSION_AND_OTHER_POSTRETIREME7

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS (Details 6) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Multi-Employer Plans
Pension expense for multi-employer plans	$38	$37	$31
Defined contribution plan - U. S. Plan
Defined Contribution Plan Disclosures
Maximum employer contribution as a percentage of compensation (as a percent)	3.50%
Company costs associated with defined contribution plans	92	97	93
Defined contribution plan - Non U. S. Plan
Defined Contribution Plan Disclosures
Company costs associated with defined contribution plans	$36	$32	$29

INCOME_TAXES_Details

INCOME TAXES (Details) (USD $)	12 Months Ended
INCOME TAXES (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Taxes [Abstract]
Income before income taxes, United States	$1,567,000,000	$2,451,000,000	$3,526,000,000
Income before income taxes, International	7,758,000,000	9,026,000,000	8,283,000,000
INCOME BEFORE INCOME TAXES	9,325,000,000	11,477,000,000	11,809,000,000
Income tax payments	1,926,000,000	2,162,000,000	981,000,000
Income tax expense (benefit)
Current income tax expense (benefit), United States	867,000,000	713,000,000	602,000,000
Deferred income tax expense (benefit), United States	-97,000,000	305,000,000	936,000,000
Current income tax expense (benefit), State and Local	81,000,000	102,000,000	74,000,000
Deferred income tax expense (benefit), State and Local	-21,000,000	38,000,000	33,000,000
Current income tax expense (benefit), International	1,293,000,000	1,388,000,000	1,415,000,000
Deferred income tax expense (benefit), International	78,000,000	305,000,000	-337,000,000
Current income tax expense (benefit), total	2,241,000,000	2,203,000,000	2,091,000,000
Deferred income tax expense (benefit), total	-40,000,000	648,000,000	632,000,000
Reconciliation of the statutory U.S. federal tax rate and effective tax rates
Statutory U.S. federal tax rate (as a percent)	35.00%	35.00%	35.00%
State and local income taxes - net of federal benefit (as a percent)	1.00%	1.00%	1.10%
Earnings in jurisdictions taxed at rates different from the statutory U.S. federal rate (as a percent)	-11.50%	-10.30%	-9.50%
Reversal of valuation allowances (as a percent)	0.00%	0.00%	-2.40%
Equity income or loss (as a percent)	-2.20%	-1.40%	-2.00%
Other operating charges (as a percent)	2.90%	1.20%	0.40%
Other - Net	-1.60%	-0.70%	0.50%
Effective tax rate (as a percent)	23.60%	24.80%	23.10%
Tax expense (benefit) related to uncertain tax positions, including interest and penalties, foreign	18,000,000	-26,000,000	133,000,000
Uncertain tax positions, including interest and penalties, foreign (as a percent)	0.20%	-0.20%	1.10%
Income Tax Expense (Benefit) Unusual or Infrequent Items Transaction Gains (Losses)	55,000,000	279,000,000	57,000,000
Receivables write-down, impairments and others charges	352,000,000
Net Gains From Investee Transactions, Equity Investment Sales and other gains		501,000,000	76,000,000
Effective Income Tax Rate Reconciliation, net gains and other transactions	1.90%	0.90%	0.30%
Our proportionate share of unusual or infrequent items recorded by our equity method investees	18,000,000	159,000,000	-8,000,000
Effective Income Tax Rate Reconciliation, related to currency devaluation in a subsidiary	6,000,000	3,000,000
Remeasurement Charges on Subsidiary Assets	372,000,000
Effective Income Tax Rate Reconciliation, related to currency devaluation, Percent	1.50%	0.50%
Remeasurement and Translation loss due to currency devaluation		149,000,000
Income Tax expenses (benefit) of unusual or infrequent items recorded by our equity method investees		-8,000,000
Effective tax impact of unusual or infrequent items recorded by our equity method investees (as a percent)		0.40%
Income Tax Expense (Benefit) Unusual or Infrequent Items Productivity, Integration, Restructuring, Transaction Costs and other activities	-191,000,000	-175,000,000	-95,000,000
Unusual or Infrequent Item Operating	1,183,000,000	895,000,000	447,000,000
Effective tax impact of restructuring charges, asset impairments, transaction gains and others one-time items (as a percent)	1.00%	1.20%	0.40%
Tax benefit (charge) associated with the reversal of valuation allowance			283,000,000
Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount	265,000,000	279,000,000	280,000,000
Gross balance of unrecognized tax benefit
Beginning balance of unrecognized tax benefits	230,000,000	302,000,000	320,000,000
Increases related to prior period tax positions	13,000,000	1,000,000	69,000,000
Decreases related to prior period tax positions	-2,000,000	-7,000,000	-15,000,000
Increases related to current period tax positions	11,000,000	8,000,000	23,000,000
Decreases related to settlements with taxing authorities	-5,000,000	-4,000,000	-45,000,000
Reductions as a result of a lapse of the applicable statute of limitations	-32,000,000	-59,000,000	-36,000,000
Increases (decreases) from effects of foreign currency exchange rates	-4,000,000	-11,000,000	-14,000,000
Ending balance of unrecognized tax benefits	211,000,000	230,000,000	302,000,000
Alternative jurisdictional tax benefits if tax positions do not prevail	38,000,000
Impact of unrecognized tax benefits on effective tax rate if Company were to prevail on all uncertain tax positions	173,000,000
Unrecognized tax benefits, interest and penalties accrued	113,000,000	105,000,000	113,000,000
Unrecognized tax benefits, interest and penalties expense or (benefit)	8,000,000	-8,000,000	33,000,000
Undistributed earnings of foreign subsidiaries	33,300,000,000
Productivity and Reinvestment [Member]
Reconciliation of the statutory U.S. federal tax rate and effective tax rates
Unusual or Infrequent Item Operating	$809,000,000	$877,000,000	$416,000,000

INCOME_TAXES_Details_2

INCOME TAXES (Details 2) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Deferred tax assets:
Property, plant and equipment	$96	$102
Trademarks and other intangible assets, deferred tax asset	68	63
Equity method investments (including foreign currency translation adjustment), deferred tax asset	462	243
Derivative financial instrument, deferred tax asset	134	50
Other liabilities, deferred tax asset	1,082	1,102
Benefit plans, deferred tax asset	1,673	1,237
Net operating/capital loss carryforwards, deferred tax asset	729	790
Other, deferred tax asset	196	225
Gross deferred tax assets	4,440	3,812
Valuation allowances	-649	-586
Total deferred tax assets	3,791	3,226
Deferred tax liabilities:
Property, plant and equipment	-2,342	-2,417
Trademarks and other intangible assets, deferred tax liabilities	-4,020	-4,192
Equity method investments (including foreign currency translation adjustment), deferred tax liability	-1,038	-1,070
Derivative financial instruments, deferred tax liabilities	-457	-147
Other liabilities, deferred tax liability	-110	-69
Benefit Plans, deferred tax liabilities	-487	-473
Other, deferred tax liability	-944	-810
Total deferred tax liabilities	-9,398	-9,178
Net deferred tax liabilities	-5,607	-5,952
Noncurrent deferred tax assets recorded in other assets	319	328
Current deferred tax assets recorded in prepaid expenses and other assets	160	211
Current deferred tax liabilities recorded in accounts payable and accrued expenses	450	339
Net deferred tax assets or (liabilities) located in countries outside the United States	643	198
Loss carryforwards	6,408
Loss carryforwards expiring within next five years	$497

INCOME_TAXES_Details_3

INCOME TAXES (Details 3) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Deferred tax asset valuation allowances
Balance at beginning of year	$586
Balance at end of year	649	586
Net increase or (decrease) in valuation allowances	63	99	-372
Valuation Allowance of Deferred Tax Assets [Member]
Deferred tax asset valuation allowances
Balance at beginning of year	586	487	859
Additions	104	169	126
(Decrease) due to transfer to assets held for sale	0	0	-146
Deductions	-41	-70	-352
Balance at end of year	$649	$586	$487

OTHER_COMPREHENSIVE_INCOME_Det

OTHER COMPREHENSIVE INCOME (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
AOCI attributable to the shareowners of The Coca-Cola Company
Accumulated other comprehensive income (loss)	($5,777)	($3,432)
CONSOLIDATED NET INCOME	7,124	8,626	9,086
Total comprehensive income	4,774	8,576	8,513
Foreign currency translation adjustments:
Translation adjustment arising in the period	-2,560	-1,046
Reclassification adjustments recognized in net income	0	-194
Derivatives:
Reclassification adjustments recognized in net income	-50
Available-for-sale securities:
Reclassification adjustments recognized in net income	-17
Pension and other benefit liabilities:
Reclassification adjustments recognized in net income	60
Foreign currency translation adjustments:
Translation adjustment arising in the period	183	56
Reclassification adjustments recognized in the period	0	0
Derivatives:
Reclassification adjustments recognized in net income	18
Availiable-for-sale securities:
Reclassification adjustments recognized in net income	4
Pension and other benefits liabilities:
Reclassification adjustments recognized in net income	-21
Foreign currency translation adjustments:
Translation adjustment arising in the period	-2,377	-990
Reclassification adjustments recognized in net income	0	-194
Net foreign currency translation adjustment	-2,382	-1,187	-182
Derivatives:
Reclassification adjustments recognized in net income	-32
Net gain (loss) on derivatives	357	151	99
Available-for-sale securities:
Reclassification adjustments recognized in net income	-13
Net change in unrealized gain (loss) on available-for-sale securities	714	-80	178
Pension and other benefits liabilities:
Reclassification adjustments recognized in net income	39
Net change in pension and other benefit liabilities	-1,039	1,066	-668
Amortization of prior service cost (credit)	-19
TOTAL EQUITY ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY
AOCI attributable to the shareowners of The Coca-Cola Company
Foreign currency translation adjustment	-5,226	-2,849
Accumulated derivative net gains (losses)	554	197
Unrealized net gains (losses) on available-for-sale securities	972	258
Adjustments to pension and other benefit liabilities	-2,077	-1,038
Accumulated other comprehensive income (loss)	-5,777	-3,432
CONSOLIDATED NET INCOME	7,098
Total comprehensive income	4,753
Foreign currency translation adjustments:
Net foreign currency translation adjustment	-2,560	-1,240	-219
Derivatives:
Unrealized gains (losses) arising during the year	620	425	77
Reclassification adjustments recognized in net income	-50	-167	82
Net gain (loss) on derivatives	570	258	159
Available-for-sale securities:
Unrealized gains (losses) arising during the year	1,139	-134	248
Reclassification adjustments recognized in net income	-17	12	-6
Net change in unrealized gain (loss) in available-for-sale securities	1,122	-122	242
Pension and other benefit liabilities:
Net pension and other benefits arising during the year	-1,666	1,490	-1,132
Reclassification adjustments recognized in net income	60	198	92
Net change in pension and other benefits liabilities	-1,606	1,688	-1,040
Other comprehensive income (loss) attributable to The Coca-Cola Company	-2,474	584	-858
Foreign currency translation adjustments:
Net foreign currency translation adjustment	183	56	-1
Derivatives:
Unrealized gains (losses) arising during the year	-231	-173	-29
Reclassification adjustments recognized in net income	18	66	-31
Net gain (loss) on derivatives	-213	-107	-60
Availiable-for-sale securities:
Unrealized gains (losses) arising during the year	-412	42	-64
Reclassification adjustments recognized in net income	4	0	0
Net change in unrealized gain (loss) on availiable-for-sale securities	-408	42	-64
Pension and other benefits liabilities:
Net pension and other benefits arising during the year	588	-550	405
Reclassification adjustments recognized in net income	-21	-72	-33
Net change in pension and other benefit liabilities	567	-622	372
Other comprehensive income (loss) attributable to The Coca-Cola Company	129	-631	247
Foreign currency translation adjustments:
Net foreign currency translation adjustment	-2,377	-1,184	-220
Derivatives:
Unrealized gains (losses) arising during the year	389	252	48
Reclassification adjustments recognized in net income	-32	-101	51
Net gain (loss) on derivatives	357	151	99
Available-for-sale securities:
Unrealized gains (losses) arising during the year	727	-92	184
Reclassification adjustments recognized in net income	-13	12	-6
Net change in unrealized gain (loss) on available-for-sale securities	714	-80	178
Pension and other benefits liabilities:
Net pension and other benefits arising during the year	-1,078	940	-727
Reclassification adjustments recognized in net income	39	126	59
Net change in pension and other benefit liabilities	-1,039	1,066	-668
Other comprehensive income (loss) attributable to The Coca-Cola Company	-2,345	-47	-611
Noncontrolling Interest [Member]
AOCI attributable to the shareowners of The Coca-Cola Company
CONSOLIDATED NET INCOME	26
Total comprehensive income	21
Foreign currency translation adjustments:
Net foreign currency translation adjustment	-5
Derivatives:
Net gain (loss) on derivatives	0
Available-for-sale securities:
Net change in unrealized gain (loss) on available-for-sale securities	0
Pension and other benefits liabilities:
Net change in pension and other benefit liabilities	0
Total
AOCI attributable to the shareowners of The Coca-Cola Company
CONSOLIDATED NET INCOME	7,124
Total comprehensive income	4,774
Foreign currency translation adjustments:
Net foreign currency translation adjustment	-2,382
Derivatives:
Net gain (loss) on derivatives	357
Available-for-sale securities:
Net change in unrealized gain (loss) on available-for-sale securities	714
Pension and other benefits liabilities:
Net change in pension and other benefit liabilities	-1,039
Amortization of net actuarial loss
Pension and other benefit liabilities:
Reclassification adjustments recognized in net income	79
Net operating revenues \| Foreign currency contracts
Derivatives:
Reclassification adjustments recognized in net income	-121
Cost of goods sold \| Foreign currency and commodities contracts [Member]
Derivatives:
Reclassification adjustments recognized in net income	-37
Other income (loss) - net \| Foreign currency contracts
Derivatives:
Reclassification adjustments recognized in net income	108
Other income (loss) - net \| Available-for-Sale Securities
Available-for-sale securities:
Reclassification adjustments recognized in net income	-17
Other income (loss) - net \| Insignificant items [Member]
Pension and other benefit liabilities:
Reclassification adjustments recognized in net income	$0

FAIR_VALUE_MEASUREMENTS_Detail

FAIR VALUE MEASUREMENTS (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014
Assets and liabilities measured at fair value on a recurring basis
Net Gains From Investee Transactions, Equity Investment Sales and other gains	$501	$76
Asset Impairment Charges	195
Trading securities	372		409
Available-for-sale securities	4,842		7,879
Level 1
Assets and liabilities measured at fair value on a recurring basis
Trading securities	206		228
Available-for-sale securities	1,453		4,116
Derivatives	17		9
Total assets	1,676		4,353
Derivatives	10		2
Total liabilities	10		2
Level 2
Assets and liabilities measured at fair value on a recurring basis
Trading securities	163		177
Available-for-sale securities	3,281		3,627
Derivatives	822		1,721
Total assets	4,266		5,525
Derivatives	165		558
Total liabilities	165		558
Level 3
Assets and liabilities measured at fair value on a recurring basis
Trading securities	3		4
Available-for-sale securities	108		136
Derivatives	0		0
Total assets	111		140
Derivatives	0		0
Total liabilities	0		0
Netting Adjustment
Assets and liabilities measured at fair value on a recurring basis
Trading securities	0		0
Available-for-sale securities	0		0
Derivatives	-150		-437
Total assets	-150		-437
Derivatives	-151		-437
Total liabilities	-151		-437
Fair Value Measurements
Assets and liabilities measured at fair value on a recurring basis
Trading securities	372		409
Available-for-sale securities	4,842		7,879
Derivatives	689		1,293
Total assets	5,903		9,581
Derivatives	24		123
Total liabilities	24		123
Prepaid expenses and other assets
Assets and liabilities measured at fair value on a recurring basis
Derivatives	129		567
Other assets
Assets and liabilities measured at fair value on a recurring basis
Derivatives	560		726
Accounts payable and accrued expenses
Assets and liabilities measured at fair value on a recurring basis
Derivatives	12		14
Other liabilities
Assets and liabilities measured at fair value on a recurring basis
Derivatives	$12		$109

FAIR_VALUE_MEASUREMENTS_Detail1

FAIR VALUE MEASUREMENTS (Details 2) (USD $)	12 Months Ended			3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2012	Dec. 31, 2014
Assets measured at fair value on a nonrecurring basis
Valuation of shares in equity method investee		$501	$76
Intangible assets		-195
Assets held for sale	-494
Available-for-sale securities	7,879	4,842			7,879
Nonrecurring gain (Loss) fair value adjustment	-544	-170
Level 1
Assets measured at fair value on a nonrecurring basis
Valuation of shares in equity method investee Gain (Loss)	-32
Level 1 \| Coca-Cola FEMSA
Assets measured at fair value on a nonrecurring basis
Valuation of shares in equity method investee		139
Level 3
Assets measured at fair value on a nonrecurring basis
Intangible assets	-18
Philippines Bottling Operations
Assets measured at fair value on a nonrecurring basis
Assets held for sale			-108
Philippines Bottling Operations \| Level 3
Assets measured at fair value on a nonrecurring basis
Assets held for sale		0
CCEJ \| Level 1
Assets measured at fair value on a nonrecurring basis
Exchange of investment in equity securities	0
CCEJ \| Level 1 \| Equity method investments
Assets measured at fair value on a nonrecurring basis
Exchange of investment in equity securities				-114
North America
Assets measured at fair value on a nonrecurring basis
Assets held for sale	-494
Brazilian Bottling Operations
Assets measured at fair value on a nonrecurring basis
Valuation of shares in equity method investee Gain (Loss)	($32)
Percentage of shares sold through options	24.00%				10.00%

FAIR_VALUE_MEASUREMENTS_Detail2

FAIR VALUE MEASUREMENTS (Details 3) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Pension Plans, Defined Benefit [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	$8,902	$8,746	$7,584
Pension Plans, Defined Benefit [Member] \| Cash and cash equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	261	514
Pension Plans, Defined Benefit [Member] \| Equity securities U.S.-based companies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	1,816	1,702
Pension Plans, Defined Benefit [Member] \| Equity securities International-based companies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	1,063	1,284
Pension Plans, Defined Benefit [Member] \| Government bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	866	768
Pension Plans, Defined Benefit [Member] \| Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	1,566	1,506
Pension Plans, Defined Benefit [Member] \| Mutual, pooled and commingled funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	1,263	1,587
Pension Plans, Defined Benefit [Member] \| Hedge funds/limited partnerships
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	799	543
Pension Plans, Defined Benefit [Member] \| Real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	408	251
Pension Plans, Defined Benefit [Member] \| Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	860	591
Other postretirement benefits
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	246	243	202
Other postretirement benefits \| Cash and cash equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	10	10
Other postretirement benefits \| Equity securities U.S.-based companies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	114	112
Other postretirement benefits \| Equity securities International-based companies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	7	8
Other postretirement benefits \| Government bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	79	79
Other postretirement benefits \| Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	9	9
Other postretirement benefits \| Mutual, pooled and commingled funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	16	18
Other postretirement benefits \| Hedge funds/limited partnerships
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	5	3
Other postretirement benefits \| Real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	3	2
Other postretirement benefits \| Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	3	2
Level 1 \| Pension Plans, Defined Benefit [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	3,102	3,338
Level 1 \| Pension Plans, Defined Benefit [Member] \| Cash and cash equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	161	331
Level 1 \| Pension Plans, Defined Benefit [Member] \| Equity securities U.S.-based companies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	1,793	1,680
Level 1 \| Pension Plans, Defined Benefit [Member] \| Equity securities International-based companies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	1,050	1,271
Level 1 \| Pension Plans, Defined Benefit [Member] \| Government bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 1 \| Pension Plans, Defined Benefit [Member] \| Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 1 \| Pension Plans, Defined Benefit [Member] \| Mutual, pooled and commingled funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	98	56
Level 1 \| Pension Plans, Defined Benefit [Member] \| Hedge funds/limited partnerships
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 1 \| Pension Plans, Defined Benefit [Member] \| Real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 1 \| Pension Plans, Defined Benefit [Member] \| Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 1 \| Other postretirement benefits
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	216	207
Level 1 \| Other postretirement benefits \| Cash and cash equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	9	0
Level 1 \| Other postretirement benefits \| Equity securities U.S.-based companies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	114	112
Level 1 \| Other postretirement benefits \| Equity securities International-based companies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	7	8
Level 1 \| Other postretirement benefits \| Government bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	76	76
Level 1 \| Other postretirement benefits \| Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 1 \| Other postretirement benefits \| Mutual, pooled and commingled funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	10	11
Level 1 \| Other postretirement benefits \| Hedge funds/limited partnerships
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 1 \| Other postretirement benefits \| Real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 1 \| Other postretirement benefits \| Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 2 \| Pension Plans, Defined Benefit [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	3,894	4,116
Level 2 \| Pension Plans, Defined Benefit [Member] \| Cash and cash equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	100	183
Level 2 \| Pension Plans, Defined Benefit [Member] \| Equity securities U.S.-based companies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	6	7
Level 2 \| Pension Plans, Defined Benefit [Member] \| Equity securities International-based companies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	13	13
Level 2 \| Pension Plans, Defined Benefit [Member] \| Government bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	863	719
Level 2 \| Pension Plans, Defined Benefit [Member] \| Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	1,533	1,466
Level 2 \| Pension Plans, Defined Benefit [Member] \| Mutual, pooled and commingled funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	1,134	1,531
Level 2 \| Pension Plans, Defined Benefit [Member] \| Hedge funds/limited partnerships
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	215	190
Level 2 \| Pension Plans, Defined Benefit [Member] \| Real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	16	0
Level 2 \| Pension Plans, Defined Benefit [Member] \| Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	14	7
Level 2 \| Other postretirement benefits
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	20	30
Level 2 \| Other postretirement benefits \| Cash and cash equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	1	10
Level 2 \| Other postretirement benefits \| Equity securities U.S.-based companies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 2 \| Other postretirement benefits \| Equity securities International-based companies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 2 \| Other postretirement benefits \| Government bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	3	3
Level 2 \| Other postretirement benefits \| Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	9	9
Level 2 \| Other postretirement benefits \| Mutual, pooled and commingled funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	6	7
Level 2 \| Other postretirement benefits \| Hedge funds/limited partnerships
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	1	1
Level 2 \| Other postretirement benefits \| Real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 2 \| Other postretirement benefits \| Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 3 \| Pension Plans, Defined Benefit [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	1,906	1,292
Reconciliation of the beginning and ending balance of Level 3 assets for U.S. and non-U.S. pension plans
Balance at the beginning of the period	1,292	1,181
Actual return on plan assets:
Related to assets sold during the year	47	28
Related to assets still held at the reporting date	80	42
Purchases, sales and settlements-net	536	279
Transfers in and/or out of Level 3-net	-18	-250
Foreign currency translation	-31	12
Balance at the end of the period	1,906	1,292
Level 3 \| Pension Plans, Defined Benefit [Member] \| Cash and cash equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 3 \| Pension Plans, Defined Benefit [Member] \| Equity securities
Reconciliation of the beginning and ending balance of Level 3 assets for U.S. and non-U.S. pension plans
Balance at the beginning of the period	15	14
Actual return on plan assets:
Related to assets sold during the year	0	0
Related to assets still held at the reporting date	1	0
Purchases, sales and settlements-net	1	1
Transfers in and/or out of Level 3-net	0	0
Foreign currency translation	0	0
Balance at the end of the period	17	15
Level 3 \| Pension Plans, Defined Benefit [Member] \| Equity securities U.S.-based companies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	17	15
Level 3 \| Pension Plans, Defined Benefit [Member] \| Equity securities International-based companies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 3 \| Pension Plans, Defined Benefit [Member] \| Government bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	3	49
Level 3 \| Pension Plans, Defined Benefit [Member] \| Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	33	40
Level 3 \| Pension Plans, Defined Benefit [Member] \| Fixed Income Securities
Reconciliation of the beginning and ending balance of Level 3 assets for U.S. and non-U.S. pension plans
Balance at the beginning of the period	89	0
Actual return on plan assets:
Related to assets sold during the year	-2	-2
Related to assets still held at the reporting date	17	-4
Purchases, sales and settlements-net	-41	95
Transfers in and/or out of Level 3-net	-27	0
Foreign currency translation	0	0
Balance at the end of the period	36	89
Level 3 \| Pension Plans, Defined Benefit [Member] \| Mutual, pooled and commingled funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	31	0
Reconciliation of the beginning and ending balance of Level 3 assets for U.S. and non-U.S. pension plans
Balance at the beginning of the period	0	0
Actual return on plan assets:
Related to assets sold during the year	0	0
Related to assets still held at the reporting date	0	0
Purchases, sales and settlements-net	31	0
Transfers in and/or out of Level 3-net	0	0
Foreign currency translation	0	0
Balance at the end of the period	31	0
Level 3 \| Pension Plans, Defined Benefit [Member] \| Hedge funds/limited partnerships
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	584	353
Reconciliation of the beginning and ending balance of Level 3 assets for U.S. and non-U.S. pension plans
Balance at the beginning of the period	353	400
Actual return on plan assets:
Related to assets sold during the year	42	24
Related to assets still held at the reporting date	-17	-6
Purchases, sales and settlements-net	198	14
Transfers in and/or out of Level 3-net	9	-78
Foreign currency translation	-1	-1
Balance at the end of the period	584	353
Level 3 \| Pension Plans, Defined Benefit [Member] \| Real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	392	251
Reconciliation of the beginning and ending balance of Level 3 assets for U.S. and non-U.S. pension plans
Balance at the beginning of the period	251	257
Actual return on plan assets:
Related to assets sold during the year	7	6
Related to assets still held at the reporting date	29	13
Purchases, sales and settlements-net	106	-24
Transfers in and/or out of Level 3-net	0	0
Foreign currency translation	-1	-1
Balance at the end of the period	392	251
Level 3 \| Pension Plans, Defined Benefit [Member] \| Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	846	584
Reconciliation of the beginning and ending balance of Level 3 assets for U.S. and non-U.S. pension plans
Balance at the beginning of the period	584	510
Actual return on plan assets:
Related to assets sold during the year	0	0
Related to assets still held at the reporting date	50	39
Purchases, sales and settlements-net	241	193
Transfers in and/or out of Level 3-net	0	-172
Foreign currency translation	-29	14
Balance at the end of the period	846	584
Level 3 \| Other postretirement benefits
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	10	6
Level 3 \| Other postretirement benefits \| Cash and cash equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 3 \| Other postretirement benefits \| Equity securities U.S.-based companies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 3 \| Other postretirement benefits \| Equity securities International-based companies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 3 \| Other postretirement benefits \| Government bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 3 \| Other postretirement benefits \| Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 3 \| Other postretirement benefits \| Mutual, pooled and commingled funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	0	0
Level 3 \| Other postretirement benefits \| Hedge funds/limited partnerships
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	4	2
Level 3 \| Other postretirement benefits \| Real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	3	2
Level 3 \| Other postretirement benefits \| Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value of Plan Assets	$3	$2

FAIR_VALUE_MEASUREMENTS_FAIR_V

FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS (Details 4) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term Debt	$22,615	$20,178
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term Debt, Fair Value	$23,411	$20,352

SIGNIFICANT_OPERATING_AND_NONO1

SIGNIFICANT OPERATING AND NONOPERATING ITEMS (Details) (USD $)	12 Months Ended			3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014	Mar. 28, 2014
Other Operating Charges
Other operating charges	$1,183	$895	$447
Unusual or Infrequent Event Charges	352
Write-down of receivables and Trademark impairment		195
Restructuring and transition of the Russian Juice operations	36
Impairment of trademarks		113
Goodwill, Impairment Loss		82
Equity Income (Loss) - Net
Our proportionate share of unusual or infrequent items recorded by our equity method investees	18	159	-8
Other Income (Loss) - Net
Loss on disposal group held for sale	494
Gain (Loss) on Sale of Previously Unissued Stock by Equity Investee		139
Impairment of certain cost method investments			16
Remeasurement Charges on Subsidiary Assets	372
Brazilian Bottling Operations
Other Income (Loss) - Net
Equity Method Investment, Realized Gain (Loss) on Disposal	-32
Gain on sale of investment in subsidiary		615
Percentage of shares sold through options	24.00%			10.00%
Andina and Polar merger
Other Income (Loss) - Net
Net gain or (loss) in exchange of equity securities			185
Philippines Bottling Operations
Other Income (Loss) - Net
Loss on disposal group held for sale			108
Asia Pacific
Other Operating Charges
Productivity, integration and restructuring initiatives	36	26	3
Restructuring and Related Cost, Accelerated Depreciation		22
Goodwill, Impairment Loss		0
North America
Other Operating Charges
Productivity, integration and restructuring initiatives	281	282	227
Goodwill, Impairment Loss		0
Other Income (Loss) - Net
Gain (loss) on North America refranchised territories	-799
Corporate
Other Operating Charges
Write-down of receivables and Trademark impairment		195
Productivity, integration and restructuring initiatives	124	121	38
Other Income (Loss) - Net
Gain (Loss) on Sale of Previously Unissued Stock by Equity Investee		139	92
Premium paid for ownership interest			82
Equity Method Investment, Realized Gain (Loss) on Disposal	-32
Gain on sale of investment in subsidiary		615
Corporate \| Andina and Polar merger
Other Income (Loss) - Net
Net gain or (loss) in exchange of equity securities			185
Corporate \| Philippines Bottling Operations
Other Income (Loss) - Net
Net gain or (loss) in exchange of equity securities			-108
Venezuelan subsidiary
Other Operating Charges
Write-down of receivables and Trademark impairment	314
Other Income (Loss) - Net
Remeasurement Charges on Subsidiary Assets	372	140
Venezuelan subsidiary \| Corporate
Other Income (Loss) - Net
Remeasurement Charges on Subsidiary Assets		140		146	226
CCEJ \| Corporate
Other Income (Loss) - Net
Net gain or (loss) in exchange of equity securities		-114
Coca-Cola FEMSA
Other Income (Loss) - Net
Gain (Loss) on Sale of Previously Unissued Stock by Equity Investee			92
Mikuni [Member]
Other Income (Loss) - Net
Premium paid for ownership interest			82
Productivity and Reinvestment [Member]
Other Operating Charges
Productivity, integration and restructuring initiatives	601	494	270
Integration of German Bottling and Distribution Operation [Member]
Other Operating Charges
Productivity, integration and restructuring initiatives	208	187	148
Restructuring charges other than productivity and productivity and reinvestments initiatives [Member]
Other Operating Charges
Productivity, integration and restructuring initiatives		188	163
Productivity Initiatives
Other Operating Charges
Reversal of restructuring accruals			10
Integration of CCE's North American Operations [Member]
Other Operating Charges
Reversal of restructuring accruals			6
License Agreement with Nestle [Member]
Other Operating Charges
Other operating charges			20
License Agreement with Nestle [Member] \| North America
Other Operating Charges
Other operating charges			20
Brazil Juice Expenses [Member]
Other Operating Charges
Unusual or Infrequent Event Charges			8
BPW Nestle Joint Venture [Member]
Equity Income (Loss) - Net
Our proportionate share of unusual or infrequent items recorded by our equity method investees			11
BPW Nestle Joint Venture [Member] \| Asia Pacific
Equity Income (Loss) - Net
Our proportionate share of unusual or infrequent items recorded by our equity method investees			$4

PRODUCTIVITY_INTEGRATION_AND_R2

PRODUCTIVITY, INTEGRATION AND RESTRUCTURING INITIATIVES (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2007
Integration of German Bottling and Distribution Operation [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date	$835
Number of German bottling and distribution operations for which integration initiatives began in 2008				18
Restructuring Reserve
Accrued balance as of December 31	127
Costs incurred	208	187	148
Accrued balance as of December 31	101	127
Productivity and Reinvestment [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date	1,365
Restructuring Reserve
Accrued balance as of December 31	112	26
Costs incurred	601	494	270
Payments	-402	-381	-230
Noncash and exchange	-26	-27	-14
Accrued balance as of December 31	285	112	26
Productivity and Reinvestment [Member] \| Severance pay and benefits
Restructuring Reserve
Accrued balance as of December 31	88	12
Costs incurred	277	188	21
Payments	-103	-113	-8
Noncash and exchange	-2	1	-1
Accrued balance as of December 31	260	88	12
Productivity and Reinvestment [Member] \| Outside Services [Member]
Restructuring Reserve
Accrued balance as of December 31	6	6
Costs incurred	77	59	61
Payments	-79	-59	-55
Noncash and exchange	0	0	0
Accrued balance as of December 31	4	6	6
Productivity and Reinvestment [Member] \| Other direct costs [Member]
Restructuring Reserve
Accrued balance as of December 31	18	8
Costs incurred	247	247	188
Payments	-220	-209	-167
Noncash and exchange	-24	-28	-13
Accrued balance as of December 31	$21	$18	$8

OPERATING_SEGMENTS_Details

OPERATING SEGMENTS (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Segment Reporting Information [Line Items]
Concentrate operations	38.00%	38.00%	38.00%
Finished products operations	62.00%	62.00%	62.00%
Sales Revenue Net Percentage	100.00%	100.00%	100.00%
Sales Revenue, Goods, Net	$45,998	$46,854	$48,017
Property, Plant and Equipment, Net	14,633	14,967	14,476
United States
Segment Reporting Information [Line Items]
Sales Revenue, Goods, Net	19,763	19,820	19,732
Property, Plant and Equipment, Net	8,683	8,841	8,509
International
Segment Reporting Information [Line Items]
Sales Revenue, Goods, Net	26,235	27,034	28,285
Property, Plant and Equipment, Net	$5,950	$6,126	$5,967

OPERATING_SEGMENTS_Details_2

OPERATING SEGMENTS (Details 2) (USD $)	12 Months Ended			3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014	Mar. 28, 2014
Net operating revenues:
Sales Revenue, Goods, Net	$45,998	$46,854	$48,017
Intersegment Revenue	0	0	0
Revenue for Reportable Segments	45,998	46,854	48,017
Operating Income (Loss)	9,708	10,228	10,779
Interest income	594	534	471
Interest expense	483	463	397
Depreciation and amortization	1,976	1,977	1,982
Equity income (loss) - net	769	602	819
Income (loss) before income taxes	9,325	11,477	11,809
Identifiable operating assets	78,398	78,543	75,726	78,398
Investments	13,625	11,512	10,448	13,625
Capital expenditures	2,406	2,550	2,780
Ratio of net property, plant and equipment in Germany to total consolidated property, plant and equipment - net (as a percent)	10.00%	11.00%	10.00%	10.00%
Other operating charges	1,183	895	447
Restructuring and transition of the Russian Juice operations	36
Asset Impairment Charges		195
Our proportionate share of unusual or infrequent items recorded by our equity method investees	18	159	-8
Remeasurement Charges on Subsidiary Assets	372
Gain (Loss) on Sale of Previously Unissued Stock by Equity Investee		139
Venezuelan subsidiary
Net operating revenues:
Asset Impairment Charges	314
Remeasurement Charges on Subsidiary Assets	372	140
Andina and Polar merger
Net operating revenues:
Net gain or (loss) in exchange of equity securities			185
Eurasia and Africa
Net operating revenues:
Sales Revenue, Goods, Net	2,730	2,763	2,697
Intersegment Revenue	0	0	0
Revenue for Reportable Segments	2,730	2,763	2,697
Operating Income (Loss)	1,084	1,087	1,078
Interest income	0	0	0
Interest expense	0	0	0
Depreciation and amortization	47	42	33
Equity income (loss) - net	35	22	20
Income (loss) before income taxes	1,125	1,109	1,101
Identifiable operating assets	1,298	1,273	1,299	1,298
Investments	1,081	1,157	1,155	1,081
Capital expenditures	30	40	51
Productivity, integration and restructuring initiatives	26	2
Europe
Net operating revenues:
Sales Revenue, Goods, Net	4,844	4,645	4,481
Intersegment Revenue	692	689	642
Revenue for Reportable Segments	5,536	5,334	5,123
Operating Income (Loss)	2,852	2,859	2,960
Interest income	0	0	0
Interest expense	0	0	0
Depreciation and amortization	75	86	100
Equity income (loss) - net	31	24	45
Income (loss) before income taxes	2,892	2,923	3,015
Identifiable operating assets	3,358	3,713	2,976	3,358
Investments	90	106	271	90
Capital expenditures	54	34	30
Productivity, integration and restructuring initiatives	111	57	1
Our proportionate share of unusual or infrequent items recorded by our equity method investees	2
Latin America
Net operating revenues:
Sales Revenue, Goods, Net	4,597	4,748	4,560
Intersegment Revenue	60	191	271
Revenue for Reportable Segments	4,657	4,939	4,831
Operating Income (Loss)	2,316	2,908	2,879
Interest income	0	0	0
Interest expense	0	0	0
Depreciation and amortization	56	58	70
Equity income (loss) - net	10	13	4
Income (loss) before income taxes	2,319	2,920	2,882
Identifiable operating assets	2,426	2,918	2,759	2,426
Investments	757	545	539	757
Capital expenditures	55	63	88
Productivity, integration and restructuring initiatives	20
Gain (charges) related to subsidiary	-275
North America
Net operating revenues:
Sales Revenue, Goods, Net	21,462	21,574	21,665
Intersegment Revenue	17	16	15
Revenue for Reportable Segments	21,479	21,590	21,680
Operating Income (Loss)	2,447	2,432	2,597
Interest income	0	0	0
Interest expense	0	0	0
Depreciation and amortization	1,195	1,192	1,083
Equity income (loss) - net	-16	2	13
Income (loss) before income taxes	1,633	2,434	2,624
Identifiable operating assets	33,066	33,964	34,114	33,066
Investments	48	49	39	48
Capital expenditures	1,293	1,374	1,447
Productivity, integration and restructuring initiatives	281	282	227
Gain (loss) on North America refranchised territories	-799
Asia Pacific
Net operating revenues:
Sales Revenue, Goods, Net	5,257	5,372	5,680
Intersegment Revenue	489	497	628
Revenue for Reportable Segments	5,746	5,869	6,308
Operating Income (Loss)	2,448	2,478	2,516
Interest income	0	0	0
Interest expense	0	0	0
Depreciation and amortization	96	130	119
Equity income (loss) - net	12	19	2
Income (loss) before income taxes	2,464	2,494	2,523
Identifiable operating assets	1,793	1,922	2,163	1,793
Investments	157	143	127	157
Capital expenditures	76	117	107
Productivity, integration and restructuring initiatives	36	26	3
Restructuring and Related Cost, Accelerated Depreciation		22
Bottling Investments
Net operating revenues:
Sales Revenue, Goods, Net	6,972	7,598	8,807
Intersegment Revenue	67	78	88
Revenue for Reportable Segments	7,039	7,676	8,895
Operating Income (Loss)	9	115	140
Interest income	0	0	0
Interest expense	0	0	0
Depreciation and amortization	315	335	406
Equity income (loss) - net	691	524	732
Income (loss) before income taxes	715	679	904
Identifiable operating assets	6,975	7,011	9,648	6,975
Investments	8,781	9,424	8,253	8,781
Capital expenditures	628	643	867
Productivity, integration and restructuring initiatives	211	194	164
Restructuring and transition of the Russian Juice operations	42
Our proportionate share of unusual or infrequent items recorded by our equity method investees	16	159	-8
Gain (charges) related to subsidiary	25
Bottling Investments \| Venezuelan subsidiary
Net operating revenues:
Our proportionate share of unusual or infrequent items recorded by our equity method investees		9
Corporate
Net operating revenues:
Sales Revenue, Goods, Net	136	154	127
Intersegment Revenue	0	0	0
Revenue for Reportable Segments	136	154	127
Operating Income (Loss)	-1,448	-1,651	-1,391
Interest income	594	534	471
Interest expense	483	463	397
Depreciation and amortization	192	134	171
Equity income (loss) - net	6	-2	3
Income (loss) before income taxes	-1,823	-1,082	-1,240
Identifiable operating assets	29,482	27,742	22,767	29,482
Investments	2,711	88	64	2,711
Capital expenditures	270	279	190
Productivity, integration and restructuring initiatives	124	121	38
Asset Impairment Charges		195
Gains (Losses) on Extinguishment of Debt		-53
Cost method investments, other-than-temporary decline in fair value			16
Gain (charges) related to subsidiary	-411
Gain (Loss) on Sale of Previously Unissued Stock by Equity Investee		139	92
Premium paid for ownership interest			82
Gain on sale of investment in subsidiary		615
Equity Method Investment, Realized Gain (Loss) on Disposal	-32
Corporate \| Venezuelan subsidiary
Net operating revenues:
Remeasurement Charges on Subsidiary Assets		140		146	226
Corporate \| Andina and Polar merger
Net operating revenues:
Net gain or (loss) in exchange of equity securities			185
Corporate \| Philippines Bottling Operations
Net operating revenues:
Net gain or (loss) in exchange of equity securities			-108
Eliminations
Net operating revenues:
Sales Revenue, Goods, Net	0	0	0
Intersegment Revenue	-1,325	-1,471	-1,644
Revenue for Reportable Segments	-1,325	-1,471	-1,644
Operating Income (Loss)	0	0	0
Interest income	0	0	0
Interest expense	0	0	0
Depreciation and amortization	0	0	0
Equity income (loss) - net	0	0	0
Income (loss) before income taxes	0	0	0
Identifiable operating assets	0	0	0	0
Investments	0	0	0	0
Capital expenditures	0	0	0
License Agreement with Nestle [Member]
Net operating revenues:
Other operating charges			20
License Agreement with Nestle [Member] \| North America
Net operating revenues:
Other operating charges			20
BPW Nestle Joint Venture [Member]
Net operating revenues:
Our proportionate share of unusual or infrequent items recorded by our equity method investees			11
BPW Nestle Joint Venture [Member] \| Eurasia and Africa
Net operating revenues:
Our proportionate share of unusual or infrequent items recorded by our equity method investees			1
BPW Nestle Joint Venture [Member] \| Europe
Net operating revenues:
Our proportionate share of unusual or infrequent items recorded by our equity method investees			4
BPW Nestle Joint Venture [Member] \| Latin America
Net operating revenues:
Our proportionate share of unusual or infrequent items recorded by our equity method investees			2
BPW Nestle Joint Venture [Member] \| Asia Pacific
Net operating revenues:
Our proportionate share of unusual or infrequent items recorded by our equity method investees			4
Other operating charges [Member] \| Brazil Juice Expenses [Member] \| North America
Net operating revenues:
Other operating charges			21
CCEJ \| Corporate
Net operating revenues:
Net gain or (loss) in exchange of equity securities		($114)

NET_CHANGE_IN_OPERATING_ASSETS2

NET CHANGE IN OPERATING ASSETS AND LIABILITIES (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Net change in operating assets and liabilities
(Increase) decrease in trade accounts receivable	($253)	$28	($33)
(Increase) decrease in inventories	35	-105	-286
(Increase) decrease in prepaid expenses and other assets	194	-163	-29
Increase (decrease) in accounts payable and accrued expenses	-250	-158	-556
Increase (decrease) in accrued taxes	151	22	770
Increase (decrease) in other liabilities	-316	-556	-946
Net change in operating assets and liabilities	($439)	($932)	($1,080)